PARADIGM pathway analysis of mRNASeq expression data
Breast Invasive Carcinoma (Primary solid tumor)
21 August 2015  |  analyses__2015_08_21
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2015): PARADIGM pathway analysis of mRNASeq expression data. Broad Institute of MIT and Harvard. doi:10.7908/C16972QX
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 55 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Class IB PI3K non-lipid kinase events 309
Signaling events mediated by Stem cell factor receptor (c-Kit) 291
Signaling mediated by p38-alpha and p38-beta 249
EGFR-dependent Endothelin signaling events 248
Reelin signaling pathway 231
HIF-1-alpha transcription factor network 207
FOXA2 and FOXA3 transcription factor networks 164
Glucocorticoid receptor regulatory network 164
Angiopoietin receptor Tie2-mediated signaling 163
p75(NTR)-mediated signaling 158
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 1093 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 1093 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Class IB PI3K non-lipid kinase events 0.2827 309 927 3 -0.22 -1000 1000 -1000 -0.021 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.2662 291 22714 78 -0.61 0.19 1000 -1000 -0.064 -1000
Signaling mediated by p38-alpha and p38-beta 0.2278 249 10957 44 -0.4 0 1000 -1000 -0.046 -1000
EGFR-dependent Endothelin signaling events 0.2269 248 5222 21 -0.33 0 1000 -1000 -0.065 -1000
Reelin signaling pathway 0.2113 231 12956 56 -0.47 0 1000 -1000 -0.087 -1000
HIF-1-alpha transcription factor network 0.1894 207 15744 76 -0.75 0.019 1000 -1000 -0.081 -1000
FOXA2 and FOXA3 transcription factor networks 0.1500 164 7568 46 -1.2 0.023 1000 -1000 -0.041 -1000
Glucocorticoid receptor regulatory network 0.1500 164 18722 114 -0.92 0.34 1000 -1000 -0.073 -1000
Angiopoietin receptor Tie2-mediated signaling 0.1491 163 14430 88 -0.38 0.04 1000 -1000 -0.091 -1000
p75(NTR)-mediated signaling 0.1446 158 19789 125 -0.37 0 1000 -1000 -0.089 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.1446 158 10810 68 -0.5 0.15 1000 -1000 -0.099 -1000
FOXM1 transcription factor network 0.1409 154 7875 51 -0.44 0.014 1000 -1000 -0.13 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.1382 151 8163 54 -0.47 0.022 1000 -1000 -0.085 -1000
IL4-mediated signaling events 0.1336 146 13326 91 -0.98 0.51 1000 -1000 -0.13 -1000
Arf6 signaling events 0.1299 142 8818 62 -0.33 0.017 1000 -1000 -0.051 -1000
Wnt signaling 0.1272 139 978 7 -0.17 -0.007 1000 -1000 -0.042 -1000
Aurora B signaling 0.1263 138 9266 67 -0.31 0.009 1000 -1000 -0.063 -1000
Endothelins 0.1180 129 12434 96 -0.37 0.038 1000 -1000 -0.069 -1000
ErbB2/ErbB3 signaling events 0.1162 127 8296 65 -0.38 0.018 1000 -1000 -0.063 -1000
Ephrin B reverse signaling 0.1125 123 5906 48 -0.3 0.17 1000 -1000 -0.073 -1000
EPHB forward signaling 0.1125 123 10493 85 -0.3 0.16 1000 -1000 -0.091 -1000
IGF1 pathway 0.1080 118 6757 57 -0.18 0.08 1000 -1000 -0.088 -1000
ErbB4 signaling events 0.1043 114 7882 69 -0.41 0.056 1000 -1000 -0.068 -1000
Calcium signaling in the CD4+ TCR pathway 0.0979 107 3332 31 -0.32 0.012 1000 -1000 -0.085 -1000
Signaling events regulated by Ret tyrosine kinase 0.0970 106 8752 82 -0.17 0 1000 -1000 -0.079 -1000
BMP receptor signaling 0.0961 105 8508 81 -0.54 0.026 1000 -1000 -0.079 -1000
IL23-mediated signaling events 0.0961 105 6304 60 -0.46 0.018 1000 -1000 -0.12 -1000
Syndecan-1-mediated signaling events 0.0933 102 3495 34 -0.22 0 1000 -1000 -0.061 -1000
Noncanonical Wnt signaling pathway 0.0933 102 2668 26 -0.17 0 1000 -1000 -0.066 -1000
Nongenotropic Androgen signaling 0.0933 102 5338 52 -0.23 0.11 1000 -1000 -0.059 -1000
Glypican 1 network 0.0897 98 4720 48 -0.32 0.032 1000 -1000 -0.045 -1000
IL6-mediated signaling events 0.0869 95 7126 75 -0.28 0.05 1000 -1000 -0.075 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0869 95 11453 120 -0.58 0.24 1000 -1000 -0.075 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0851 93 7914 85 -0.24 0.011 1000 -1000 -0.072 -1000
Aurora C signaling 0.0851 93 655 7 -0.17 0 1000 -1000 -0.036 -1000
Integrins in angiogenesis 0.0842 92 7774 84 -0.33 0 1000 -1000 -0.083 -1000
Plasma membrane estrogen receptor signaling 0.0842 92 7967 86 -0.19 0.094 1000 -1000 -0.074 -1000
Signaling events mediated by PTP1B 0.0814 89 6821 76 -0.64 0.071 1000 -1000 -0.077 -1000
amb2 Integrin signaling 0.0814 89 7318 82 -0.48 0 1000 -1000 -0.07 -1000
Visual signal transduction: Rods 0.0778 85 4458 52 -0.48 0 1000 -1000 -0.081 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0732 80 2731 34 -0.096 0 1000 -1000 -0.062 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.0686 75 3905 52 -0.19 0.029 1000 -1000 -0.057 -1000
Ephrin A reverse signaling 0.0677 74 522 7 -0.074 0 1000 -1000 -0.029 -1000
S1P1 pathway 0.0668 73 2639 36 -0.33 0.008 1000 -1000 -0.061 -1000
Syndecan-3-mediated signaling events 0.0668 73 2577 35 -0.34 0 1000 -1000 -0.064 -1000
Signaling events mediated by the Hedgehog family 0.0631 69 3606 52 -0.22 0.032 1000 -1000 -0.07 -1000
PDGFR-alpha signaling pathway 0.0631 69 3041 44 -0.36 0.019 1000 -1000 -0.051 -1000
E-cadherin signaling in keratinocytes 0.0631 69 2976 43 -0.29 0.04 1000 -1000 -0.065 -1000
LPA receptor mediated events 0.0604 66 6750 102 -0.29 0.028 1000 -1000 -0.08 -1000
Fc-epsilon receptor I signaling in mast cells 0.0576 63 6137 97 -0.24 0.028 1000 -1000 -0.082 -1000
Visual signal transduction: Cones 0.0540 59 2277 38 -0.17 0.011 1000 -1000 -0.06 -1000
Ras signaling in the CD4+ TCR pathway 0.0522 57 981 17 -0.12 -0.001 1000 -1000 -0.055 -1000
Nectin adhesion pathway 0.0512 56 3565 63 -0.087 0.001 1000 -1000 -0.069 -1000
PLK1 signaling events 0.0503 55 4676 85 -0.22 0.029 1000 -1000 -0.048 -1000
Rapid glucocorticoid signaling 0.0503 55 1104 20 -0.19 0.027 1000 -1000 -0.033 -1000
Glypican 2 network 0.0494 54 217 4 -0.038 -0.032 1000 -1000 -0.031 -1000
FAS signaling pathway (CD95) 0.0485 53 2494 47 -0.47 0.013 1000 -1000 -0.045 -1000
Signaling events mediated by PRL 0.0485 53 1827 34 -0.17 0.021 1000 -1000 -0.061 -1000
Presenilin action in Notch and Wnt signaling 0.0476 52 3186 61 -0.41 0.014 1000 -1000 -0.072 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0476 52 1732 33 -0.54 0 1000 -1000 -0.055 -1000
Signaling events mediated by HDAC Class III 0.0467 51 2049 40 -0.56 0.022 1000 -1000 -0.046 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0467 51 3842 74 -0.29 0.072 1000 -1000 -0.08 -1000
TCGA08_rtk_signaling 0.0457 50 1306 26 -0.29 0.027 1000 -1000 -0.032 -1000
LPA4-mediated signaling events 0.0448 49 589 12 -0.16 0.02 1000 -1000 -0.019 -1000
Effects of Botulinum toxin 0.0439 48 1257 26 -0.099 0.001 1000 -1000 -0.061 -1000
Syndecan-4-mediated signaling events 0.0439 48 3234 67 -0.32 0.005 1000 -1000 -0.077 -1000
IL27-mediated signaling events 0.0403 44 2263 51 -0.29 0.035 1000 -1000 -0.067 -1000
Canonical Wnt signaling pathway 0.0393 43 2198 51 -0.41 0.14 1000 -1000 -0.048 -1000
IL12-mediated signaling events 0.0384 42 3699 87 -0.35 0.047 1000 -1000 -0.1 -1000
TCR signaling in naïve CD8+ T cells 0.0384 42 3983 93 -0.16 0.077 1000 -1000 -0.068 -1000
Coregulation of Androgen receptor activity 0.0366 40 3084 76 -0.17 0.034 1000 -1000 -0.047 -1000
Insulin Pathway 0.0366 40 3019 74 -0.2 0.033 1000 -1000 -0.082 -1000
Regulation of Androgen receptor activity 0.0357 39 2792 70 -0.25 0.021 1000 -1000 -0.073 -1000
Regulation of nuclear SMAD2/3 signaling 0.0339 37 5046 136 -0.3 0.052 1000 -1000 -0.076 -1000
Regulation of Telomerase 0.0320 35 3657 102 -0.33 0.026 1000 -1000 -0.09 -1000
Syndecan-2-mediated signaling events 0.0311 34 2383 69 -0.2 0.033 1000 -1000 -0.06 -1000
TCGA08_retinoblastoma 0.0311 34 277 8 -0.052 0.01 1000 -1000 -0.023 -1000
IL2 signaling events mediated by STAT5 0.0302 33 737 22 -0.11 0.063 1000 -1000 -0.044 -1000
BCR signaling pathway 0.0302 33 3307 99 -0.13 0.042 1000 -1000 -0.079 -1000
Thromboxane A2 receptor signaling 0.0293 32 3405 105 -0.29 0.066 1000 -1000 -0.062 -1000
Regulation of p38-alpha and p38-beta 0.0293 32 1780 54 -0.35 0.029 1000 -1000 -0.07 -1000
Aurora A signaling 0.0265 29 1754 60 -0.21 0.006 1000 -1000 -0.057 -1000
Arf6 trafficking events 0.0265 29 2092 71 -0.44 0.032 1000 -1000 -0.061 -1000
Osteopontin-mediated events 0.0247 27 1051 38 -0.24 0.022 1000 -1000 -0.097 -1000
TCGA08_p53 0.0238 26 188 7 -0.025 0.017 1000 -1000 -0.022 -1000
BARD1 signaling events 0.0192 21 1243 57 -0.11 0.024 1000 -1000 -0.064 -1000
Hedgehog signaling events mediated by Gli proteins 0.0183 20 1355 65 -0.067 0.044 1000 -1000 -0.059 -1000
Class I PI3K signaling events mediated by Akt 0.0174 19 1311 68 -0.25 0.053 1000 -1000 -0.074 -1000
Ceramide signaling pathway 0.0174 19 1488 76 -0.18 0.049 1000 -1000 -0.055 -1000
TRAIL signaling pathway 0.0174 19 949 48 -0.075 0.044 1000 -1000 -0.056 -1000
Caspase cascade in apoptosis 0.0165 18 1386 74 -0.046 0.045 1000 -1000 -0.052 -1000
Cellular roles of Anthrax toxin 0.0165 18 707 39 -0.14 0.019 1000 -1000 -0.03 -1000
Retinoic acid receptors-mediated signaling 0.0165 18 1074 58 -0.1 0.037 1000 -1000 -0.057 -1000
IL2 signaling events mediated by PI3K 0.0156 17 1026 58 -0.044 0.06 1000 -1000 -0.068 -1000
E-cadherin signaling events 0.0156 17 87 5 -0.02 0 1000 -1000 -0.035 -1000
Signaling mediated by p38-gamma and p38-delta 0.0146 16 244 15 -0.018 0.022 1000 -1000 -0.056 -1000
PLK2 and PLK4 events 0.0137 15 47 3 -0.012 0.013 1000 -1000 -0.024 -1000
JNK signaling in the CD4+ TCR pathway 0.0137 15 261 17 -0.019 0.043 1000 -1000 -0.059 -1000
IL1-mediated signaling events 0.0128 14 876 62 -0.037 0.031 1000 -1000 -0.094 -1000
mTOR signaling pathway 0.0119 13 702 53 -0.021 0.025 1000 -1000 -0.056 -1000
S1P4 pathway 0.0119 13 330 25 -0.045 0.008 1000 -1000 -0.052 -1000
S1P5 pathway 0.0110 12 210 17 -0.045 0.024 1000 -1000 -0.052 -1000
E-cadherin signaling in the nascent adherens junction 0.0110 12 933 76 -0.02 0.05 1000 -1000 -0.078 -1000
S1P3 pathway 0.0110 12 541 42 -0.033 0.021 1000 -1000 -0.06 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0101 11 1380 125 -0.17 0.082 1000 -1000 -0.087 -1000
p38 MAPK signaling pathway 0.0101 11 519 44 -0.066 0.025 1000 -1000 -0.062 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0091 10 398 37 -0.047 0.034 1000 -1000 -0.074 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0091 10 837 83 -0.038 0.053 1000 -1000 -0.072 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0082 9 279 28 -0.045 0.02 1000 -1000 -0.051 -1000
a4b1 and a4b7 Integrin signaling 0.0082 9 48 5 -0.009 -0.002 1000 -1000 -0.038 -1000
Signaling events mediated by HDAC Class II 0.0073 8 619 75 -0.15 0 1000 -1000 -0.058 -1000
IFN-gamma pathway 0.0073 8 604 68 -0.066 0.075 1000 -1000 -0.081 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0073 8 375 45 -0.025 0.072 1000 -1000 -0.08 -1000
EPO signaling pathway 0.0064 7 396 55 -0.036 0.058 1000 -1000 -0.086 -1000
Class I PI3K signaling events 0.0064 7 582 73 -0.044 0.059 1000 -1000 -0.066 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0055 6 148 23 -0.029 0.041 1000 -1000 -0.066 -1000
HIF-2-alpha transcription factor network 0.0055 6 299 43 -0.17 0.18 1000 -1000 -0.069 -1000
VEGFR1 specific signals 0.0055 6 390 56 -0.17 0.065 1000 -1000 -0.087 -1000
Circadian rhythm pathway 0.0046 5 111 22 -0.015 0.042 1000 -1000 -0.054 -1000
Signaling events mediated by HDAC Class I 0.0046 5 530 104 -0.095 0.046 1000 -1000 -0.064 -1000
FoxO family signaling 0.0046 5 348 64 -0.038 0.09 1000 -1000 -0.072 -1000
Atypical NF-kappaB pathway 0.0046 5 184 31 -0.02 0.03 1000 -1000 -0.054 -1000
PDGFR-beta signaling pathway 0.0046 5 577 97 -0.026 0.05 1000 -1000 -0.086 -1000
Canonical NF-kappaB pathway 0.0037 4 173 39 -0.021 0.077 1000 -1000 -0.067 -1000
ceramide signaling pathway 0.0037 4 237 49 -0.027 0.054 1000 -1000 -0.042 -1000
Paxillin-dependent events mediated by a4b1 0.0037 4 144 36 -0.011 0.022 1000 -1000 -0.068 -1000
Arf6 downstream pathway 0.0027 3 142 43 -0.023 0.023 1000 -1000 -0.038 -1000
Insulin-mediated glucose transport 0.0018 2 82 32 -0.13 0.032 1000 -1000 -0.057 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0000 0 9 27 -0.001 0.029 1000 -1000 -0.053 -1000
Arf1 pathway 0.0000 0 25 54 -0.001 0.025 1000 -1000 -0.044 -1000
Alternative NF-kappaB pathway 0.0000 0 11 13 -0.003 0 1000 -1000 -0.059 -1000
Total NA 8287 484788 7203 -30 -990 131000 -131000 -8.5 -131000
Class IB PI3K non-lipid kinase events

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process 0.22 0.35 0.78 309 -10000 0 309
PI3K Class IB/PDE3B -0.22 0.35 -10000 0 -0.79 309 309
PDE3B -0.22 0.36 -10000 0 -0.79 309 309
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.16 0.22 -10000 0 -0.39 499 499
CRKL -0.17 0.23 -10000 0 -0.41 498 498
HRAS -0.16 0.17 -10000 0 -0.49 46 46
mol:PIP3 -0.17 0.21 -10000 0 -0.4 501 501
SPRED1 0 0 -10000 0 -10000 0 0
SPRED2 0 0 -10000 0 -10000 0 0
GAB1 -0.18 0.24 -10000 0 -0.44 500 500
FOXO3 -0.15 0.21 -10000 0 -0.37 498 498
AKT1 -0.16 0.22 -10000 0 -0.41 499 499
BAD -0.15 0.21 -10000 0 -0.37 498 498
megakaryocyte differentiation -0.18 0.23 -10000 0 -0.43 500 500
GSK3B -0.15 0.21 -10000 0 -0.37 498 498
RAF1 -0.092 0.17 -10000 0 -0.44 28 28
SHC1 0 0 -10000 0 -10000 0 0
STAT3 -0.18 0.24 -10000 0 -0.44 500 500
STAT1 -0.45 0.56 -10000 0 -1 510 510
HRAS/SPRED1 -0.13 0.14 -10000 0 -0.39 44 44
cell proliferation -0.18 0.24 -10000 0 -0.44 501 501
PIK3CA 0 0.009 -10000 0 -0.29 1 1
TEC -0.002 0.041 -10000 0 -0.79 3 3
RPS6KB1 -0.18 0.24 -10000 0 -0.44 502 502
HRAS/SPRED2 -0.13 0.14 -10000 0 -0.39 44 44
LYN/TEC/p62DOK -0.19 0.2 -10000 0 -0.4 500 500
MAPK3 -0.054 0.13 -10000 0 -0.32 21 21
STAP1 -0.2 0.24 -10000 0 -0.45 502 502
GRAP2 -0.014 0.1 -10000 0 -0.72 21 21
JAK2 -0.4 0.44 -10000 0 -0.87 510 510
STAT1 (dimer) -0.44 0.54 -10000 0 -1 510 510
mol:Gleevec 0.006 0.009 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.19 0.2 -10000 0 -0.41 500 500
actin filament polymerization -0.18 0.24 -10000 0 -0.44 500 500
LYN 0 0 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.27 0.33 -10000 0 -0.62 506 506
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
CBL/CRKL/GRB2 -0.17 0.18 -10000 0 -0.36 496 496
PI3K -0.19 0.21 -10000 0 -0.41 504 504
PTEN -0.001 0.034 -10000 0 -0.79 2 2
SCF/KIT/EPO/EPOR -0.56 0.69 -10000 0 -1.3 498 498
MAPK8 -0.19 0.24 -10000 0 -0.45 501 501
STAT3 (dimer) -0.18 0.23 -10000 0 -0.43 500 500
positive regulation of transcription -0.041 0.11 -10000 0 -0.25 21 21
mol:GDP -0.17 0.18 -10000 0 -0.49 58 58
PIK3C2B -0.18 0.24 -10000 0 -0.44 500 500
CBL/CRKL -0.15 0.22 -10000 0 -0.38 498 498
FER -0.19 0.24 -10000 0 -0.44 505 505
SH2B3 -0.18 0.24 -10000 0 -0.44 500 500
PDPK1 -0.15 0.2 -10000 0 -0.36 500 500
SNAI2 -0.19 0.25 -10000 0 -0.45 502 502
positive regulation of cell proliferation -0.32 0.4 -10000 0 -0.75 512 512
KITLG 0.002 0.067 -10000 0 -0.48 16 16
cell motility -0.32 0.4 -10000 0 -0.75 512 512
PTPN6 0.015 0.021 -10000 0 -0.29 2 2
EPOR -0.096 0.16 -10000 0 -10000 0 0
STAT5A (dimer) -0.26 0.34 -10000 0 -0.62 512 512
SOCS1 -0.005 0.043 -10000 0 -0.79 1 1
cell migration 0.19 0.24 0.44 508 -10000 0 508
SOS1 0 0 -10000 0 -10000 0 0
EPO -0.044 0.11 -10000 0 -0.3 177 177
VAV1 -0.003 0.043 -10000 0 -0.59 5 5
GRB10 -0.18 0.24 -10000 0 -0.44 500 500
PTPN11 0.013 0.013 -10000 0 -10000 0 0
SCF/KIT -0.22 0.23 -10000 0 -0.46 512 512
GO:0007205 0.009 0.013 -10000 0 -10000 0 0
MAP2K1 -0.064 0.14 -10000 0 -0.35 21 21
CBL 0 0 -10000 0 -10000 0 0
KIT -0.61 0.73 -10000 0 -1.4 496 496
MAP2K2 -0.064 0.14 -10000 0 -0.35 21 21
SHC/Grb2/SOS1 -0.19 0.2 -10000 0 -0.4 498 498
STAT5A -0.27 0.35 -10000 0 -0.64 512 512
GRB2 0 0.009 -10000 0 -0.29 1 1
response to radiation -0.18 0.24 -10000 0 -0.44 502 502
SHC/GRAP2 -0.01 0.077 -10000 0 -0.6 18 18
PTPRO -0.18 0.24 -10000 0 -0.44 500 500
SH2B2 -0.19 0.24 -10000 0 -0.44 500 500
DOK1 -0.001 0.018 -10000 0 -0.29 4 4
MATK -0.19 0.25 -10000 0 -0.45 508 508
CREBBP 0.02 0.018 -10000 0 -10000 0 0
BCL2 -0.13 0.3 -10000 0 -1.5 37 37
Signaling mediated by p38-alpha and p38-beta

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.4 0.62 -9999 0 -1.3 369 369
MKNK1 0 0 -9999 0 -10000 0 0
MAPK14 -0.081 0.15 -9999 0 -0.29 369 369
ATF2/c-Jun -0.052 0.15 -9999 0 -0.78 14 14
MAPK11 -0.083 0.16 -9999 0 -0.3 372 372
MITF -0.092 0.2 -9999 0 -0.36 377 377
MAPKAPK5 -0.088 0.19 -9999 0 -0.35 372 372
KRT8 -0.095 0.2 -9999 0 -0.36 373 373
MAPKAPK3 0 0 -9999 0 -10000 0 0
MAPKAPK2 0 0.009 -9999 0 -0.29 1 1
p38alpha-beta/CK2 -0.12 0.23 -9999 0 -0.44 372 372
CEBPB -0.088 0.19 -9999 0 -0.35 372 372
SLC9A1 -0.088 0.19 -9999 0 -0.35 372 372
mol:GDP 0 0 -9999 0 -10000 0 0
ATF2 -0.082 0.19 -9999 0 -0.34 374 374
p38alpha-beta/MNK1 -0.12 0.17 -9999 0 -0.35 372 372
JUN -0.051 0.15 -9999 0 -0.77 14 14
PPARGC1A -0.21 0.36 -9999 0 -0.57 452 452
USF1 -0.088 0.19 -9999 0 -0.35 372 372
RAB5/GDP/GDI1 -0.085 0.12 -9999 0 -0.38 16 16
NOS2 -0.092 0.21 -9999 0 -0.87 16 16
DDIT3 -0.088 0.19 -9999 0 -0.35 372 372
RAB5A 0 0 -9999 0 -10000 0 0
HSPB1 -0.074 0.17 -9999 0 -0.43 54 54
p38alpha-beta/HBP1 -0.12 0.17 -9999 0 -0.52 19 19
CREB1 -0.093 0.2 -9999 0 -0.37 372 372
RAB5/GDP 0 0 -9999 0 -10000 0 0
EIF4E -0.069 0.17 -9999 0 -0.49 16 16
RPS6KA4 -0.088 0.19 -9999 0 -0.35 372 372
PLA2G4A -0.13 0.27 -9999 0 -0.72 141 141
GDI1 -0.088 0.19 -9999 0 -0.35 372 372
TP53 -0.11 0.23 -9999 0 -0.44 372 372
RPS6KA5 -0.095 0.2 -9999 0 -0.36 381 381
ESR1 -0.17 0.25 -9999 0 -0.42 506 506
HBP1 0 0 -9999 0 -10000 0 0
MEF2C -0.09 0.2 -9999 0 -0.35 372 372
MEF2A -0.089 0.19 -9999 0 -0.35 372 372
EIF4EBP1 -0.093 0.2 -9999 0 -0.37 372 372
KRT19 -0.1 0.21 -9999 0 -0.37 377 377
ELK4 -0.088 0.19 -9999 0 -0.35 372 372
ATF6 -0.088 0.19 -9999 0 -0.35 372 372
ATF1 -0.093 0.2 -9999 0 -0.37 372 372
p38alpha-beta/MAPKAPK2 -0.12 0.17 -9999 0 -0.52 20 20
p38alpha-beta/MAPKAPK3 -0.12 0.17 -9999 0 -0.35 372 372
EGFR-dependent Endothelin signaling events

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS -0.003 0.028 -9999 0 -10000 0 0
EGFR -0.29 0.38 -9999 0 -0.78 410 410
EGF/EGFR -0.28 0.3 -9999 0 -0.53 563 563
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.25 0.26 -9999 0 -0.49 552 552
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA -0.002 0.035 -9999 0 -0.62 3 3
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.15 0.31 -9999 0 -0.78 214 214
EGF/EGFR dimer/SHC -0.29 0.3 -9999 0 -0.57 552 552
mol:GDP -0.24 0.26 -9999 0 -0.48 552 552
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 -0.059 0.21 -9999 0 -0.78 83 83
GRB2/SOS1 0 0.006 -9999 0 -10000 0 0
HRAS/GTP -0.23 0.24 -9999 0 -0.45 552 552
SHC1 0 0 -9999 0 -10000 0 0
HRAS/GDP -0.23 0.24 -9999 0 -0.45 552 552
FRAP1 -0.24 0.25 -9999 0 -0.46 552 552
EGF/EGFR dimer -0.33 0.35 -9999 0 -0.66 552 552
SOS1 0 0 -9999 0 -10000 0 0
GRB2 0 0.009 -9999 0 -0.29 1 1
ETA receptor/Endothelin-1 -0.046 0.16 -9999 0 -0.6 84 84
Reelin signaling pathway

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 -0.006 0.034 -9999 0 -10000 0 0
VLDLR -0.025 0.14 -9999 0 -0.79 35 35
CRKL 0 0 -9999 0 -10000 0 0
LRPAP1 0 0 -9999 0 -10000 0 0
FYN -0.001 0.034 -9999 0 -0.79 2 2
ITGA3 -0.004 0.05 -9999 0 -0.57 7 7
RELN/VLDLR/Fyn -0.32 0.27 -9999 0 -0.54 660 660
MAPK8IP1/MKK7/MAP3K11/JNK1 -0.005 0.046 -9999 0 -0.44 12 12
AKT1 -0.18 0.18 -9999 0 -0.36 230 230
MAP2K7 0 0 -9999 0 -10000 0 0
RAPGEF1 0 0 -9999 0 -10000 0 0
DAB1 -0.017 0.069 -9999 0 -0.29 65 65
RELN/LRP8/DAB1 -0.31 0.24 -9999 0 -0.5 652 652
LRPAP1/LRP8 -0.019 0.057 -9999 0 -10000 0 0
RELN/LRP8/DAB1/Fyn -0.29 0.23 -9999 0 -0.47 652 652
DAB1/alpha3/beta1 Integrin -0.27 0.22 -9999 0 -0.58 147 147
long-term memory -0.35 0.29 -9999 0 -0.53 706 706
DAB1/LIS1 -0.28 0.23 -9999 0 -0.45 660 660
DAB1/CRLK/C3G -0.27 0.22 -9999 0 -0.49 277 277
PIK3CA 0 0.009 -9999 0 -0.29 1 1
DAB1/NCK2 -0.28 0.23 -9999 0 -0.46 660 660
ARHGEF2 0 0 -9999 0 -10000 0 0
mol:Src family inhibitors PP1 and PP2 0 0 -9999 0 -10000 0 0
GRIN2A -0.091 0.25 -9999 0 -0.74 135 135
CDK5R1 -0.008 0.049 -9999 0 -0.29 31 31
RELN -0.47 0.39 -9999 0 -0.78 654 654
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
RELN/LRP8/Fyn -0.32 0.26 -9999 0 -0.53 652 652
GRIN2A/RELN/LRP8/DAB1/Fyn -0.33 0.29 -9999 0 -0.53 672 672
MAPK8 -0.006 0.071 -9999 0 -0.79 9 9
RELN/VLDLR/DAB1 -0.31 0.25 -9999 0 -0.5 660 660
ITGB1 0 0 -9999 0 -10000 0 0
MAP1B -0.3 0.25 -9999 0 -0.49 666 666
RELN/LRP8 -0.32 0.26 -9999 0 -0.53 651 651
GRIN2B/RELN/LRP8/DAB1/Fyn -0.31 0.25 -9999 0 -0.49 689 689
PI3K -0.008 0.068 -9999 0 -0.6 14 14
mol:PP2 0 0 -9999 0 -10000 0 0
alpha3/beta1 Integrin -0.003 0.037 -9999 0 -0.6 4 4
RAP1A -0.25 0.2 -9999 0 -0.54 142 142
PAFAH1B1 0 0 -9999 0 -10000 0 0
MAPK8IP1 -0.004 0.046 -9999 0 -0.48 8 8
CRLK/C3G 0 0 -9999 0 -10000 0 0
GRIN2B -0.053 0.2 -9999 0 -0.77 75 75
NCK2 0 0 -9999 0 -10000 0 0
neuron differentiation -0.12 0.13 -9999 0 -0.48 13 13
neuron adhesion -0.23 0.19 -9999 0 -0.5 145 145
LRP8 -0.03 0.089 -9999 0 -0.29 113 113
GSK3B -0.17 0.18 -9999 0 -0.46 71 71
RELN/VLDLR/DAB1/Fyn -0.29 0.24 -9999 0 -0.47 660 660
MAP3K11 0 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.21 0.18 -9999 0 -0.35 667 667
CDK5 -0.002 0.023 -9999 0 -10000 0 0
MAPT -0.045 0.24 -9999 0 -0.72 120 120
neuron migration -0.22 0.23 -9999 0 -0.41 652 652
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 -0.13 0.11 -9999 0 -0.48 13 13
RELN/VLDLR -0.31 0.25 -9999 0 -0.5 660 660
HIF-1-alpha transcription factor network

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.41 0.46 -9999 0 -1 271 271
HDAC7 0 0.002 -9999 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.32 0.31 -9999 0 -0.78 225 225
SMAD4 -0.001 0.024 -9999 0 -0.78 1 1
ID2 -0.41 0.46 -9999 0 -0.99 297 297
AP1 -0.18 0.28 -9999 0 -0.61 330 330
ABCG2 -0.43 0.5 -9999 0 -1.1 288 288
HIF1A -0.051 0.064 -9999 0 -10000 0 0
TFF3 -0.48 0.52 -9999 0 -1.1 343 343
GATA2 -0.013 0.13 -9999 0 -0.63 41 41
AKT1 -0.052 0.08 -9999 0 -10000 0 0
response to hypoxia -0.074 0.086 -9999 0 -0.25 28 28
MCL1 -0.41 0.46 -9999 0 -0.99 297 297
NDRG1 -0.41 0.46 -9999 0 -1 296 296
SERPINE1 -0.41 0.46 -9999 0 -1 298 298
FECH -0.41 0.46 -9999 0 -1 296 296
FURIN -0.41 0.46 -9999 0 -0.99 299 299
NCOA2 -0.03 0.17 -9999 0 -0.79 54 54
EP300 -0.051 0.12 -9999 0 -0.36 53 53
HMOX1 -0.41 0.46 -9999 0 -1 297 297
BHLHE40 -0.41 0.46 -9999 0 -1 281 281
BHLHE41 -0.41 0.47 -9999 0 -1 298 298
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.049 0.055 -9999 0 -0.6 1 1
ENG -0.025 0.078 -9999 0 -0.54 1 1
JUN 0.003 0.064 -9999 0 -0.79 7 7
RORA -0.41 0.46 -9999 0 -1 297 297
ABCB1 -0.34 0.55 -9999 0 -1.4 215 215
TFRC -0.41 0.46 -9999 0 -1 281 281
CXCR4 -0.41 0.46 -9999 0 -1 298 298
TF -0.64 0.57 -9999 0 -1.1 542 542
CITED2 -0.41 0.46 -9999 0 -0.99 297 297
HIF1A/ARNT -0.48 0.53 -9999 0 -1.2 302 302
LDHA -0.048 0.047 -9999 0 -10000 0 0
ETS1 -0.41 0.46 -9999 0 -1 296 296
PGK1 -0.41 0.46 -9999 0 -0.99 297 297
NOS2 -0.41 0.46 -9999 0 -1 298 298
ITGB2 -0.41 0.46 -9999 0 -0.99 299 299
ALDOA -0.41 0.46 -9999 0 -1 299 299
Cbp/p300/CITED2 -0.42 0.44 -9999 0 -1.1 255 255
FOS -0.23 0.37 -9999 0 -0.79 329 329
HK2 -0.41 0.46 -9999 0 -0.99 299 299
SP1 0.012 0.023 -9999 0 -10000 0 0
GCK -0.13 0.36 -9999 0 -1.6 56 56
HK1 -0.41 0.46 -9999 0 -1 285 285
NPM1 -0.41 0.46 -9999 0 -0.99 297 297
EGLN1 -0.41 0.46 -9999 0 -0.99 298 298
CREB1 0.019 0 -9999 0 -10000 0 0
PGM1 -0.41 0.46 -9999 0 -1 297 297
SMAD3 0 0 -9999 0 -10000 0 0
EDN1 -0.19 0.4 -9999 0 -1.2 120 120
IGFBP1 -0.5 0.52 -9999 0 -1.1 363 363
VEGFA -0.24 0.31 -9999 0 -0.74 127 127
HIF1A/JAB1 -0.028 0.026 -9999 0 -10000 0 0
CP -0.52 0.55 -9999 0 -1.1 403 403
CXCL12 -0.43 0.5 -9999 0 -1.1 308 308
COPS5 0.009 0.006 -9999 0 -10000 0 0
SMAD3/SMAD4 -0.001 0.018 -9999 0 -0.6 1 1
BNIP3 -0.41 0.46 -9999 0 -1 280 280
EGLN3 -0.41 0.46 -9999 0 -1 287 287
CA9 -0.45 0.48 -9999 0 -1 312 312
TERT -0.42 0.47 -9999 0 -1 304 304
ENO1 -0.41 0.46 -9999 0 -1 281 281
PFKL -0.41 0.46 -9999 0 -0.99 297 297
NCOA1 0 0.024 -9999 0 -0.79 1 1
ADM -0.44 0.49 -9999 0 -1 320 320
ARNT -0.051 0.064 -9999 0 -10000 0 0
HNF4A -0.002 0.046 -9999 0 -0.29 22 22
ADFP -0.41 0.46 -9999 0 -1 301 301
SLC2A1 -0.24 0.32 -9999 0 -0.75 134 134
LEP -0.75 0.52 -9999 0 -1.1 613 613
HIF1A/ARNT/Cbp/p300 -0.33 0.33 -9999 0 -0.8 240 240
EPO -0.23 0.28 -9999 0 -0.87 50 50
CREBBP -0.051 0.12 -9999 0 -0.36 53 53
HIF1A/ARNT/Cbp/p300/HDAC7 -0.31 0.31 -9999 0 -0.8 191 191
PFKFB3 -0.41 0.46 -9999 0 -1 300 300
NT5E -0.41 0.47 -9999 0 -1 297 297
FOXA2 and FOXA3 transcription factor networks

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.24 0.28 -9999 0 -0.73 154 154
PCK1 -1 0.7 -9999 0 -1.6 660 660
HNF4A -0.25 0.28 -9999 0 -0.85 79 79
KCNJ11 -0.27 0.31 -9999 0 -0.83 152 152
AKT1 -0.14 0.14 -9999 0 -0.4 29 29
response to starvation -0.001 0.008 -9999 0 -10000 0 0
DLK1 -0.49 0.55 -9999 0 -1.2 357 357
NKX2-1 -0.054 0.15 -9999 0 -0.55 2 2
ACADM -0.24 0.28 -9999 0 -0.78 128 128
TAT -1.2 0.68 -9999 0 -1.6 770 770
CEBPB 0.006 0.007 -9999 0 -10000 0 0
CEBPA -0.002 0.076 -9999 0 -0.79 10 10
TTR -0.45 0.28 -9999 0 -0.75 381 381
PKLR -0.24 0.28 -9999 0 -0.77 124 124
APOA1 -0.3 0.3 -9999 0 -0.89 101 101
CPT1C -0.24 0.28 -9999 0 -0.79 112 112
ALAS1 -0.14 0.15 -9999 0 -10000 0 0
TFRC -0.45 0.26 -9999 0 -0.77 266 266
FOXF1 -0.003 0.053 -9999 0 -0.52 9 9
NF1 0.017 0.024 -9999 0 -0.78 1 1
HNF1A (dimer) 0.003 0.027 -9999 0 -0.34 1 1
CPT1A -0.24 0.28 -9999 0 -0.77 120 120
HMGCS1 -0.24 0.28 -9999 0 -0.74 150 150
NR3C1 -0.11 0.13 -9999 0 -0.42 72 72
CPT1B -0.24 0.28 -9999 0 -0.76 134 134
chromatin remodeling 0 0 -9999 0 -10000 0 0
SP1 0.002 0.007 -9999 0 -10000 0 0
GCK -0.28 0.35 -9999 0 -0.95 151 151
CREB1 -0.059 0.067 -9999 0 -10000 0 0
IGFBP1 -0.44 0.59 -9999 0 -1.5 244 244
PDX1 -0.13 0.15 -9999 0 -10000 0 0
UCP2 -0.24 0.28 -9999 0 -0.76 132 132
ALDOB -0.26 0.3 -9999 0 -0.81 142 142
AFP -0.68 0.6 -9999 0 -1.2 543 543
BDH1 -0.24 0.28 -9999 0 -0.75 143 143
HADH -0.26 0.3 -9999 0 -0.81 132 132
F2 -0.29 0.3 -9999 0 -0.87 106 106
HNF1A 0.003 0.027 -9999 0 -0.34 1 1
G6PC -0.2 0.12 -9999 0 -0.64 8 8
SLC2A2 -0.16 0.17 -9999 0 -0.54 2 2
INS 0.023 0.066 -9999 0 -10000 0 0
FOXA1 -0.24 0.28 -9999 0 -0.55 338 338
FOXA3 -0.42 0.23 -9999 0 -0.55 708 708
FOXA2 -0.31 0.34 -9999 0 -0.84 202 202
ABCC8 -0.34 0.43 -9999 0 -1.1 207 207
ALB -0.93 0.64 -9999 0 -1.4 697 697
Glucocorticoid receptor regulatory network

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.024 0.079 -10000 0 -10000 0 0
SMARCC2 0.012 0.01 -10000 0 -10000 0 0
SMARCC1 0.012 0.01 -10000 0 -10000 0 0
TBX21 -0.13 0.25 -10000 0 -0.72 105 105
SUMO2 0 0.01 -10000 0 -0.29 1 1
STAT1 (dimer) 0.014 0.04 -10000 0 -0.29 19 19
FKBP4 -0.002 0.026 -10000 0 -0.29 9 9
FKBP5 -0.015 0.1 -10000 0 -0.68 24 24
GR alpha/HSP90/FKBP51/HSP90 0.11 0.14 0.31 122 -0.41 22 144
PRL -0.086 0.12 -10000 0 -0.56 1 1
cortisol/GR alpha (dimer)/TIF2 0.26 0.3 0.53 490 -0.55 31 521
RELA -0.039 0.083 -10000 0 -0.27 5 5
FGG 0.23 0.22 0.48 346 -0.52 2 348
GR beta/TIF2 0.1 0.2 0.33 152 -0.57 56 208
IFNG -0.42 0.35 -10000 0 -0.75 507 507
apoptosis -0.27 0.3 0.59 3 -0.66 283 286
CREB1 -0.009 0.031 -10000 0 -10000 0 0
histone acetylation 0.022 0.14 0.4 42 -0.37 41 83
BGLAP -0.1 0.15 -10000 0 -0.49 36 36
GR/PKAc 0.11 0.12 0.32 72 -0.46 4 76
NF kappa B1 p50/RelA -0.066 0.15 -10000 0 -0.39 56 56
SMARCD1 0.012 0.01 -10000 0 -10000 0 0
MDM2 0.12 0.1 0.26 259 -10000 0 259
GATA3 -0.026 0.16 -10000 0 -0.57 70 70
AKT1 0 0.004 -10000 0 -10000 0 0
CSF2 -0.039 0.11 0.36 3 -0.48 17 20
GSK3B 0 0.004 -10000 0 -10000 0 0
NR1I3 -0.21 0.26 0.61 2 -0.65 136 138
CSN2 0.19 0.18 0.42 227 -0.53 1 228
BRG1/BAF155/BAF170/BAF60A -0.003 0.032 -10000 0 -0.46 5 5
NFATC1 0.001 0.042 -10000 0 -0.79 3 3
POU2F1 0.007 0.013 -10000 0 -10000 0 0
CDKN1A 0.046 0.072 -10000 0 -1.5 2 2
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.007 0.008 -10000 0 -10000 0 0
SFN -0.016 0.099 -10000 0 -0.79 15 15
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.1 0.14 0.33 65 -0.41 19 84
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.36 0.43 0.54 3 -0.89 387 390
JUN -0.31 0.29 -10000 0 -0.6 447 447
IL4 -0.12 0.16 -10000 0 -0.52 40 40
CDK5R1 -0.008 0.05 -10000 0 -0.3 31 31
PRKACA 0 0 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.41 0.4 -10000 0 -0.73 589 589
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.11 0.13 0.32 85 -0.39 15 100
cortisol/GR alpha (monomer) 0.34 0.32 0.62 528 -0.51 3 531
NCOA2 -0.039 0.17 -10000 0 -0.79 54 54
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.28 0.38 -10000 0 -0.86 329 329
AP-1/NFAT1-c-4 -0.65 0.52 -10000 0 -1 658 658
AFP -0.6 0.7 -10000 0 -1.5 370 370
SUV420H1 0 0 -10000 0 -10000 0 0
IRF1 0.19 0.16 0.45 125 -10000 0 125
TP53 0.032 0.023 -10000 0 -0.5 2 2
PPP5C 0 0 -10000 0 -10000 0 0
KRT17 -0.82 0.8 -10000 0 -1.7 485 485
KRT14 -0.81 0.77 -10000 0 -1.5 567 567
TBP 0.019 0.007 -10000 0 -10000 0 0
CREBBP 0.14 0.14 0.29 369 -10000 0 369
HDAC1 0 0.004 -10000 0 -10000 0 0
HDAC2 0.001 0.004 -10000 0 -10000 0 0
AP-1 -0.66 0.52 -10000 0 -1 659 659
MAPK14 0 0.003 -10000 0 -10000 0 0
MAPK10 -0.12 0.29 -10000 0 -0.79 171 171
MAPK11 -0.002 0.042 -10000 0 -0.8 3 3
KRT5 -0.92 0.81 -10000 0 -1.7 575 575
interleukin-1 receptor activity -0.001 0.003 -10000 0 -10000 0 0
NCOA1 0.014 0.024 -10000 0 -0.78 1 1
STAT1 0.014 0.04 -10000 0 -0.29 19 19
CGA -0.16 0.18 -10000 0 -0.52 96 96
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.2 0.18 0.37 540 -10000 0 540
MAPK3 0 0.003 -10000 0 -10000 0 0
MAPK1 0 0.003 -10000 0 -10000 0 0
ICAM1 -0.18 0.25 -10000 0 -0.58 203 203
NFKB1 -0.039 0.083 -10000 0 -0.26 9 9
MAPK8 -0.23 0.22 -10000 0 -0.49 331 331
MAPK9 0 0.003 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) -0.29 0.31 0.59 3 -0.71 284 287
BAX 0.048 0.032 -10000 0 -10000 0 0
POMC -0.19 0.32 -10000 0 -0.94 96 96
EP300 0.14 0.14 0.28 430 -10000 0 430
cortisol/GR alpha (dimer)/p53 0.31 0.26 0.54 510 -0.56 1 511
proteasomal ubiquitin-dependent protein catabolic process 0.085 0.079 0.24 61 -10000 0 61
SGK1 0.22 0.21 0.42 20 -1.2 7 27
IL13 -0.31 0.28 -10000 0 -0.65 295 295
IL6 -0.49 0.62 -10000 0 -1.3 410 410
PRKACG 0 0 -10000 0 -10000 0 0
IL5 -0.27 0.23 -10000 0 -0.64 131 131
IL2 -0.41 0.35 -10000 0 -0.76 461 461
CDK5 -0.002 0.024 -10000 0 -0.3 4 4
PRKACB -0.016 0.077 -10000 0 -0.33 53 53
HSP90AA1 0 0.009 -10000 0 -0.29 1 1
IL8 -0.2 0.3 -10000 0 -0.63 255 255
CDK5R1/CDK5 -0.007 0.036 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.055 0.1 -10000 0 -0.46 13 13
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.28 0.24 0.5 502 -0.49 2 504
SMARCA4 0.012 0.013 -10000 0 -10000 0 0
chromatin remodeling 0.2 0.16 0.36 404 -0.44 3 407
NF kappa B1 p50/RelA/Cbp 0.06 0.17 0.32 170 -0.4 6 176
JUN (dimer) -0.31 0.29 -10000 0 -0.6 448 448
YWHAH 0 0 -10000 0 -10000 0 0
VIPR1 -0.13 0.25 -10000 0 -0.66 124 124
NR3C1 0.2 0.2 0.42 379 -0.48 10 389
NR4A1 -0.063 0.24 -10000 0 -0.73 117 117
TIF2/SUV420H1 -0.03 0.13 -10000 0 -0.6 54 54
MAPKKK cascade -0.27 0.3 0.59 3 -0.66 283 286
cortisol/GR alpha (dimer)/Src-1 0.3 0.26 0.53 511 -0.57 1 512
PBX1 0.005 0.037 -10000 0 -0.54 4 4
POU1F1 0.003 0.015 -10000 0 -0.29 2 2
SELE -0.22 0.36 -10000 0 -0.71 277 277
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.2 0.16 0.36 404 -0.45 3 407
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.28 0.24 0.5 502 -0.49 2 504
mol:cortisol 0.19 0.2 0.36 529 -10000 0 529
MMP1 -0.22 0.11 -10000 0 -10000 0 0
Angiopoietin receptor Tie2-mediated signaling

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.14 0.42 -10000 0 -0.91 248 248
NCK1/PAK1/Dok-R -0.096 0.18 -10000 0 -0.42 248 248
NCK1/Dok-R -0.26 0.48 -10000 0 -1.1 248 248
PIK3CA 0.003 0.011 -10000 0 -0.29 1 1
mol:beta2-estradiol 0.039 0.1 0.24 207 -10000 0 207
RELA 0 0 -10000 0 -10000 0 0
SHC1 0.008 0.006 -10000 0 -10000 0 0
Rac/GDP 0 0 -10000 0 -10000 0 0
F2 0.04 0.11 0.25 203 -0.32 11 214
TNIP2 0 0 -10000 0 -10000 0 0
NF kappa B/RelA -0.24 0.44 -10000 0 -1 248 248
FN1 -0.12 0.14 -10000 0 -0.29 431 431
PLD2 -0.21 0.54 -10000 0 -1.2 248 248
PTPN11 0 0 -10000 0 -10000 0 0
GRB14 -0.1 0.22 -10000 0 -0.48 231 231
ELK1 -0.17 0.48 -10000 0 -1 248 248
GRB7 -0.023 0.085 -10000 0 -0.31 79 79
PAK1 -0.007 0.044 -10000 0 -0.29 25 25
Tie2/Ang1/alpha5/beta1 Integrin -0.22 0.5 -10000 0 -1.1 248 248
CDKN1A -0.072 0.28 -10000 0 -0.61 182 182
ITGA5 0 0.009 -10000 0 -0.29 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R -0.26 0.48 -10000 0 -1.1 248 248
CRK 0 0 -10000 0 -10000 0 0
mol:NO -0.077 0.32 -10000 0 -0.66 248 248
PLG -0.22 0.54 -10000 0 -1.2 248 248
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis -0.19 0.38 -10000 0 -0.88 248 248
GRB2 0 0.009 -10000 0 -0.29 1 1
PIK3R1 -0.002 0.09 -10000 0 -0.79 14 14
ANGPT2 -0.12 0.28 -10000 0 -0.74 120 120
BMX -0.38 0.6 -10000 0 -1.4 249 249
ANGPT1 -0.25 0.58 -10000 0 -1.4 218 218
tube development -0.09 0.31 -10000 0 -0.64 247 247
ANGPT4 -0.24 0.36 -10000 0 -0.79 331 331
response to hypoxia -0.011 0.031 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 -0.3 0.55 -10000 0 -1.3 248 248
alpha5/beta1 Integrin 0 0.006 -10000 0 -10000 0 0
FGF2 -0.32 0.39 -10000 0 -0.79 446 446
STAT5A (dimer) -0.11 0.36 -10000 0 -0.77 206 206
mol:L-citrulline -0.077 0.32 -10000 0 -0.66 248 248
AGTR1 -0.2 0.34 -10000 0 -0.7 328 328
MAPK14 -0.2 0.52 -10000 0 -1.1 248 248
Tie2/SHP2 -0.11 0.3 -10000 0 -1.3 58 58
TEK -0.11 0.34 -10000 0 -1.5 58 58
RPS6KB1 -0.13 0.41 -10000 0 -0.87 248 248
Angiotensin II/AT1 -0.15 0.26 -10000 0 -0.61 268 268
Tie2/Ang1/GRB2 -0.28 0.53 -10000 0 -1.2 248 248
MAPK3 -0.18 0.49 -10000 0 -1.1 248 248
MAPK1 -0.18 0.49 -10000 0 -1.1 248 248
Tie2/Ang1/GRB7 -0.27 0.53 -10000 0 -1.2 248 248
NFKB1 0 0 -10000 0 -10000 0 0
MAPK8 -0.21 0.54 -10000 0 -1.2 248 248
PI3K -0.17 0.48 -10000 0 -1.1 248 248
FES -0.2 0.51 -10000 0 -1.1 248 248
Crk/Dok-R -0.26 0.48 -10000 0 -1.1 248 248
Tie2/Ang1/ABIN2 -0.28 0.53 -10000 0 -1.2 248 248
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity -0.11 0.38 -10000 0 -0.8 248 248
STAT5A -0.004 0.067 -10000 0 -0.79 8 8
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 -0.13 0.41 -10000 0 -0.87 248 248
Tie2/Ang2 -0.15 0.42 -10000 0 -0.93 206 206
Tie2/Ang1 -0.24 0.59 -10000 0 -1.3 248 248
FOXO1 -0.11 0.38 -10000 0 -0.81 248 248
ELF1 0.013 0.024 -10000 0 -10000 0 0
ELF2 -0.21 0.53 -10000 0 -1.2 248 248
mol:Choline -0.2 0.51 -10000 0 -1.1 248 248
cell migration -0.045 0.11 -10000 0 -0.24 178 178
FYN -0.11 0.35 -10000 0 -0.75 226 226
DOK2 -0.003 0.045 -10000 0 -0.79 3 3
negative regulation of cell cycle -0.061 0.26 -10000 0 -0.54 197 197
ETS1 -0.031 0.12 -10000 0 -0.96 6 6
PXN -0.09 0.34 -10000 0 -0.71 248 248
ITGB1 0 0 -10000 0 -10000 0 0
NOS3 -0.097 0.36 -10000 0 -0.75 248 248
RAC1 0 0 -10000 0 -10000 0 0
TNF -0.042 0.14 -10000 0 -0.76 18 18
MAPKKK cascade -0.2 0.51 -10000 0 -1.1 248 248
RASA1 0 0 -10000 0 -10000 0 0
Tie2/Ang1/Shc -0.23 0.55 -10000 0 -1.2 248 248
NCK1 0 0 -10000 0 -10000 0 0
vasculogenesis -0.063 0.29 -10000 0 -0.58 248 248
mol:Phosphatidic acid -0.2 0.51 -10000 0 -1.1 248 248
mol:Angiotensin II 0.001 0.001 -10000 0 -10000 0 0
mol:NADP -0.077 0.32 -10000 0 -0.66 248 248
Rac1/GTP -0.18 0.34 -10000 0 -0.81 248 248
MMP2 -0.21 0.54 -10000 0 -1.2 249 249
p75(NTR)-mediated signaling

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 -0.001 0.018 -9999 0 -0.6 1 1
Necdin/E2F1 -0.082 0.15 -9999 0 -0.68 43 43
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.14 0.21 -9999 0 -0.45 344 344
NGF (dimer)/p75(NTR)/BEX1 -0.25 0.31 -9999 0 -0.62 423 423
NT-4/5 (dimer)/p75(NTR) -0.37 0.41 -9999 0 -0.75 541 541
IKBKB -0.001 0.013 -9999 0 -0.29 2 2
AKT1 -0.14 0.22 -9999 0 -0.45 348 348
IKBKG 0 0 -9999 0 -10000 0 0
BDNF -0.064 0.21 -9999 0 -0.66 105 105
MGDIs/NGR/p75(NTR)/LINGO1 -0.2 0.24 -9999 0 -0.55 334 334
FURIN 0 0.009 -9999 0 -0.29 1 1
proBDNF (dimer)/p75(NTR)/Sortilin -0.2 0.28 -9999 0 -0.56 378 378
LINGO1 -0.07 0.12 -9999 0 -0.29 261 261
Sortilin/TRAF6/NRIF -0.001 0.024 -9999 0 -0.78 1 1
proBDNF (dimer) -0.064 0.21 -9999 0 -0.66 105 105
NTRK1 -0.011 0.07 -9999 0 -0.37 33 33
RTN4R -0.011 0.056 -9999 0 -0.29 41 41
neuron apoptosis -0.13 0.26 -9999 0 -0.48 334 334
IRAK1 -0.001 0.018 -9999 0 -0.29 4 4
SHC1 -0.15 0.26 -9999 0 -0.52 342 342
ARHGDIA 0 0 -9999 0 -10000 0 0
RhoA/GTP 0 0 -9999 0 -10000 0 0
Gamma Secretase -0.001 0.014 -9999 0 -0.44 1 1
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 -0.15 0.23 -9999 0 -0.48 342 342
MAGEH1 -0.001 0.024 -9999 0 -0.79 1 1
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.17 0.26 -9999 0 -0.52 356 356
Mammalian IAPs/DIABLO -0.005 0.044 -9999 0 -0.47 9 9
proNGF (dimer) -0.014 0.097 -9999 0 -0.62 24 24
MAGED1 -0.001 0.018 -9999 0 -0.29 4 4
APP 0 0 -9999 0 -10000 0 0
NT-4/5 (dimer) -0.27 0.37 -9999 0 -0.79 371 371
ZNF274 0 0 -9999 0 -10000 0 0
RhoA/GDP/RHOGDI -0.14 0.21 -9999 0 -0.45 342 342
NGF -0.014 0.098 -9999 0 -0.62 24 24
cell cycle arrest -0.11 0.23 -9999 0 -0.43 342 342
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK -0.1 0.16 -9999 0 -0.33 342 342
NT-4/5 (dimer)/p75(NTR)/TRAF6 -0.33 0.36 -9999 0 -0.66 541 541
NCSTN 0 0 -9999 0 -10000 0 0
mol:GTP -0.17 0.25 -9999 0 -0.54 342 342
PSENEN -0.001 0.013 -9999 0 -0.29 2 2
mol:ceramide -0.13 0.24 -9999 0 -0.47 342 342
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.082 0.12 -9999 0 -0.48 13 13
p75(NTR)/beta APP -0.18 0.28 -9999 0 -0.6 334 334
BEX1 -0.15 0.27 -9999 0 -0.51 317 317
mol:GDP -0.16 0.26 -9999 0 -0.53 342 342
NGF (dimer) -0.081 0.18 -9999 0 -0.48 172 172
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI -0.18 0.22 -9999 0 -0.5 334 334
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
RAC1/GTP -0.14 0.22 -9999 0 -0.46 342 342
MYD88 0 0 -9999 0 -10000 0 0
CHUK 0 0 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA -0.17 0.26 -9999 0 -0.54 342 342
RHOB 0 0 -9999 0 -10000 0 0
RHOA 0 0 -9999 0 -10000 0 0
MAGE-G1/E2F1 -0.059 0.087 -9999 0 -10000 0 0
NT3 (dimer) -0.13 0.29 -9999 0 -0.79 172 172
TP53 -0.16 0.22 -9999 0 -0.45 378 378
PRDM4 -0.13 0.24 -9999 0 -0.48 342 342
BDNF (dimer) -0.17 0.23 -9999 0 -0.56 226 226
PIK3CA 0 0.009 -9999 0 -0.29 1 1
SORT1 -0.001 0.024 -9999 0 -0.79 1 1
activation of caspase activity -0.14 0.21 -9999 0 -0.44 344 344
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.15 0.23 -9999 0 -0.48 342 342
RHOC 0 0 -9999 0 -10000 0 0
XIAP 0 0 -9999 0 -10000 0 0
MAPK10 -0.15 0.27 -9999 0 -0.68 124 124
DIABLO 0 0 -9999 0 -10000 0 0
SMPD2 -0.13 0.24 -9999 0 -0.48 342 342
APH1B -0.001 0.024 -9999 0 -0.79 1 1
APH1A 0 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin -0.17 0.25 -9999 0 -0.53 342 342
PSEN1 0 0 -9999 0 -10000 0 0
APAF-1/Pro-Caspase 9 0 0 -9999 0 -10000 0 0
NT3 (dimer)/p75(NTR) -0.27 0.35 -9999 0 -0.68 434 434
MAPK8 -0.1 0.24 -9999 0 -0.64 54 54
MAPK9 -0.1 0.23 -9999 0 -0.6 61 61
APAF1 0 0 -9999 0 -10000 0 0
NTF3 -0.13 0.29 -9999 0 -0.79 172 172
NTF4 -0.27 0.37 -9999 0 -0.79 371 371
NDN -0.031 0.15 -9999 0 -0.79 43 43
RAC1/GDP 0 0 -9999 0 -10000 0 0
RhoA-B-C/GDP -0.14 0.2 -9999 0 -0.42 342 342
p75 CTF/Sortilin/TRAF6/NRIF 0 0.014 -9999 0 -0.47 1 1
RhoA-B-C/GTP -0.17 0.25 -9999 0 -0.54 342 342
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.17 0.24 -9999 0 -0.48 378 378
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.18 0.26 -9999 0 -0.51 378 378
PRKACB -0.016 0.077 -9999 0 -0.33 53 53
proBDNF (dimer)/p75 ECD -0.048 0.16 -9999 0 -0.6 79 79
ChemicalAbstracts:86-01-1 0 0 -9999 0 -10000 0 0
BIRC3 -0.01 0.077 -9999 0 -0.79 9 9
BIRC2 0 0 -9999 0 -10000 0 0
neuron projection morphogenesis -0.12 0.25 -9999 0 -0.46 342 342
BAD -0.11 0.24 -9999 0 -0.56 113 113
RIPK2 -0.001 0.02 -9999 0 -0.29 5 5
NGFR -0.24 0.36 -9999 0 -0.79 334 334
CYCS -0.14 0.21 -9999 0 -0.44 342 342
ADAM17 0 0 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 -0.15 0.22 -9999 0 -0.48 342 342
BCL2L11 -0.11 0.24 -9999 0 -0.56 113 113
BDNF (dimer)/p75(NTR) -0.23 0.32 -9999 0 -0.65 378 378
PI3K -0.16 0.23 -9999 0 -0.49 348 348
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 -0.15 0.23 -9999 0 -0.48 342 342
NDNL2 0 0 -9999 0 -10000 0 0
YWHAE 0 0 -9999 0 -10000 0 0
PRKCI 0 0.009 -9999 0 -0.29 1 1
NGF (dimer)/p75(NTR) -0.19 0.29 -9999 0 -0.61 342 342
ChemicalAbstracts:146-91-8 0 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE -0.15 0.23 -9999 0 -0.48 342 342
TRAF6 0 0 -9999 0 -10000 0 0
RAC1 0 0 -9999 0 -10000 0 0
PRKCZ -0.001 0.024 -9999 0 -0.79 1 1
PLG -0.002 0.025 -9999 0 -0.29 8 8
oligodendrocyte cell fate commitment 0 0 -9999 0 -10000 0 0
CASP6 -0.18 0.26 -9999 0 -0.51 386 386
SQSTM1 0 0.009 -9999 0 -0.29 1 1
NGFRAP1 -0.002 0.041 -9999 0 -0.79 3 3
CASP3 -0.1 0.22 -9999 0 -0.51 113 113
E2F1 -0.092 0.14 -9999 0 -0.29 345 345
CASP9 0 0 -9999 0 -10000 0 0
IKK complex -0.064 0.11 -9999 0 -0.56 22 22
NGF (dimer)/TRKA -0.018 0.088 -9999 0 -0.6 21 21
MMP7 -0.12 0.28 -9999 0 -0.7 191 191
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.14 0.21 -9999 0 -0.45 342 342
MMP3 -0.12 0.16 -9999 0 -0.31 421 421
APAF-1/Caspase 9 -0.1 0.16 -9999 0 -0.56 23 23
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 -0.078 0.16 -10000 0 -0.34 285 285
NFATC2 -0.055 0.27 -10000 0 -0.76 126 126
NFATC3 -0.048 0.12 -10000 0 -0.31 42 42
CD40LG -0.36 0.57 -10000 0 -1.1 333 333
ITCH 0.016 0.095 -10000 0 -10000 0 0
CBLB 0.016 0.095 -10000 0 -10000 0 0
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.25 0.36 -10000 0 -1.1 119 119
JUNB -0.001 0.013 -10000 0 -0.29 2 2
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.034 0.1 -10000 0 -0.33 109 109
T cell anergy -0.024 0.16 -10000 0 -0.48 109 109
TLE4 -0.031 0.26 -10000 0 -0.73 100 100
Jun/NFAT1-c-4/p21SNFT -0.28 0.43 -10000 0 -0.93 289 289
AP-1/NFAT1-c-4 -0.5 0.65 -10000 0 -1.4 337 337
IKZF1 -0.019 0.21 -10000 0 -0.64 81 81
T-helper 2 cell differentiation -0.11 0.3 -10000 0 -0.84 117 117
AP-1/NFAT1 -0.23 0.32 -10000 0 -0.64 375 375
CALM1 -0.018 0.053 -10000 0 -10000 0 0
EGR2 -0.27 0.63 -10000 0 -1.5 174 174
EGR3 -0.36 0.71 -10000 0 -1.5 283 283
NFAT1/FOXP3 -0.12 0.22 -10000 0 -0.57 144 144
EGR1 -0.24 0.37 -10000 0 -0.79 347 347
JUN -0.001 0.066 -10000 0 -0.8 7 7
EGR4 -0.015 0.078 -10000 0 -0.29 80 80
mol:Ca2+ -0.021 0.061 -10000 0 -10000 0 0
GBP3 -0.023 0.22 -10000 0 -0.67 89 89
FOSL1 -0.009 0.061 -10000 0 -0.79 3 3
NFAT1-c-4/MAF/IRF4 -0.3 0.46 -10000 0 -0.95 309 309
DGKA -0.018 0.21 -10000 0 -0.63 81 81
CREM 0 0.001 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.38 0.52 -10000 0 -1.1 338 338
CTLA4 -0.089 0.24 -10000 0 -0.64 93 93
NFAT1-c-4 (dimer)/EGR1 -0.42 0.56 -10000 0 -1.2 334 334
NFAT1-c-4 (dimer)/EGR4 -0.28 0.45 -10000 0 -0.91 320 320
FOS -0.24 0.37 -10000 0 -0.8 329 329
IFNG -0.15 0.27 -10000 0 -0.83 112 112
T cell activation -0.17 0.35 -10000 0 -0.79 192 192
MAF -0.001 0.024 -10000 0 -0.79 1 1
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.15 0.36 0.69 268 -10000 0 268
TNF -0.3 0.51 -10000 0 -1 316 316
FASLG -0.34 0.67 -10000 0 -1.3 328 328
TBX21 -0.022 0.15 -10000 0 -0.66 55 55
BATF3 -0.002 0.03 -10000 0 -0.39 5 5
PRKCQ -0.023 0.16 -10000 0 -0.68 57 57
PTPN1 -0.019 0.21 -10000 0 -0.66 69 69
NFAT1-c-4/ICER1 -0.28 0.44 -10000 0 -0.91 324 324
GATA3 -0.035 0.15 -10000 0 -0.57 70 70
T-helper 1 cell differentiation -0.15 0.26 -10000 0 -0.81 112 112
IL2RA -0.24 0.34 -10000 0 -0.88 159 159
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.018 0.21 -10000 0 -0.66 70 70
E2F1 -0.078 0.14 -10000 0 -0.28 345 345
PPARG -0.19 0.34 -10000 0 -0.79 268 268
SLC3A2 -0.018 0.21 -10000 0 -0.63 81 81
IRF4 -0.07 0.22 -10000 0 -0.73 106 106
PTGS2 -0.46 0.65 -10000 0 -1.2 400 400
CSF2 -0.35 0.55 -10000 0 -1.1 333 333
JunB/Fra1/NFAT1-c-4 -0.27 0.42 -10000 0 -0.89 298 298
IL4 -0.12 0.32 -10000 0 -0.9 113 113
IL5 -0.35 0.55 -10000 0 -1.1 329 329
IL2 -0.17 0.36 -10000 0 -0.81 191 191
IL3 -0.062 0.065 -10000 0 -10000 0 0
RNF128 -0.045 0.27 -10000 0 -0.85 109 109
NFATC1 -0.15 0.36 -10000 0 -0.7 248 248
CDK4 0.079 0.23 0.56 71 -10000 0 71
PTPRK -0.023 0.23 -10000 0 -0.66 94 94
IL8 -0.35 0.56 -10000 0 -1.1 331 331
POU2F1 0.001 0.01 -10000 0 -10000 0 0
FOXM1 transcription factor network

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.24 0.44 -9999 0 -0.93 176 176
PLK1 -0.087 0.11 -9999 0 -10000 0 0
BIRC5 -0.1 0.1 -9999 0 -10000 0 0
HSPA1B -0.24 0.44 -9999 0 -0.91 196 196
MAP2K1 0.008 0.03 -9999 0 -10000 0 0
BRCA2 -0.24 0.44 -9999 0 -0.91 202 202
FOXM1 -0.29 0.52 -9999 0 -1 242 242
XRCC1 -0.24 0.44 -9999 0 -0.9 200 200
FOXM1B/p19 -0.29 0.42 -9999 0 -0.91 251 251
Cyclin D1/CDK4 -0.22 0.41 -9999 0 -0.9 152 152
CDC2 -0.26 0.46 -9999 0 -0.9 253 253
TGFA -0.22 0.42 -9999 0 -0.92 157 157
SKP2 -0.24 0.44 -9999 0 -0.95 159 159
CCNE1 -0.056 0.13 -9999 0 -0.3 223 223
CKS1B -0.24 0.44 -9999 0 -0.91 192 192
RB1 -0.12 0.13 -9999 0 -0.9 1 1
FOXM1C/SP1 -0.3 0.45 -9999 0 -0.98 229 229
AURKB -0.079 0.11 -9999 0 -10000 0 0
CENPF -0.27 0.46 -9999 0 -0.95 212 212
CDK4 0.007 0.022 -9999 0 -0.3 4 4
MYC -0.21 0.41 -9999 0 -0.83 213 213
CHEK2 0.008 0.033 -9999 0 -0.32 2 2
ONECUT1 -0.24 0.43 -9999 0 -0.89 202 202
CDKN2A -0.038 0.11 -9999 0 -0.29 188 188
LAMA4 -0.24 0.44 -9999 0 -0.93 189 189
FOXM1B/HNF6 -0.27 0.49 -9999 0 -1.1 188 188
FOS -0.44 0.67 -9999 0 -1.3 371 371
SP1 0 0 -9999 0 -10000 0 0
CDC25B -0.24 0.44 -9999 0 -0.91 201 201
response to radiation -0.007 0.03 -9999 0 -10000 0 0
CENPB -0.24 0.44 -9999 0 -0.9 206 206
CENPA -0.27 0.46 -9999 0 -0.95 213 213
NEK2 -0.29 0.45 -9999 0 -0.96 211 211
HIST1H2BA -0.24 0.44 -9999 0 -0.92 189 189
CCNA2 -0.11 0.15 -9999 0 -0.3 427 427
EP300 0 0 -9999 0 -10000 0 0
CCNB1/CDK1 -0.28 0.49 -9999 0 -1 216 216
CCNB2 -0.27 0.46 -9999 0 -0.95 212 212
CCNB1 -0.26 0.46 -9999 0 -0.95 219 219
ETV5 -0.24 0.44 -9999 0 -0.92 190 190
ESR1 -0.34 0.58 -9999 0 -1.3 238 238
CCND1 -0.23 0.42 -9999 0 -0.92 153 153
GSK3A 0.014 0.021 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 -0.081 0.14 -9999 0 -0.33 189 189
CDK2 0.006 0.009 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.01 0.036 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.33 0.38 -9999 0 -0.91 242 242
GAS1 -0.28 0.5 -9999 0 -1.1 172 172
MMP2 -0.24 0.44 -9999 0 -0.91 209 209
RB1/FOXM1C -0.24 0.44 -9999 0 -0.93 186 186
CREBBP 0 0 -9999 0 -10000 0 0
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0 0 -9999 0 -10000 0 0
VLDLR -0.025 0.14 -9999 0 -0.79 35 35
LRPAP1 0 0 -9999 0 -10000 0 0
NUDC 0 0 -9999 0 -10000 0 0
RELN/LRP8 -0.32 0.26 -9999 0 -0.53 651 651
CaM/Ca2+ 0 0 -9999 0 -10000 0 0
KATNA1 0 0.009 -9999 0 -0.29 1 1
GO:0030286 0 0 -9999 0 -10000 0 0
ABL1 -0.28 0.25 -9999 0 -0.48 651 651
IQGAP1/CaM 0 0 -9999 0 -10000 0 0
DAB1 -0.017 0.069 -9999 0 -0.29 65 65
IQGAP1 0 0 -9999 0 -10000 0 0
PLA2G7 -0.015 0.091 -9999 0 -0.43 39 39
CALM1 0 0 -9999 0 -10000 0 0
DYNLT1 0 0 -9999 0 -10000 0 0
mol:Ca2+ 0 0 -9999 0 -10000 0 0
LRPAP1/LRP8 -0.019 0.057 -9999 0 -10000 0 0
UniProt:Q4QZ09 0 0 -9999 0 -10000 0 0
CLIP1 0 0 -9999 0 -10000 0 0
CDK5R1 -0.008 0.049 -9999 0 -0.29 31 31
LIS1/Poliovirus Protein 3A 0 0 -9999 0 -10000 0 0
CDK5R2 -0.044 0.1 -9999 0 -0.29 164 164
mol:PP1 0 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1 -0.33 0.27 -9999 0 -0.55 660 660
YWHAE 0 0 -9999 0 -10000 0 0
NDEL1/14-3-3 E -0.23 0.19 -9999 0 -0.45 184 184
MAP1B -0.008 0.054 -9999 0 -0.37 23 23
RAC1 0 0 -9999 0 -10000 0 0
p35/CDK5 -0.26 0.21 -9999 0 -0.42 651 651
RELN -0.47 0.39 -9999 0 -0.78 654 654
PAFAH/LIS1 -0.009 0.056 -9999 0 -0.52 11 11
LIS1/CLIP170 0 0 -9999 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain -0.18 0.15 -9999 0 -0.4 25 25
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.2 0.18 -9999 0 -0.33 663 663
GO:0005869 0 0 -9999 0 -10000 0 0
NDEL1 -0.25 0.2 -9999 0 -0.43 412 412
LIS1/IQGAP1 0 0 -9999 0 -10000 0 0
RHOA 0 0 -9999 0 -10000 0 0
PAFAH1B1 0.022 0 -9999 0 -10000 0 0
PAFAH1B3 -0.035 0.095 -9999 0 -0.29 131 131
PAFAH1B2 -0.005 0.063 -9999 0 -0.79 7 7
MAP1B/LIS1/Dynein heavy chain -0.005 0.034 -9999 0 -10000 0 0
NDEL1/Katanin 60/Dynein heavy chain -0.22 0.18 -9999 0 -0.43 185 185
LRP8 -0.03 0.089 -9999 0 -0.29 113 113
NDEL1/Katanin 60 -0.23 0.19 -9999 0 -0.45 185 185
P39/CDK5 -0.27 0.22 -9999 0 -0.44 651 651
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0 0 -9999 0 -10000 0 0
CDK5 -0.26 0.24 -9999 0 -0.45 651 651
PPP2R5D 0 0 -9999 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0 0 -9999 0 -10000 0 0
CSNK2A1 0 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 -0.28 0.24 -9999 0 -0.46 660 660
RELN/VLDLR -0.31 0.25 -9999 0 -0.5 660 660
CDC42 0 0 -9999 0 -10000 0 0
IL4-mediated signaling events

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.45 0.46 -10000 0 -1.2 216 216
STAT6 (cleaved dimer) -0.5 0.45 -10000 0 -0.96 427 427
IGHG1 -0.16 0.16 -10000 0 -0.36 115 115
IGHG3 -0.45 0.44 -10000 0 -0.94 390 390
AKT1 -0.2 0.24 -10000 0 -0.63 104 104
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.15 0.2 -10000 0 -0.58 62 62
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.22 0.24 -10000 0 -0.58 169 169
THY1 -0.45 0.46 -10000 0 -1.1 230 230
MYB -0.017 0.11 -10000 0 -0.73 26 26
HMGA1 -0.014 0.063 -10000 0 -0.29 53 53
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.28 0.29 -10000 0 -0.66 249 249
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.21 0.23 -10000 0 -0.56 126 126
SP1 0.018 0.006 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.024 0.028 -10000 0 -0.76 1 1
STAT6 (dimer)/ETS1 -0.48 0.44 -10000 0 -0.99 371 371
SOCS1 -0.29 0.31 -10000 0 -0.74 208 208
SOCS3 -0.22 0.26 -10000 0 -0.81 68 68
FCER2 -0.58 0.64 -10000 0 -1.4 375 375
PARP14 0.004 0.018 -10000 0 -0.3 3 3
CCL17 -0.46 0.46 -10000 0 -1.2 227 227
GRB2 0 0.009 -10000 0 -0.29 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.16 0.19 -10000 0 -0.56 36 36
T cell proliferation -0.45 0.48 -10000 0 -1.1 304 304
IL4R/JAK1 -0.45 0.46 -10000 0 -1.1 303 303
EGR2 -0.58 0.62 -10000 0 -1.3 352 352
JAK2 -0.008 0.035 -10000 0 -0.81 1 1
JAK3 0.01 0.035 -10000 0 -0.29 14 14
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
JAK1 0.004 0.026 -10000 0 -0.78 1 1
COL1A2 -0.14 0.16 -10000 0 -1.6 3 3
CCL26 -0.46 0.46 -10000 0 -1.1 232 232
IL4R -0.48 0.49 -10000 0 -1.1 304 304
PTPN6 0.022 0.018 -10000 0 -0.28 2 2
IL13RA2 -0.46 0.46 -10000 0 -1.1 258 258
IL13RA1 -0.007 0.025 -10000 0 -10000 0 0
IRF4 -0.22 0.48 -10000 0 -1.5 114 114
ARG1 -0.11 0.12 -10000 0 -10000 0 0
CBL -0.26 0.28 -10000 0 -0.64 220 220
GTF3A 0.013 0.015 -10000 0 -0.29 2 2
PIK3CA 0 0.009 -10000 0 -0.29 1 1
IL13RA1/JAK2 -0.013 0.041 -10000 0 -0.61 1 1
IRF4/BCL6 -0.2 0.42 -10000 0 -1.4 117 117
CD40LG -0.031 0.18 -10000 0 -0.71 67 67
MAPK14 -0.25 0.28 -10000 0 -0.64 215 215
mitosis -0.2 0.23 -10000 0 -0.6 104 104
STAT6 -0.52 0.54 -10000 0 -1.1 371 371
SPI1 0.007 0.024 -10000 0 -0.29 6 6
RPS6KB1 -0.18 0.22 -10000 0 -0.59 88 88
STAT6 (dimer) -0.52 0.54 -10000 0 -1.1 369 369
STAT6 (dimer)/PARP14 -0.5 0.51 -10000 0 -1.1 369 369
mast cell activation 0.012 0.012 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.2 0.23 -10000 0 -0.58 114 114
FRAP1 -0.2 0.24 -10000 0 -0.63 104 104
LTA -0.46 0.46 -10000 0 -1.1 267 267
FES -0.002 0.041 -10000 0 -0.79 3 3
T-helper 1 cell differentiation 0.51 0.52 1.1 371 -10000 0 371
CCL11 -0.48 0.44 -10000 0 -1.1 285 285
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.2 0.23 -10000 0 -0.58 117 117
IL2RG -0.004 0.088 -10000 0 -0.37 48 48
IL10 -0.46 0.46 -10000 0 -1.1 278 278
IRS1 -0.032 0.16 -10000 0 -0.79 45 45
IRS2 -0.033 0.16 -10000 0 -0.79 46 46
IL4 -0.11 0.11 -10000 0 -10000 0 0
IL5 -0.46 0.46 -10000 0 -1.1 256 256
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.37 0.36 -10000 0 -0.81 310 310
COL1A1 -0.18 0.17 -10000 0 -1.7 1 1
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.46 0.47 -10000 0 -1.2 240 240
IL2R gamma/JAK3 -0.011 0.071 -10000 0 -0.45 20 20
TFF3 -0.56 0.58 -10000 0 -1.3 313 313
ALOX15 -0.53 0.57 -10000 0 -1.3 290 290
MYBL1 -0.042 0.1 -10000 0 -0.29 155 155
T-helper 2 cell differentiation -0.39 0.38 -10000 0 -0.84 338 338
SHC1 0 0 -10000 0 -10000 0 0
CEBPB 0.009 0.009 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.21 0.23 -10000 0 -0.57 139 139
mol:PI-3-4-5-P3 -0.2 0.24 -10000 0 -0.63 104 104
PI3K -0.21 0.25 -10000 0 -0.67 105 105
DOK2 -0.003 0.045 -10000 0 -0.79 3 3
ETS1 0.018 0.058 -10000 0 -0.75 6 6
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.15 0.18 -10000 0 -0.56 26 26
ITGB3 -0.48 0.5 -10000 0 -1.2 250 250
PIGR -0.98 0.75 -10000 0 -1.5 682 682
IGHE 0.045 0.04 -10000 0 -10000 0 0
MAPKKK cascade -0.15 0.18 -10000 0 -0.55 26 26
BCL6 0.001 0.059 -10000 0 -0.78 6 6
OPRM1 -0.46 0.46 -10000 0 -1.2 219 219
RETNLB -0.46 0.46 -10000 0 -1.1 236 236
SELP -0.62 0.68 -10000 0 -1.5 332 332
AICDA -0.44 0.44 -10000 0 -1 302 302
Arf6 signaling events

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B -0.004 0.043 -9999 0 -0.64 4 4
ARNO/beta Arrestin1-2 -0.12 0.18 -9999 0 -0.42 254 254
EGFR -0.29 0.38 -9999 0 -0.78 410 410
EPHA2 -0.004 0.058 -9999 0 -0.79 6 6
USP6 0 0 -9999 0 -10000 0 0
IQSEC1 0 0 -9999 0 -10000 0 0
EGFR/EGFR/EGF/EGF -0.33 0.35 -9999 0 -0.66 552 552
ARRB2 -0.051 0.15 -9999 0 -0.44 148 148
mol:GTP 0.017 0.018 -9999 0 -0.15 5 5
ARRB1 -0.002 0.035 -9999 0 -0.62 3 3
FBXO8 0 0 -9999 0 -10000 0 0
TSHR -0.037 0.16 -9999 0 -0.74 54 54
EGF -0.15 0.31 -9999 0 -0.78 214 214
somatostatin receptor activity 0 0 -9999 0 -0.001 385 385
ARAP2 -0.004 0.058 -9999 0 -0.79 6 6
mol:GDP -0.14 0.18 -9999 0 -0.35 351 351
mol:PI-3-4-5-P3 0 0 -9999 0 -0.001 278 278
ITGA2B -0.018 0.078 -9999 0 -0.32 62 62
ARF6 0 0 -9999 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 -0.003 0.036 -9999 0 -0.47 6 6
ADAP1 -0.005 0.05 -9999 0 -0.41 13 13
KIF13B -0.001 0.034 -9999 0 -0.79 2 2
HGF/MET -0.14 0.27 -9999 0 -0.64 240 240
PXN 0 0 -9999 0 -10000 0 0
ARF6/GTP -0.13 0.15 -9999 0 -0.31 373 373
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.29 0.3 -9999 0 -0.57 552 552
ADRB2 -0.18 0.33 -9999 0 -0.79 253 253
receptor agonist activity 0 0 -9999 0 0 387 387
actin filament binding 0 0 -9999 0 -0.001 373 373
SRC 0 0.009 -9999 0 -0.29 1 1
ITGB3 -0.028 0.14 -9999 0 -0.74 41 41
GNAQ -0.002 0.041 -9999 0 -0.79 3 3
EFA6/PI-4-5-P2 0 0.001 -9999 0 -0.001 354 354
ARF6/GDP -0.014 0.083 -9999 0 -0.41 18 18
ARF6/GDP/GULP/ACAP1 -0.15 0.2 -9999 0 -0.47 235 235
alphaIIb/beta3 Integrin/paxillin/GIT1 -0.025 0.094 -9999 0 -0.48 40 40
ACAP1 -0.02 0.095 -9999 0 -0.38 57 57
ACAP2 0 0 -9999 0 -10000 0 0
LHCGR/beta Arrestin2 -0.088 0.22 -9999 0 -0.65 148 148
EFNA1 0 0.009 -9999 0 -0.29 1 1
HGF -0.053 0.2 -9999 0 -0.79 73 73
CYTH3 0.01 0.027 -9999 0 -0.61 2 2
CYTH2 0.006 0.002 -9999 0 -10000 0 0
NCK1 0 0 -9999 0 -10000 0 0
fibronectin binding 0 0 -9999 0 0 317 317
endosomal lumen acidification 0 0 -9999 0 -0.001 313 313
microtubule-based process 0 0 -9999 0 -10000 0 0
GULP1 -0.053 0.2 -9999 0 -0.79 73 73
GNAQ/ARNO 0.004 0.025 -9999 0 -0.45 3 3
mol:Phosphatidic acid 0 0 -9999 0 -10000 0 0
PIP3-E 0 0 -9999 0 0 381 381
MET -0.14 0.3 -9999 0 -0.78 189 189
GNA14 -0.013 0.084 -9999 0 -0.46 30 30
GNA15 -0.003 0.033 -9999 0 -0.36 8 8
GIT1 -0.001 0.02 -9999 0 -0.29 5 5
mol:PI-4-5-P2 0 0 -9999 0 -0.001 375 375
GNA11 -0.003 0.048 -9999 0 -0.79 4 4
LHCGR -0.11 0.27 -9999 0 -0.79 148 148
AGTR1 -0.21 0.34 -9999 0 -0.7 328 328
desensitization of G-protein coupled receptor protein signaling pathway -0.088 0.22 -9999 0 -0.65 148 148
IPCEF1/ARNO -0.23 0.24 -9999 0 -0.46 552 552
alphaIIb/beta3 Integrin -0.033 0.12 -9999 0 -0.62 40 40
Wnt signaling

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.16 0.25 -9999 0 -0.44 385 385
FZD6 -0.007 0.075 -9999 0 -0.79 10 10
WNT6 -0.16 0.31 -9999 0 -0.69 255 255
WNT4 -0.021 0.12 -9999 0 -0.55 43 43
FZD3 -0.011 0.092 -9999 0 -0.79 15 15
WNT5A -0.016 0.1 -9999 0 -0.61 28 28
WNT11 -0.17 0.32 -9999 0 -0.76 242 242
Aurora B signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.053 0.067 -9999 0 -10000 0 0
STMN1 -0.11 0.12 -9999 0 -0.37 80 80
Aurora B/RasGAP/Survivin -0.18 0.13 -9999 0 -10000 0 0
Chromosomal passenger complex/Cul3 protein complex -0.16 0.15 -9999 0 -0.33 435 435
BIRC5 -0.21 0.14 -9999 0 -0.3 720 720
DES -0.29 0.34 -9999 0 -0.65 499 499
Aurora C/Aurora B/INCENP -0.069 0.076 -9999 0 -0.3 12 12
Aurora B/TACC1 -0.1 0.13 -9999 0 -0.61 42 42
Aurora B/PP2A -0.098 0.097 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 -0.008 0.017 -9999 0 -10000 0 0
mitotic metaphase/anaphase transition -0.003 0.003 -9999 0 -10000 0 0
NDC80 -0.21 0.18 -9999 0 -0.37 550 550
Cul3 protein complex -0.21 0.25 -9999 0 -0.52 435 435
KIF2C -0.045 0.034 -9999 0 -10000 0 0
PEBP1 0.002 0.005 -9999 0 -10000 0 0
KIF20A -0.22 0.13 -9999 0 -0.3 820 820
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP -0.098 0.097 -9999 0 -10000 0 0
SEPT1 -0.009 0.052 -9999 0 -0.29 35 35
SMC2 0 0 -9999 0 -10000 0 0
SMC4 -0.004 0.034 -9999 0 -0.29 15 15
NSUN2/NPM1/Nucleolin 0.005 0.019 -9999 0 -10000 0 0
PSMA3 0 0 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.003 0.002 -9999 0 -10000 0 0
H3F3B -0.034 0.046 -9999 0 -10000 0 0
AURKB -0.16 0.15 -9999 0 -0.29 625 625
AURKC -0.005 0.043 -9999 0 -0.32 18 18
CDCA8 -0.099 0.14 -9999 0 -0.3 373 373
cytokinesis -0.11 0.08 -9999 0 -10000 0 0
Aurora B/Septin1 -0.098 0.088 -9999 0 -10000 0 0
AURKA -0.14 0.15 -9999 0 -0.3 506 506
INCENP 0.003 0.005 -9999 0 -10000 0 0
KLHL13 -0.31 0.38 -9999 0 -0.79 434 434
BUB1 -0.2 0.14 -9999 0 -0.3 731 731
hSgo1/Aurora B/Survivin -0.26 0.18 -9999 0 -0.41 538 538
EVI5 0.009 0.004 -9999 0 -10000 0 0
RhoA/GTP -0.1 0.1 -9999 0 -0.35 14 14
SGOL1 -0.18 0.14 -9999 0 -0.29 682 682
CENPA -0.059 0.064 -9999 0 -10000 0 0
NCAPG -0.14 0.15 -9999 0 -0.29 537 537
Aurora B/HC8 Proteasome -0.098 0.097 -9999 0 -10000 0 0
NCAPD2 -0.002 0.025 -9999 0 -0.29 8 8
Aurora B/PP1-gamma -0.098 0.097 -9999 0 -10000 0 0
RHOA 0 0 -9999 0 -10000 0 0
NCAPH -0.11 0.14 -9999 0 -0.29 422 422
NPM1 -0.019 0.025 -9999 0 -10000 0 0
RASA1 0 0 -9999 0 -10000 0 0
KLHL9 -0.001 0.034 -9999 0 -0.79 2 2
mitotic prometaphase -0.006 0.005 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.098 0.096 -9999 0 -10000 0 0
PPP1CC 0 0 -9999 0 -10000 0 0
Centraspindlin -0.12 0.11 -9999 0 -0.37 37 37
RhoA/GDP 0 0 -9999 0 -10000 0 0
NSUN2 -0.019 0.025 -9999 0 -10000 0 0
MYLK -0.088 0.15 -9999 0 -0.47 140 140
KIF23 -0.088 0.14 -9999 0 -0.3 334 334
VIM -0.094 0.1 -9999 0 -0.68 2 2
RACGAP1 -0.007 0.058 -9999 0 -0.3 41 41
mitosis 0 0 -9999 0 -10000 0 0
NCL -0.019 0.025 -9999 0 -10000 0 0
Chromosomal passenger complex -0.084 0.079 -9999 0 -10000 0 0
Chromosomal passenger complex/EVI5 -0.16 0.18 -9999 0 -0.37 137 137
TACC1 -0.03 0.15 -9999 0 -0.79 42 42
PPP2R5D 0 0 -9999 0 -10000 0 0
CUL3 0 0 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
Endothelins

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.01 0.2 -9999 0 -0.6 89 89
PTK2B 0.006 0.006 -9999 0 -10000 0 0
mol:Ca2+ 0.021 0.2 -9999 0 -0.97 33 33
EDN1 -0.035 0.24 -9999 0 -0.81 85 85
EDN3 -0.37 0.39 -9999 0 -0.78 511 511
EDN2 -0.076 0.14 -9999 0 -0.79 8 8
HRAS/GDP -0.03 0.21 -9999 0 -0.55 95 95
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.003 0.14 -9999 0 -0.48 48 48
ADCY4 -0.14 0.29 -9999 0 -0.55 313 313
ADCY5 -0.27 0.36 -9999 0 -0.6 515 515
ADCY6 -0.13 0.27 -9999 0 -0.52 294 294
ADCY7 -0.13 0.27 -9999 0 -0.52 294 294
ADCY1 -0.15 0.29 -9999 0 -0.56 309 309
ADCY2 -0.17 0.32 -9999 0 -0.59 327 327
ADCY3 -0.13 0.27 -9999 0 -0.52 294 294
ADCY8 -0.14 0.27 -9999 0 -0.53 294 294
ADCY9 -0.13 0.27 -9999 0 -0.52 294 294
arachidonic acid secretion -0.11 0.3 -9999 0 -0.59 211 211
ETB receptor/Endothelin-1/Gq/GTP -0.034 0.18 -9999 0 -0.39 163 163
GNAO1 -0.03 0.13 -9999 0 -0.79 26 26
HRAS 0.003 0.029 -9999 0 -10000 0 0
ETA receptor/Endothelin-1/G12/GTP 0.038 0.21 -9999 0 -0.56 89 89
ETA receptor/Endothelin-1/Gs/GTP -0.087 0.32 -9999 0 -0.56 294 294
mol:GTP -0.001 0.006 -9999 0 -10000 0 0
COL3A1 -0.019 0.21 -9999 0 -0.6 89 89
EDNRB -0.074 0.24 -9999 0 -0.79 114 114
response to oxidative stress 0 0 -9999 0 -10000 0 0
CYSLTR2 -0.025 0.25 -9999 0 -0.69 107 107
CYSLTR1 -0.021 0.24 -9999 0 -0.67 102 102
SLC9A1 0.002 0.1 -9999 0 -0.31 69 69
mol:GDP -0.038 0.22 -9999 0 -0.57 107 107
SLC9A3 -0.053 0.28 -9999 0 -0.66 163 163
RAF1 -0.085 0.25 -9999 0 -0.54 167 167
JUN 0.027 0.18 -9999 0 -0.85 30 30
JAK2 -0.01 0.2 -9999 0 -0.6 89 89
mol:IP3 -0.03 0.18 -9999 0 -0.53 73 73
ETA receptor/Endothelin-1 0.035 0.25 -9999 0 -0.69 89 89
PLCB1 -0.052 0.21 -9999 0 -0.79 82 82
PLCB2 0.007 0.026 -9999 0 -0.79 1 1
ETA receptor/Endothelin-3 -0.27 0.31 -9999 0 -0.6 510 510
FOS -0.25 0.5 -9999 0 -0.98 336 336
Gai/GDP -0.016 0.16 -9999 0 -0.82 26 26
CRK 0.006 0.006 -9999 0 -10000 0 0
mol:Ca ++ -0.051 0.25 -9999 0 -0.67 116 116
BCAR1 0.005 0.006 -9999 0 -10000 0 0
PRKCB1 -0.032 0.17 -9999 0 -0.48 88 88
GNAQ 0.008 0.043 -9999 0 -0.79 3 3
GNAZ -0.007 0.075 -9999 0 -0.79 10 10
GNAL -0.19 0.33 -9999 0 -0.79 258 258
Gs family/GDP -0.17 0.26 -9999 0 -0.57 262 262
ETA receptor/Endothelin-1/Gq/GTP 0.017 0.13 -9999 0 -0.43 50 50
MAPK14 -0.032 0.17 -9999 0 -0.48 94 94
TRPC6 0.018 0.22 -9999 0 -1.1 33 33
GNAI2 0 0 -9999 0 -10000 0 0
GNAI3 0 0 -9999 0 -10000 0 0
GNAI1 -0.045 0.18 -9999 0 -0.79 62 62
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.041 0.18 -9999 0 -0.46 120 120
ETB receptor/Endothelin-2 -0.11 0.21 -9999 0 -0.65 121 121
ETB receptor/Endothelin-3 -0.34 0.34 -9999 0 -0.65 568 568
ETB receptor/Endothelin-1 -0.082 0.27 -9999 0 -0.66 184 184
MAPK3 -0.2 0.41 -9999 0 -0.79 339 339
MAPK1 -0.2 0.41 -9999 0 -0.79 339 339
Rac1/GDP -0.028 0.2 -9999 0 -0.53 100 100
cAMP biosynthetic process -0.18 0.3 -9999 0 -0.6 303 303
MAPK8 0.019 0.2 -9999 0 -0.8 39 39
SRC 0 0.009 -9999 0 -0.29 1 1
ETB receptor/Endothelin-1/Gi/GTP -0.05 0.18 -9999 0 -0.52 93 93
p130Cas/CRK/Src/PYK2 -0.015 0.22 -9999 0 -0.64 74 74
mol:K + 0 0 -9999 0 -10000 0 0
G12/GDP -0.028 0.2 -9999 0 -0.53 103 103
COL1A2 -0.056 0.26 -9999 0 -0.7 105 105
EntrezGene:2778 0 0 -9999 0 -10000 0 0
ETA receptor/Endothelin-2 -0.03 0.12 -9999 0 -0.61 11 11
mol:DAG -0.03 0.18 -9999 0 -0.53 73 73
MAP2K2 -0.13 0.32 -9999 0 -0.57 343 343
MAP2K1 -0.13 0.32 -9999 0 -0.57 345 345
EDNRA 0.025 0.08 -9999 0 -0.56 6 6
positive regulation of muscle contraction -0.011 0.17 -9999 0 -0.52 89 89
Gq family/GDP -0.074 0.16 -9999 0 -0.61 62 62
HRAS/GTP -0.053 0.21 -9999 0 -0.49 136 136
PRKCH -0.024 0.17 -9999 0 -0.53 68 68
RAC1 0 0 -9999 0 -10000 0 0
PRKCA -0.036 0.2 -9999 0 -0.61 77 77
PRKCB -0.035 0.2 -9999 0 -0.62 66 66
PRKCE -0.024 0.17 -9999 0 -0.53 65 65
PRKCD -0.025 0.17 -9999 0 -0.57 55 55
PRKCG -0.034 0.18 -9999 0 -0.56 62 62
regulation of vascular smooth muscle contraction -0.3 0.57 -9999 0 -1.1 336 336
PRKCQ -0.045 0.21 -9999 0 -0.61 94 94
PLA2G4A -0.12 0.33 -9999 0 -0.66 210 210
GNA14 -0.003 0.086 -9999 0 -0.46 30 30
GNA15 0.007 0.035 -9999 0 -0.36 8 8
GNA12 0 0 -9999 0 -10000 0 0
GNA11 0.006 0.049 -9999 0 -0.79 4 4
Rac1/GTP 0.038 0.21 -9999 0 -0.56 89 89
MMP1 -0.12 0.13 -9999 0 -10000 0 0
ErbB2/ErbB3 signaling events

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 0.013 0.01 -9999 0 -10000 0 0
RAS family/GTP -0.11 0.14 -9999 0 -0.45 18 18
NFATC4 -0.087 0.16 -9999 0 -0.3 185 185
ERBB2IP 0.008 0.008 -9999 0 -10000 0 0
HSP90 (dimer) 0 0.009 -9999 0 -0.29 1 1
mammary gland morphogenesis -0.15 0.18 -9999 0 -0.39 403 403
JUN -0.018 0.08 -9999 0 -0.37 6 6
HRAS -0.003 0.028 -9999 0 -10000 0 0
DOCK7 -0.12 0.19 -9999 0 -0.36 403 403
ErbB2/ErbB3/neuregulin 1 beta/SHC -0.18 0.22 -9999 0 -0.46 403 403
AKT1 0.008 0.005 -9999 0 -10000 0 0
BAD 0.018 0.006 -9999 0 -10000 0 0
MAPK10 -0.11 0.13 -9999 0 -0.35 174 174
mol:GTP -0.001 0.001 -9999 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta -0.16 0.2 -9999 0 -0.42 403 403
RAF1 -0.08 0.16 -9999 0 -0.51 10 10
ErbB2/ErbB3/neuregulin 2 -0.25 0.25 -9999 0 -0.5 528 528
STAT3 0.001 0.003 -9999 0 -10000 0 0
cell migration -0.062 0.13 -9999 0 -0.31 94 94
mol:PI-3-4-5-P3 -0.002 0.003 -9999 0 -10000 0 0
cell proliferation -0.14 0.22 -9999 0 -0.51 176 176
FOS -0.16 0.26 -9999 0 -0.53 333 333
NRAS -0.001 0.013 -9999 0 -0.3 2 2
mol:Ca2+ -0.15 0.18 -9999 0 -0.39 403 403
MAPK3 -0.11 0.19 -9999 0 -0.42 174 174
MAPK1 -0.11 0.19 -9999 0 -0.47 65 65
JAK2 -0.12 0.19 -9999 0 -0.36 404 404
NF2 -0.006 0.009 -9999 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 -0.13 0.18 -9999 0 -0.36 403 403
NRG1 -0.29 0.38 -9999 0 -0.78 406 406
GRB2/SOS1 0 0.006 -9999 0 -10000 0 0
MAPK8 -0.11 0.17 -9999 0 -0.32 408 408
MAPK9 -0.069 0.087 -9999 0 -0.3 3 3
ERBB2 -0.017 0.059 -9999 0 -0.63 1 1
ERBB3 0 0.054 -9999 0 -0.79 5 5
SHC1 0.002 0.004 -9999 0 -10000 0 0
RAC1 0 0 -9999 0 -10000 0 0
apoptosis 0.014 0.017 -9999 0 -10000 0 0
STAT3 (dimer) 0.001 0.003 -9999 0 -10000 0 0
RNF41 0.018 0.014 -9999 0 -10000 0 0
FRAP1 0.008 0.004 -9999 0 -10000 0 0
RAC1-CDC42/GTP -0.098 0.12 -9999 0 -0.33 26 26
ErbB2/ErbB2/HSP90 (dimer) -0.013 0.046 -9999 0 -0.54 1 1
CHRNA1 -0.092 0.16 -9999 0 -0.41 61 61
myelination -0.081 0.16 -9999 0 -0.36 31 31
PPP3CB -0.12 0.18 -9999 0 -0.34 403 403
KRAS -0.001 0.012 -9999 0 -0.29 2 2
RAC1-CDC42/GDP -0.11 0.15 -9999 0 -0.4 27 27
NRG2 -0.38 0.39 -9999 0 -0.79 523 523
mol:GDP -0.12 0.18 -9999 0 -0.35 403 403
SOS1 0 0 -9999 0 -10000 0 0
MAP2K2 -0.072 0.15 -9999 0 -0.5 9 9
SRC 0 0.009 -9999 0 -0.29 1 1
mol:cAMP -0.002 0.002 -9999 0 -10000 0 0
PTPN11 -0.14 0.18 -9999 0 -0.36 403 403
MAP2K1 -0.13 0.21 -9999 0 -0.48 173 173
heart morphogenesis -0.15 0.18 -9999 0 -0.39 403 403
RAS family/GDP -0.11 0.14 -9999 0 -0.58 8 8
GRB2 0 0.009 -9999 0 -0.29 1 1
PRKACA -0.01 0.014 -9999 0 -10000 0 0
CHRNE 0.007 0.023 -9999 0 -0.18 6 6
HSP90AA1 0 0.009 -9999 0 -0.29 1 1
activation of caspase activity -0.008 0.005 -9999 0 -10000 0 0
nervous system development -0.15 0.18 -9999 0 -0.39 403 403
CDC42 0 0 -9999 0 -10000 0 0
Ephrin B reverse signaling

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 -0.001 0.024 -10000 0 -0.79 1 1
EPHB2 -0.003 0.039 -10000 0 -10000 0 0
EFNB1 0.017 0.05 -10000 0 -0.6 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.16 0.2 -10000 0 -0.41 424 424
Ephrin B2/EPHB1-2 -0.18 0.23 -10000 0 -0.47 424 424
neuron projection morphogenesis -0.15 0.19 -10000 0 -0.39 424 424
Ephrin B1/EPHB1-2/Tiam1 -0.17 0.22 -10000 0 -0.44 424 424
DNM1 -0.005 0.064 -10000 0 -0.73 8 8
cell-cell signaling -0.001 0.002 -10000 0 -10000 0 0
MAP2K4 -0.003 0.13 -10000 0 -0.74 33 33
YES1 -0.025 0.17 -10000 0 -0.98 32 32
Ephrin B1/EPHB1-2/NCK2 -0.17 0.22 -10000 0 -0.44 424 424
PI3K -0.028 0.14 -10000 0 -0.68 45 45
mol:GDP -0.17 0.21 -10000 0 -0.44 424 424
ITGA2B -0.018 0.077 -10000 0 -0.32 62 62
endothelial cell proliferation -0.001 0.016 -10000 0 -0.52 1 1
FYN -0.025 0.16 -10000 0 -0.97 32 32
MAP3K7 -0.022 0.14 -10000 0 -0.79 32 32
FGR -0.027 0.16 -10000 0 -0.98 32 32
TIAM1 -0.001 0.018 -10000 0 -0.29 4 4
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
RGS3 0 0 -10000 0 -10000 0 0
cell adhesion -0.046 0.16 -10000 0 -0.62 72 72
LYN -0.025 0.16 -10000 0 -0.97 32 32
Ephrin B1/EPHB1-2/Src Family Kinases -0.026 0.16 -10000 0 -0.92 32 32
Ephrin B1/EPHB1-2 -0.028 0.14 -10000 0 -0.86 32 32
SRC -0.027 0.16 -10000 0 -0.98 32 32
ITGB3 -0.028 0.14 -10000 0 -0.74 41 41
EPHB1 -0.3 0.38 -10000 0 -0.78 424 424
EPHB4 0 0.009 -10000 0 -0.29 1 1
RAC1 0 0 -10000 0 -10000 0 0
Ephrin B2/EPHB4 -0.001 0.017 -10000 0 -0.52 1 1
alphaIIb/beta3 Integrin -0.033 0.12 -10000 0 -0.62 40 40
BLK -0.027 0.17 -10000 0 -0.98 32 32
HCK -0.027 0.16 -10000 0 -0.98 32 32
regulation of stress fiber formation 0.17 0.21 0.44 424 -10000 0 424
MAPK8 0.001 0.14 -10000 0 -0.7 38 38
Ephrin B1/EPHB1-2/RGS3 -0.17 0.22 -10000 0 -0.44 424 424
endothelial cell migration -0.016 0.12 -10000 0 -0.68 33 33
NCK2 0 0 -10000 0 -10000 0 0
PTPN13 -0.017 0.15 -10000 0 -0.9 32 32
regulation of focal adhesion formation 0.17 0.21 0.44 424 -10000 0 424
chemotaxis 0.17 0.21 0.44 424 -10000 0 424
PIK3CA 0 0.009 -10000 0 -0.29 1 1
Rac1/GTP -0.16 0.2 -10000 0 -0.4 424 424
angiogenesis -0.028 0.14 -10000 0 -0.85 32 32
LCK -0.029 0.17 -10000 0 -0.98 32 32
EPHB forward signaling

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 -0.052 0.15 -10000 0 -0.52 103 103
cell-cell adhesion 0.16 0.21 0.67 79 -10000 0 79
Ephrin B/EPHB2/RasGAP -0.041 0.13 -10000 0 -0.44 96 96
ITSN1 -0.001 0.034 -10000 0 -0.79 2 2
PIK3CA 0 0.009 -10000 0 -0.29 1 1
SHC1 0 0 -10000 0 -10000 0 0
Ephrin B1/EPHB3 -0.002 0.018 -10000 0 -10000 0 0
Ephrin B1/EPHB1 -0.2 0.26 -10000 0 -0.52 423 423
HRAS/GDP -0.17 0.22 -10000 0 -0.64 104 104
Ephrin B/EPHB1/GRB7 -0.22 0.28 -10000 0 -0.52 448 448
Endophilin/SYNJ1 -0.038 0.12 -10000 0 -0.41 96 96
KRAS -0.001 0.013 -10000 0 -0.29 2 2
Ephrin B/EPHB1/Src -0.21 0.27 -10000 0 -0.51 446 446
endothelial cell migration -0.006 0.054 -10000 0 -0.47 14 14
GRB2 0 0.009 -10000 0 -0.29 1 1
GRB7 -0.023 0.085 -10000 0 -0.31 79 79
PAK1 -0.047 0.14 -10000 0 -0.46 105 105
HRAS -0.003 0.028 -10000 0 -10000 0 0
RRAS -0.039 0.12 -10000 0 -0.42 96 96
DNM1 -0.005 0.063 -10000 0 -0.73 8 8
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.2 0.26 -10000 0 -0.48 446 446
lamellipodium assembly -0.16 0.21 -10000 0 -0.67 79 79
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.15 0.19 -10000 0 -0.36 424 424
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
EPHB2 -0.005 0.038 -10000 0 -10000 0 0
EPHB3 -0.004 0.035 -10000 0 -0.29 16 16
EPHB1 -0.3 0.38 -10000 0 -0.79 424 424
EPHB4 0 0.009 -10000 0 -0.29 1 1
mol:GDP -0.15 0.21 -10000 0 -0.64 97 97
Ephrin B/EPHB2 -0.041 0.13 -10000 0 -0.45 96 96
Ephrin B/EPHB3 -0.041 0.13 -10000 0 -0.45 96 96
JNK cascade -0.17 0.21 -10000 0 -0.43 423 423
Ephrin B/EPHB1 -0.21 0.28 -10000 0 -0.52 446 446
RAP1/GDP -0.13 0.18 -10000 0 -0.6 75 75
EFNB2 -0.001 0.024 -10000 0 -0.79 1 1
EFNB3 -0.069 0.22 -10000 0 -0.79 96 96
EFNB1 0 0 -10000 0 -10000 0 0
Ephrin B2/EPHB1-2 -0.19 0.23 -10000 0 -0.48 424 424
RAP1B 0 0 -10000 0 -10000 0 0
RAP1A 0 0 -10000 0 -10000 0 0
CDC42/GTP -0.17 0.23 -10000 0 -0.75 79 79
Rap1/GTP -0.17 0.22 -10000 0 -0.69 78 78
axon guidance -0.052 0.15 -10000 0 -0.52 103 103
MAPK3 -0.095 0.19 -10000 0 -0.52 75 75
MAPK1 -0.095 0.19 -10000 0 -0.52 75 75
Rac1/GDP -0.14 0.19 -10000 0 -0.58 95 95
actin cytoskeleton reorganization -0.13 0.16 -10000 0 -0.53 75 75
CDC42/GDP -0.14 0.19 -10000 0 -0.58 95 95
PI3K -0.006 0.055 -10000 0 -0.48 14 14
EFNA5 -0.074 0.23 -10000 0 -0.78 104 104
Ephrin B2/EPHB4 -0.001 0.017 -10000 0 -0.52 1 1
Ephrin B/EPHB2/Intersectin/N-WASP -0.03 0.099 -10000 0 -0.34 96 96
CDC42 0 0 -10000 0 -10000 0 0
RAS family/GTP -0.16 0.21 -10000 0 -0.66 83 83
PTK2 0.04 0.05 -10000 0 -10000 0 0
MAP4K4 -0.17 0.21 -10000 0 -0.43 423 423
SRC 0 0.009 -10000 0 -0.29 1 1
KALRN -0.014 0.11 -10000 0 -0.79 20 20
Intersectin/N-WASP -0.001 0.026 -10000 0 -0.6 2 2
neuron projection morphogenesis -0.13 0.17 -10000 0 -0.54 84 84
MAP2K1 -0.11 0.2 -10000 0 -0.55 75 75
WASL 0 0 -10000 0 -10000 0 0
Ephrin B1/EPHB1-2/NCK1 -0.18 0.23 -10000 0 -0.47 423 423
cell migration -0.12 0.22 -10000 0 -0.37 424 424
NRAS -0.001 0.013 -10000 0 -0.29 2 2
SYNJ1 -0.039 0.12 -10000 0 -0.42 96 96
PXN 0 0 -10000 0 -10000 0 0
TF -0.24 0.26 -10000 0 -0.45 624 624
HRAS/GTP -0.18 0.23 -10000 0 -0.73 82 82
Ephrin B1/EPHB1-2 -0.19 0.23 -10000 0 -0.48 423 423
cell adhesion mediated by integrin 0.01 0.13 0.42 96 -10000 0 96
RAC1 0 0 -10000 0 -10000 0 0
mol:GTP -0.19 0.25 -10000 0 -0.47 446 446
RAC1-CDC42/GTP -0.16 0.21 -10000 0 -0.68 80 80
RASA1 0 0 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.13 0.18 -10000 0 -0.6 75 75
ruffle organization -0.17 0.22 -10000 0 -0.69 79 79
NCK1 0 0 -10000 0 -10000 0 0
receptor internalization 0.002 0.14 -10000 0 -0.42 98 98
Ephrin B/EPHB2/KALRN -0.049 0.15 -10000 0 -0.49 105 105
ROCK1 0.022 0.024 -10000 0 -0.48 1 1
RAS family/GDP -0.11 0.15 -10000 0 -0.52 75 75
Rac1/GTP -0.18 0.23 -10000 0 -0.73 79 79
Ephrin B/EPHB1/Src/Paxillin -0.15 0.2 -10000 0 -0.37 446 446
IGF1 pathway

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0 0 -10000 0 -10000 0 0
PTK2 0 0 -10000 0 -10000 0 0
CRKL -0.1 0.23 -10000 0 -0.48 271 271
GRB2/SOS1/SHC 0 0.004 -10000 0 -10000 0 0
HRAS -0.003 0.028 -10000 0 -10000 0 0
IRS1/Crk -0.12 0.22 -10000 0 -0.48 271 271
IGF-1R heterotetramer/IGF1/PTP1B -0.13 0.23 -10000 0 -0.53 256 256
AKT1 -0.068 0.21 -10000 0 -0.71 54 54
BAD -0.055 0.2 -10000 0 -0.66 52 52
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.1 0.23 -10000 0 -0.48 271 271
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.12 0.23 -10000 0 -0.48 271 271
RAF1 -0.048 0.19 -10000 0 -0.62 49 49
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos -0.11 0.21 -10000 0 -0.45 271 271
YWHAZ -0.001 0.015 -10000 0 -0.29 3 3
IGF-1R heterotetramer/IGF1/IRS1 -0.13 0.24 -10000 0 -0.52 271 271
PIK3CA 0 0.009 -10000 0 -0.29 1 1
RPS6KB1 -0.068 0.21 -10000 0 -0.71 54 54
GNB2L1 0 0 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade -0.041 0.16 -10000 0 -0.51 49 49
PXN 0 0 -10000 0 -10000 0 0
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0 0.006 -10000 0 -10000 0 0
HRAS/GTP -0.1 0.19 -10000 0 -0.7 47 47
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc -0.098 0.19 -10000 0 -0.42 256 256
IGF-1R heterotetramer -0.033 0.13 -10000 0 -0.65 36 36
IGF-1R heterotetramer/IGF1/IRS/Nck -0.12 0.23 -10000 0 -0.48 271 271
Crk/p130 Cas/Paxillin -0.1 0.2 -10000 0 -0.44 256 256
IGF1R -0.033 0.13 -10000 0 -0.66 36 36
IGF1 -0.18 0.34 -10000 0 -0.81 247 247
IRS2/Crk -0.13 0.25 -10000 0 -0.5 274 274
PI3K -0.12 0.22 -10000 0 -0.47 273 273
apoptosis 0.08 0.15 0.55 50 -10000 0 50
HRAS/GDP -0.002 0.019 -10000 0 -10000 0 0
PRKCD -0.094 0.25 -10000 0 -0.53 256 256
RAF1/14-3-3 E -0.033 0.16 -10000 0 -0.52 49 49
BAD/14-3-3 -0.044 0.18 -10000 0 -0.6 50 50
PRKCZ -0.068 0.21 -10000 0 -0.7 55 55
Crk/p130 Cas/Paxillin/FAK1 -0.085 0.16 -10000 0 -0.61 49 49
PTPN1 -0.003 0.029 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.13 0.24 -10000 0 -0.56 256 256
BCAR1 0 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 -0.11 0.2 -10000 0 -0.46 256 256
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0 0 -10000 0 -10000 0 0
IRS1/NCK2 -0.12 0.22 -10000 0 -0.48 271 271
GRB10 0 0 -10000 0 -10000 0 0
PTPN11 -0.1 0.23 -10000 0 -0.48 271 271
IRS1 -0.12 0.25 -10000 0 -0.52 271 271
IRS2 -0.12 0.27 -10000 0 -0.53 285 285
IGF-1R heterotetramer/IGF1 -0.16 0.28 -10000 0 -0.66 256 256
GRB2 0 0.009 -10000 0 -0.29 1 1
PDPK1 -0.11 0.21 -10000 0 -0.45 258 258
YWHAE 0 0 -10000 0 -10000 0 0
PRKD1 -0.11 0.28 -10000 0 -0.56 269 269
SHC1 0 0 -10000 0 -10000 0 0
ErbB4 signaling events

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF -0.027 0.062 -10000 0 -0.48 2 2
epithelial cell differentiation -0.021 0.065 -10000 0 -0.48 10 10
ITCH 0.01 0.021 -10000 0 -10000 0 0
WWP1 0.007 0.068 -10000 0 -10000 0 0
FYN -0.001 0.034 -10000 0 -0.79 2 2
EGFR -0.29 0.38 -10000 0 -0.78 410 410
PRL -0.003 0.032 -10000 0 -0.29 13 13
neuron projection morphogenesis -0.1 0.21 -10000 0 -0.46 76 76
PTPRZ1 -0.41 0.39 -10000 0 -0.78 570 570
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC -0.16 0.2 -10000 0 -0.41 401 401
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.19 0.23 -10000 0 -0.49 401 401
ADAM17 0.01 0.021 -10000 0 -10000 0 0
ErbB4/ErbB4 0 0.086 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 3/neuregulin 3 -0.055 0.13 -10000 0 -0.5 64 64
NCOR1 -0.001 0.024 -10000 0 -0.79 1 1
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.18 0.22 -10000 0 -0.46 401 401
GRIN2B -0.17 0.25 -10000 0 -0.45 451 451
ErbB4/ErbB2/betacellulin -0.05 0.11 -10000 0 -0.47 62 62
STAT1 -0.005 0.038 -10000 0 -0.29 19 19
HBEGF -0.001 0.034 -10000 0 -0.79 2 2
PRLR -0.008 0.071 -10000 0 -0.54 16 16
E4ICDs/ETO2 -0.035 0.09 -10000 0 -0.55 19 19
axon guidance 0.042 0.12 -10000 0 -0.43 3 3
NEDD4 0.01 0.021 -10000 0 -10000 0 0
Prolactin receptor/Prolactin receptor/Prolactin -0.008 0.058 -10000 0 -0.6 8 8
CBFA2T3 -0.015 0.1 -10000 0 -0.68 24 24
ErbB4/ErbB2/HBEGF -0.026 0.054 -10000 0 -0.48 3 3
MAPK3 -0.15 0.18 -10000 0 -0.47 79 79
STAT1 (dimer) -0.028 0.063 -10000 0 -0.31 7 7
MAPK1 -0.15 0.18 -10000 0 -0.38 401 401
JAK2 -0.001 0.024 -10000 0 -0.79 1 1
ErbB4/ErbB2/neuregulin 1 beta -0.19 0.22 -10000 0 -0.47 401 401
NRG1 -0.21 0.3 -10000 0 -0.61 401 401
NRG3 -0.048 0.18 -10000 0 -0.62 85 85
NRG2 -0.38 0.39 -10000 0 -0.79 523 523
NRG4 -0.005 0.038 -10000 0 -0.29 19 19
heart development 0.042 0.12 -10000 0 -0.43 3 3
neural crest cell migration -0.18 0.22 -10000 0 -0.46 401 401
ERBB2 0.009 0.062 -10000 0 -0.59 1 1
WWOX/E4ICDs -0.026 0.059 -10000 0 -10000 0 0
SHC1 0 0 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 -0.19 0.21 -10000 0 -0.45 405 405
apoptosis 0.056 0.14 0.51 65 -10000 0 65
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.26 0.24 -10000 0 -0.5 523 523
ErbB4/ErbB2/epiregulin -0.082 0.14 -10000 0 -0.45 126 126
ErbB4/ErbB4/betacellulin/betacellulin -0.053 0.12 -10000 0 -0.5 62 62
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.023 0.067 -10000 0 -0.52 11 11
MDM2 0.008 0.075 -10000 0 -0.31 1 1
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.18 0.22 -10000 0 -0.47 401 401
STAT5A 0.043 0.12 -10000 0 -0.44 9 9
ErbB4/EGFR/neuregulin 1 beta -0.34 0.35 -10000 0 -0.65 558 558
DLG4 0 0 -10000 0 -10000 0 0
GRB2/SHC 0 0.006 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 -0.024 0.055 -10000 0 -0.45 1 1
STAT5A (dimer) -0.022 0.07 -10000 0 -0.53 9 9
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.024 0.11 -10000 0 -0.42 6 6
LRIG1 -0.002 0.041 -10000 0 -0.79 3 3
EREG -0.11 0.25 -10000 0 -0.79 124 124
BTC -0.045 0.18 -10000 0 -0.76 64 64
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.042 0.12 -10000 0 -0.43 3 3
ERBB4 -0.032 0.072 -10000 0 -10000 0 0
STAT5B -0.002 0.041 -10000 0 -0.79 3 3
YAP1 -0.01 0.043 -10000 0 -0.64 4 4
GRB2 0 0.009 -10000 0 -0.29 1 1
ErbB4/ErbB2/neuregulin 4 -0.027 0.055 -10000 0 -0.56 1 1
glial cell differentiation 0.024 0.055 0.45 1 -10000 0 1
WWOX -0.001 0.013 -10000 0 -0.29 2 2
cell proliferation -0.12 0.23 -10000 0 -0.46 219 219
Calcium signaling in the CD4+ TCR pathway

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 0.01 0.038 -9999 0 -0.53 3 3
NFATC2 -0.041 0.16 -9999 0 -0.55 104 104
NFATC3 0.012 0.025 -9999 0 -10000 0 0
CD40LG -0.22 0.36 -9999 0 -0.71 311 311
PTGS2 -0.32 0.46 -9999 0 -0.85 426 426
JUNB -0.001 0.013 -9999 0 -0.29 2 2
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.004 0.009 -9999 0 -10000 0 0
CaM/Ca2+ -0.004 0.009 -9999 0 -10000 0 0
CALM1 0 0.003 -9999 0 -10000 0 0
JUN -0.005 0.064 -9999 0 -0.8 7 7
mol:Ca2+ -0.007 0.009 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0 0.005 -9999 0 -10000 0 0
FOSL1 -0.009 0.061 -9999 0 -0.79 3 3
CREM 0 0.001 -9999 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.077 0.15 -9999 0 -0.53 78 78
FOS -0.24 0.37 -9999 0 -0.8 329 329
IFNG -0.22 0.35 -9999 0 -0.67 325 325
AP-1/NFAT1-c-4 -0.31 0.38 -9999 0 -0.81 326 326
FASLG -0.21 0.35 -9999 0 -0.68 304 304
NFAT1-c-4/ICER1 -0.06 0.14 -9999 0 -0.46 107 107
IL2RA -0.21 0.35 -9999 0 -0.68 308 308
FKBP12/FK506 0 0.006 -9999 0 -10000 0 0
CSF2 -0.2 0.34 -9999 0 -0.67 304 304
JunB/Fra1/NFAT1-c-4 -0.057 0.14 -9999 0 -0.47 87 87
IL4 -0.2 0.34 -9999 0 -0.67 302 302
IL2 -0.009 0.024 -9999 0 -10000 0 0
IL3 -0.024 0.026 -9999 0 -10000 0 0
FKBP1A 0 0.009 -9999 0 -0.29 1 1
BATF3 -0.002 0.03 -9999 0 -0.39 5 5
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.001 0.01 -9999 0 -10000 0 0
Signaling events regulated by Ret tyrosine kinase

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.035 0.049 -9999 0 -10000 0 0
Crk/p130 Cas/Paxillin -0.082 0.16 -9999 0 -0.47 97 97
JUN -0.051 0.14 -9999 0 -0.53 27 27
HRAS -0.003 0.028 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/GRB10 -0.15 0.2 -9999 0 -0.52 210 210
RAP1A 0 0 -9999 0 -10000 0 0
FRS2 -0.003 0.029 -9999 0 -0.29 11 11
RAP1A/GDP 0 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 -0.15 0.2 -9999 0 -0.52 210 210
EntrezGene:5979 0 0 -9999 0 -10000 0 0
PTPN11 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma -0.1 0.19 -9999 0 -0.48 206 206
RHOA 0 0 -9999 0 -10000 0 0
RAP1A/GTP -0.13 0.18 -9999 0 -0.46 210 210
GRB7 -0.023 0.085 -9999 0 -0.31 79 79
RET51/GFRalpha1/GDNF -0.15 0.2 -9999 0 -0.52 210 210
MAPKKK cascade -0.1 0.16 -9999 0 -0.53 50 50
BCAR1 0 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 -0.12 0.23 -9999 0 -0.55 218 218
lamellipodium assembly -0.083 0.15 -9999 0 -0.36 210 210
RET51/GFRalpha1/GDNF/SHC -0.15 0.2 -9999 0 -0.52 210 210
PIK3CA 0 0.009 -9999 0 -0.29 1 1
RET9/GFRalpha1/GDNF/SHC -0.1 0.19 -9999 0 -0.48 201 201
RET9/GFRalpha1/GDNF/Shank3 -0.1 0.19 -9999 0 -0.48 201 201
MAPK3 -0.12 0.17 -9999 0 -0.44 207 207
DOK1 -0.001 0.018 -9999 0 -0.29 4 4
DOK6 -0.013 0.094 -9999 0 -0.63 22 22
PXN 0 0 -9999 0 -10000 0 0
neurite development -0.11 0.16 -9999 0 -0.53 57 57
DOK5 -0.019 0.12 -9999 0 -0.79 25 25
GFRA1 -0.16 0.3 -9999 0 -0.68 257 257
MAPK8 -0.068 0.14 -9999 0 -0.43 57 57
HRAS/GTP -0.12 0.18 -9999 0 -0.48 207 207
tube development -0.094 0.17 -9999 0 -0.45 201 201
MAPK1 -0.12 0.17 -9999 0 -0.44 207 207
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.065 0.13 -9999 0 -0.33 201 201
Rac1/GDP 0 0 -9999 0 -10000 0 0
SRC 0 0.009 -9999 0 -0.29 1 1
PDLIM7 0 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 -0.14 0.2 -9999 0 -0.5 216 216
SHC1 0 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 -0.15 0.2 -9999 0 -0.52 210 210
RET51/GFRalpha1/GDNF/Dok5 -0.16 0.22 -9999 0 -0.54 226 226
PRKCA -0.021 0.13 -9999 0 -0.76 31 31
HRAS/GDP -0.002 0.019 -9999 0 -10000 0 0
CREB1 -0.073 0.15 -9999 0 -0.38 201 201
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.065 0.13 -9999 0 -0.33 201 201
RET51/GFRalpha1/GDNF/Grb7 -0.16 0.21 -9999 0 -0.54 212 212
mol:GDP 0 0 -9999 0 -10000 0 0
RET -0.11 0.16 -9999 0 -0.31 401 401
DOK4 0 0 -9999 0 -10000 0 0
JNK cascade -0.049 0.14 -9999 0 -0.52 27 27
RET9/GFRalpha1/GDNF/FRS2 -0.1 0.19 -9999 0 -0.48 201 201
SHANK3 0 0 -9999 0 -10000 0 0
RASA1 0 0 -9999 0 -10000 0 0
NCK1 0 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.065 0.13 -9999 0 -0.33 201 201
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.083 0.14 -9999 0 -0.35 207 207
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.082 0.14 -9999 0 -0.35 207 207
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.084 0.14 -9999 0 -0.36 207 207
PI3K -0.13 0.24 -9999 0 -0.59 210 210
SOS1 0 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.094 0.17 -9999 0 -0.45 201 201
GRB10 0 0 -9999 0 -10000 0 0
activation of MAPKK activity -0.078 0.13 -9999 0 -0.34 137 137
RET51/GFRalpha1/GDNF/FRS2 -0.15 0.2 -9999 0 -0.52 210 210
GAB1 0 0 -9999 0 -10000 0 0
IRS1 -0.032 0.16 -9999 0 -0.79 45 45
IRS2 -0.033 0.16 -9999 0 -0.79 46 46
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.084 0.14 -9999 0 -0.36 207 207
RET51/GFRalpha1/GDNF/PKC alpha -0.16 0.21 -9999 0 -0.53 237 237
GRB2 0 0.009 -9999 0 -0.29 1 1
PRKACA 0 0 -9999 0 -10000 0 0
GDNF -0.015 0.065 -9999 0 -0.29 56 56
RAC1 0 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.17 0.24 -9999 0 -0.59 221 221
Rac1/GTP -0.1 0.18 -9999 0 -0.44 210 210
RET9/GFRalpha1/GDNF -0.11 0.21 -9999 0 -0.53 206 206
GFRalpha1/GDNF -0.13 0.24 -9999 0 -0.6 206 206
BMP receptor signaling

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.12 0.21 -9999 0 -0.6 141 141
SMAD6-7/SMURF1 0 0.016 -9999 0 -0.52 1 1
NOG -0.025 0.13 -9999 0 -0.58 47 47
SMAD9 -0.11 0.26 -9999 0 -0.77 123 123
SMAD4 -0.001 0.024 -9999 0 -0.79 1 1
SMAD5 -0.075 0.18 -9999 0 -0.48 132 132
BMP7/USAG1 -0.34 0.34 -9999 0 -0.66 559 559
SMAD5/SKI -0.087 0.16 -9999 0 -0.51 93 93
SMAD1 0.026 0.03 -9999 0 -10000 0 0
BMP2 -0.14 0.3 -9999 0 -0.78 194 194
SMAD1/SMAD1/SMAD4 -0.002 0.014 -9999 0 -10000 0 0
BMPR1A -0.002 0.041 -9999 0 -0.79 3 3
BMPR1B -0.14 0.18 -9999 0 -0.32 468 468
BMPR1A-1B/BAMBI -0.091 0.14 -9999 0 -0.55 68 68
AHSG -0.005 0.038 -9999 0 -0.29 19 19
CER1 -0.001 0.015 -9999 0 -0.29 3 3
BMP2-4/CER1 -0.13 0.24 -9999 0 -0.56 242 242
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.1 0.2 -9999 0 -0.51 152 152
BMP2-4 (homodimer) -0.14 0.27 -9999 0 -0.64 242 242
RGMB -0.001 0.024 -9999 0 -0.79 1 1
BMP6/BMPR2/BMPR1A-1B -0.097 0.16 -9999 0 -0.54 109 109
RGMA -0.11 0.27 -9999 0 -0.79 147 147
SMURF1 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.11 0.2 -9999 0 -0.61 110 110
BMP2-4/USAG1 -0.37 0.36 -9999 0 -0.64 621 621
SMAD6/SMURF1/SMAD5 -0.087 0.16 -9999 0 -0.51 93 93
SOSTDC1 -0.38 0.39 -9999 0 -0.78 531 531
BMP7/BMPR2/BMPR1A-1B -0.1 0.17 -9999 0 -0.57 111 111
SKI 0 0 -9999 0 -10000 0 0
BMP6 (homodimer) -0.059 0.21 -9999 0 -0.79 82 82
HFE2 -0.003 0.029 -9999 0 -0.29 11 11
ZFYVE16 0 0 -9999 0 -10000 0 0
MAP3K7 0 0.009 -9999 0 -0.29 1 1
BMP2-4/CHRD -0.14 0.26 -9999 0 -0.6 246 246
SMAD5/SMAD5/SMAD4 -0.087 0.16 -9999 0 -0.51 94 94
MAPK1 0 0 -9999 0 -10000 0 0
TAK1/TAB family -0.086 0.17 -9999 0 -0.52 107 107
BMP7 (homodimer) -0.075 0.22 -9999 0 -0.79 90 90
NUP214 0 0 -9999 0 -10000 0 0
BMP6/FETUA -0.049 0.16 -9999 0 -0.61 82 82
SMAD1/SKI 0.004 0.018 -9999 0 -10000 0 0
SMAD6 -0.001 0.024 -9999 0 -0.79 1 1
CTDSP2 0 0 -9999 0 -10000 0 0
BMP2-4/FETUA -0.13 0.24 -9999 0 -0.56 242 242
MAP3K7IP1 0 0 -9999 0 -10000 0 0
GREM1 -0.037 0.12 -9999 0 -0.36 113 113
BMPR2 (homodimer) 0 0 -9999 0 -10000 0 0
GADD34/PP1CA -0.001 0.009 -9999 0 -10000 0 0
BMPR1A-1B (homodimer) -0.091 0.12 -9999 0 -0.62 29 29
CHRDL1 -0.54 0.36 -9999 0 -0.79 750 750
ENDOFIN/SMAD1 0.004 0.018 -9999 0 -10000 0 0
SMAD6-7/SMURF1/SMAD1 -0.003 0.013 -9999 0 -10000 0 0
SMAD6/SMURF1 0 0 -9999 0 -10000 0 0
BAMBI -0.033 0.14 -9999 0 -0.5 72 72
SMURF2 0 0 -9999 0 -10000 0 0
BMP2-4/CHRDL1 -0.47 0.36 -9999 0 -0.66 768 768
BMP2-4/GREM1 -0.14 0.25 -9999 0 -0.57 248 248
SMAD7 0 0 -9999 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.1 0.24 -9999 0 -0.72 123 123
SMAD1/SMAD6 0.004 0.018 -9999 0 -10000 0 0
TAK1/SMAD6 0 0.006 -9999 0 -10000 0 0
BMP7 -0.075 0.22 -9999 0 -0.79 90 90
BMP6 -0.06 0.21 -9999 0 -0.79 82 82
MAP3K7IP2 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.099 0.19 -9999 0 -0.59 107 107
PPM1A 0 0 -9999 0 -10000 0 0
SMAD1/SMURF2 0.004 0.018 -9999 0 -10000 0 0
SMAD7/SMURF1 0 0 -9999 0 -10000 0 0
CTDSPL 0 0 -9999 0 -10000 0 0
PPP1CA -0.001 0.018 -9999 0 -0.29 4 4
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0 0 -9999 0 -10000 0 0
PPP1R15A 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.13 0.24 -9999 0 -0.59 175 175
CHRD -0.032 0.13 -9999 0 -0.42 83 83
BMPR2 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.13 0.23 -9999 0 -0.54 201 201
BMP4 -0.051 0.19 -9999 0 -0.79 71 71
FST -0.04 0.17 -9999 0 -0.76 57 57
BMP2-4/NOG -0.14 0.26 -9999 0 -0.58 257 257
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.094 0.16 -9999 0 -0.53 111 111
IL23-mediated signaling events

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.16 0.39 -9999 0 -0.96 107 107
IL23A -0.17 0.39 -9999 0 -0.97 111 111
NF kappa B1 p50/RelA/I kappa B alpha -0.23 0.32 -9999 0 -0.79 211 211
positive regulation of T cell mediated cytotoxicity -0.18 0.42 -9999 0 -0.85 231 231
ITGA3 -0.16 0.38 -9999 0 -0.91 123 123
IL17F -0.1 0.28 -9999 0 -0.63 108 108
IL12B -0.05 0.12 -9999 0 -0.29 176 176
STAT1 (dimer) -0.21 0.37 -9999 0 -0.82 231 231
CD4 -0.16 0.38 -9999 0 -0.92 105 105
IL23 -0.17 0.38 -9999 0 -0.97 101 101
IL23R -0.012 0.087 -9999 0 -10000 0 0
IL1B -0.17 0.41 -9999 0 -0.97 130 130
T-helper cell lineage commitment 0 0 -9999 0 -10000 0 0
IL24 -0.16 0.38 -9999 0 -0.94 101 101
TYK2 0.012 0.017 -9999 0 -10000 0 0
STAT4 -0.032 0.16 -9999 0 -0.78 45 45
STAT3 0 0 -9999 0 -10000 0 0
IL18RAP -0.021 0.14 -9999 0 -0.73 42 42
IL12RB1 -0.001 0.07 -9999 0 -0.32 43 43
PIK3CA 0 0.009 -9999 0 -0.29 1 1
IL12Rbeta1/TYK2 -0.002 0.052 -9999 0 -0.6 2 2
IL23R/JAK2 -0.009 0.11 -9999 0 -0.63 1 1
positive regulation of chronic inflammatory response -0.18 0.42 -9999 0 -0.85 231 231
natural killer cell activation 0.002 0.008 -9999 0 -10000 0 0
JAK2 0.018 0.034 -9999 0 -0.83 1 1
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
NFKB1 0.005 0.007 -9999 0 -10000 0 0
RELA 0.005 0.007 -9999 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.16 0.37 -9999 0 -0.91 105 105
ALOX12B -0.16 0.38 -9999 0 -0.93 106 106
CXCL1 -0.34 0.63 -9999 0 -1.4 274 274
T cell proliferation -0.18 0.42 -9999 0 -0.85 231 231
NFKBIA 0.005 0.007 -9999 0 -10000 0 0
IL17A -0.068 0.24 -9999 0 -0.53 62 62
PI3K -0.24 0.32 -9999 0 -0.78 237 237
IFNG -0.005 0.027 -9999 0 -0.086 40 40
STAT3 (dimer) -0.23 0.31 -9999 0 -0.78 198 198
IL18R1 -0.007 0.11 -9999 0 -0.78 20 20
IL23/IL23R/JAK2/TYK2/SOCS3 -0.081 0.24 -9999 0 -0.55 64 64
IL18/IL18R -0.03 0.12 -9999 0 -0.53 56 56
macrophage activation -0.013 0.016 -9999 0 -0.04 155 155
TNF -0.17 0.4 -9999 0 -1 111 111
STAT3/STAT4 -0.25 0.34 -9999 0 -0.81 244 244
STAT4 (dimer) -0.23 0.39 -9999 0 -0.86 232 232
IL18 0.001 0.047 -9999 0 -0.3 5 5
IL19 -0.17 0.38 -9999 0 -0.92 115 115
STAT5A (dimer) -0.21 0.37 -9999 0 -0.82 234 234
STAT1 -0.005 0.038 -9999 0 -0.29 19 19
SOCS3 -0.004 0.058 -9999 0 -0.79 6 6
CXCL9 -0.18 0.38 -9999 0 -0.92 126 126
MPO -0.2 0.46 -9999 0 -1.1 171 171
positive regulation of humoral immune response -0.18 0.42 -9999 0 -0.85 231 231
IL23/IL23R/JAK2/TYK2 -0.19 0.44 -9999 0 -0.88 231 231
IL6 -0.46 0.7 -9999 0 -1.3 410 410
STAT5A -0.006 0.067 -9999 0 -0.79 8 8
IL2 0.004 0.028 -9999 0 -0.3 8 8
positive regulation of tyrosine phosphorylation of STAT protein 0.002 0.008 -9999 0 -10000 0 0
CD3E -0.17 0.41 -9999 0 -0.98 128 128
keratinocyte proliferation -0.18 0.42 -9999 0 -0.85 231 231
NOS2 -0.16 0.38 -9999 0 -0.9 131 131
Syndecan-1-mediated signaling events

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 -0.001 0.015 -9999 0 -0.29 3 3
CCL5 -0.014 0.079 -9999 0 -0.36 44 44
SDCBP 0 0 -9999 0 -10000 0 0
FGFR/FGF2/Syndecan-1 -0.08 0.11 -9999 0 -0.34 106 106
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.074 0.096 -9999 0 -0.35 46 46
Syndecan-1/Syntenin -0.074 0.096 -9999 0 -0.32 106 106
MAPK3 -0.047 0.095 -9999 0 -0.48 5 5
HGF/MET -0.14 0.27 -9999 0 -0.64 240 240
TGFB1/TGF beta receptor Type II -0.001 0.015 -9999 0 -0.29 3 3
BSG 0 0.009 -9999 0 -0.29 1 1
keratinocyte migration -0.073 0.095 -9999 0 -0.35 46 46
Syndecan-1/RANTES -0.081 0.11 -9999 0 -0.34 110 110
Syndecan-1/CD147 -0.065 0.093 -9999 0 -0.49 6 6
Syndecan-1/Syntenin/PIP2 -0.071 0.093 -9999 0 -0.31 106 106
LAMA5 0 0.009 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion -0.07 0.091 -9999 0 -0.3 106 106
MMP7 -0.12 0.28 -9999 0 -0.7 191 191
HGF -0.053 0.2 -9999 0 -0.79 73 73
Syndecan-1/CASK -0.076 0.1 -9999 0 -0.33 106 106
Syndecan-1/HGF/MET -0.17 0.24 -9999 0 -0.58 243 243
regulation of cell adhesion -0.038 0.093 -9999 0 -0.46 5 5
HPSE -0.007 0.051 -9999 0 -0.34 21 21
positive regulation of cell migration -0.08 0.11 -9999 0 -0.34 106 106
SDC1 -0.08 0.11 -9999 0 -0.35 106 106
Syndecan-1/Collagen -0.08 0.11 -9999 0 -0.34 106 106
PPIB -0.001 0.015 -9999 0 -0.29 3 3
MET -0.14 0.3 -9999 0 -0.78 189 189
PRKACA 0 0 -9999 0 -10000 0 0
MMP9 -0.13 0.15 -9999 0 -0.29 483 483
MAPK1 -0.047 0.095 -9999 0 -0.48 5 5
homophilic cell adhesion -0.079 0.11 -9999 0 -0.34 106 106
MMP1 -0.22 0.13 -9999 0 -0.29 824 824
Noncanonical Wnt signaling pathway

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 -0.075 0.23 -9999 0 -0.79 104 104
GNB1/GNG2 -0.14 0.23 -9999 0 -0.65 129 129
mol:DAG -0.097 0.22 -9999 0 -0.6 116 116
PLCG1 -0.13 0.21 -9999 0 -0.63 116 116
YES1 -0.14 0.23 -9999 0 -0.66 120 120
FZD3 -0.011 0.092 -9999 0 -0.79 15 15
FZD6 -0.007 0.075 -9999 0 -0.79 10 10
G protein -0.13 0.22 -9999 0 -0.64 118 118
MAP3K7 -0.069 0.19 -9999 0 -0.49 115 115
mol:Ca2+ -0.093 0.22 -9999 0 -0.58 116 116
mol:IP3 -0.097 0.22 -9999 0 -0.6 116 116
NLK -0.005 0.01 -9999 0 -10000 0 0
GNB1 0 0 -9999 0 -10000 0 0
CAMK2A -0.083 0.2 -9999 0 -0.53 123 123
MAP3K7IP1 0 0 -9999 0 -10000 0 0
Noncanonical Wnts/FZD -0.16 0.25 -9999 0 -0.44 385 385
CSNK1A1 0 0 -9999 0 -10000 0 0
GNAS -0.14 0.23 -9999 0 -0.66 121 121
GO:0007205 -0.094 0.22 -9999 0 -0.59 116 116
WNT6 -0.16 0.31 -9999 0 -0.69 255 255
WNT4 -0.021 0.12 -9999 0 -0.55 43 43
NFAT1/CK1 alpha -0.16 0.23 -9999 0 -0.63 147 147
GNG2 -0.011 0.092 -9999 0 -0.79 15 15
WNT5A -0.016 0.1 -9999 0 -0.61 28 28
WNT11 -0.17 0.32 -9999 0 -0.76 242 242
CDC42 -0.11 0.24 -9999 0 -0.63 118 118
Nongenotropic Androgen signaling

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.011 0.001 -10000 0 -10000 0 0
GNB1/GNG2 -0.071 0.17 -10000 0 -0.48 159 159
regulation of S phase of mitotic cell cycle -0.044 0.12 -10000 0 -0.34 152 152
GNAO1 -0.03 0.13 -10000 0 -0.79 26 26
HRAS -0.003 0.028 -10000 0 -10000 0 0
SHBG/T-DHT 0 0 -10000 0 -10000 0 0
PELP1 0 0 -10000 0 -10000 0 0
AKT1 0.011 0.001 -10000 0 -10000 0 0
MAP2K1 -0.045 0.16 -10000 0 -0.42 146 146
T-DHT/AR -0.082 0.21 -10000 0 -0.61 147 147
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.002 0.004 -10000 0 -0.007 328 328
GNAI2 0 0 -10000 0 -10000 0 0
GNAI3 0 0 -10000 0 -10000 0 0
GNAI1 -0.045 0.18 -10000 0 -0.79 62 62
mol:GDP -0.084 0.21 -10000 0 -0.61 150 150
cell proliferation -0.11 0.24 -10000 0 -0.55 113 113
PIK3CA 0 0.009 -10000 0 -0.29 1 1
FOS -0.23 0.42 -10000 0 -0.86 329 329
mol:Ca2+ -0.017 0.028 -10000 0 -0.076 151 151
MAPK3 -0.076 0.2 -10000 0 -0.6 66 66
MAPK1 -0.047 0.12 -10000 0 -0.3 66 66
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
mol:IP3 -0.001 0.002 -10000 0 -0.005 329 329
cAMP biosynthetic process 0.013 0.025 -10000 0 -10000 0 0
GNG2 -0.011 0.092 -10000 0 -0.79 15 15
potassium channel inhibitor activity -0.001 0.002 -10000 0 -0.005 329 329
HRAS/GTP -0.068 0.15 -10000 0 -0.45 146 146
actin cytoskeleton reorganization -0.005 0.047 -10000 0 -0.42 14 14
SRC 0 0.009 -10000 0 -0.29 1 1
voltage-gated calcium channel activity -0.001 0.002 -10000 0 -0.005 329 329
PI3K -0.007 0.059 -10000 0 -0.52 14 14
apoptosis 0.11 0.23 0.43 329 -10000 0 329
T-DHT/AR/PELP1 -0.071 0.18 -10000 0 -0.53 146 146
HRAS/GDP -0.08 0.2 -10000 0 -0.58 148 148
CREB1 -0.12 0.24 -10000 0 -0.46 329 329
RAC1-CDC42/GTP -0.006 0.048 -10000 0 -0.43 14 14
AR -0.11 0.27 -10000 0 -0.79 147 147
GNB1 0 0 -10000 0 -10000 0 0
RAF1 -0.045 0.16 -10000 0 -0.44 146 146
RAC1-CDC42/GDP -0.075 0.19 -10000 0 -0.55 146 146
T-DHT/AR/PELP1/Src -0.065 0.16 -10000 0 -0.48 146 146
MAP2K2 -0.045 0.16 -10000 0 -0.49 65 65
T-DHT/AR/PELP1/Src/PI3K -0.044 0.12 -10000 0 -0.35 152 152
GNAZ -0.007 0.075 -10000 0 -0.79 10 10
SHBG 0 0 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.04 0.11 -10000 0 -0.48 40 40
mol:T-DHT -0.001 0.001 0.001 63 -0.003 263 326
RAC1 0 0 -10000 0 -10000 0 0
GNRH1 0.006 0.056 -10000 0 -0.61 9 9
Gi family/GTP -0.051 0.1 -10000 0 -0.3 98 98
CDC42 0 0 -10000 0 -10000 0 0
Glypican 1 network

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer -0.22 0.26 -10000 0 -0.52 452 452
fibroblast growth factor receptor signaling pathway -0.22 0.26 -10000 0 -0.52 452 452
LAMA1 -0.088 0.25 -10000 0 -0.77 124 124
PRNP -0.013 0.1 -10000 0 -0.79 18 18
GPC1/SLIT2 -0.07 0.19 -10000 0 -0.6 125 125
SMAD2 0.01 0.1 -10000 0 -0.47 50 50
GPC1/PrPc/Cu2+ -0.01 0.069 -10000 0 -0.52 19 19
GPC1/Laminin alpha1 -0.068 0.19 -10000 0 -0.6 121 121
TDGF1 -0.005 0.063 -10000 0 -0.79 7 7
CRIPTO/GPC1 -0.006 0.053 -10000 0 -0.6 8 8
APP/GPC1 -0.002 0.023 -10000 0 -0.6 1 1
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.02 0.051 -10000 0 -0.52 9 9
FLT1 -0.001 0.024 -10000 0 -0.79 1 1
GPC1/TGFB/TGFBR1/TGFBR2 -0.025 0.11 -10000 0 -0.52 50 50
SERPINC1 -0.018 0.07 -10000 0 -0.29 67 67
FYN 0.02 0.053 -10000 0 -0.52 10 10
FGR 0.02 0.051 -10000 0 -0.52 9 9
positive regulation of MAPKKK cascade 0.032 0.066 -10000 0 -0.52 10 10
SLIT2 -0.089 0.25 -10000 0 -0.79 124 124
GPC1/NRG -0.22 0.29 -10000 0 -0.6 402 402
NRG1 -0.29 0.38 -10000 0 -0.78 406 406
GPC1/VEGF165 homodimer/VEGFR1 homodimer -0.003 0.029 -10000 0 -0.52 2 2
LYN 0.021 0.048 -10000 0 -0.51 8 8
mol:Spermine 0.009 0.024 -10000 0 -0.61 1 1
cell growth -0.22 0.26 -10000 0 -0.52 452 452
BMP signaling pathway 0.002 0.032 0.36 7 -10000 0 7
SRC 0.021 0.048 -10000 0 -0.51 8 8
TGFBR1 0 0.009 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.26 0.37 -10000 0 -0.75 382 382
GPC1 -0.002 0.032 -10000 0 -0.36 7 7
TGFBR1 (dimer) 0 0.009 -10000 0 -10000 0 0
VEGFA -0.003 0.031 -10000 0 -0.29 12 12
BLK -0.006 0.082 -10000 0 -0.56 10 10
HCK 0.018 0.052 -10000 0 -0.51 8 8
FGF2 -0.32 0.39 -10000 0 -0.79 446 446
FGFR1 -0.009 0.08 -10000 0 -0.68 14 14
VEGFR1 homodimer -0.001 0.024 -10000 0 -0.79 1 1
TGFBR2 -0.035 0.16 -10000 0 -0.79 49 49
cell death -0.002 0.023 -10000 0 -0.6 1 1
ATIII/GPC1 -0.013 0.05 -10000 0 -0.61 1 1
PLA2G2A/GPC1 -0.2 0.28 -10000 0 -0.6 356 356
LCK 0.008 0.082 -10000 0 -0.53 21 21
neuron differentiation -0.22 0.29 -10000 0 -0.6 402 402
PrPc/Cu2+ -0.01 0.077 -10000 0 -0.61 18 18
APP 0 0 -10000 0 -10000 0 0
TGFBR2 (dimer) -0.035 0.16 -10000 0 -0.79 49 49
IL6-mediated signaling events

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.065 0.22 -9999 0 -0.68 40 40
CRP -0.07 0.22 -9999 0 -0.66 50 50
cell cycle arrest -0.084 0.24 -9999 0 -0.71 71 71
TIMP1 -0.063 0.2 -9999 0 -0.56 63 63
IL6ST -0.086 0.26 -9999 0 -0.78 138 138
Rac1/GDP -0.12 0.23 -9999 0 -0.67 91 91
AP1 -0.13 0.23 -9999 0 -0.48 270 270
GAB2 0.005 0.043 -9999 0 -0.39 10 10
TNFSF11 -0.076 0.22 -9999 0 -0.67 45 45
HSP90B1 0.015 0.047 -9999 0 -10000 0 0
GAB1 0.008 0.006 -9999 0 -10000 0 0
MAPK14 -0.13 0.25 -9999 0 -0.72 96 96
AKT1 0.038 0.042 -9999 0 -10000 0 0
FOXO1 0.046 0.061 -9999 0 -0.42 12 12
MAP2K6 -0.15 0.26 -9999 0 -0.68 119 119
mol:GTP 0 0.001 -9999 0 -10000 0 0
MAP2K4 -0.086 0.23 -9999 0 -0.64 88 88
MITF -0.14 0.26 -9999 0 -0.49 229 229
positive regulation of NF-kappaB transcription factor activity 0 0 -9999 0 -10000 0 0
TYK2 0 0 -9999 0 -10000 0 0
A2M 0.013 0.13 -9999 0 -1.5 8 8
CEBPB 0.016 0.007 -9999 0 -10000 0 0
GRB2/SOS1/GAB family/SHP2 -0.044 0.093 -9999 0 -0.59 5 5
STAT3 -0.091 0.26 -9999 0 -0.77 71 71
STAT1 -0.013 0.021 -9999 0 -10000 0 0
CEBPD -0.067 0.22 -9999 0 -0.64 63 63
PIK3CA 0.012 0.009 -9999 0 -0.29 1 1
PI3K -0.008 0.067 -9999 0 -0.6 14 14
JUN -0.005 0.063 -9999 0 -0.79 7 7
PIAS3/MITF -0.16 0.22 -9999 0 -0.7 91 91
MAPK11 -0.13 0.25 -9999 0 -0.73 97 97
STAT3 (dimer)/FOXO1 -0.036 0.22 -9999 0 -0.6 63 63
GRB2/SOS1/GAB family -0.14 0.2 -9999 0 -0.72 71 71
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.16 0.26 -9999 0 -0.38 502 502
GRB2 0.008 0.011 -9999 0 -0.29 1 1
JAK2 -0.001 0.024 -9999 0 -0.79 1 1
LBP -0.24 0.45 -9999 0 -0.96 277 277
PIK3R1 0.002 0.09 -9999 0 -0.79 14 14
JAK1 0.009 0.025 -9999 0 -0.79 1 1
MYC -0.078 0.26 -9999 0 -0.8 69 69
FGG -0.075 0.22 -9999 0 -0.63 63 63
macrophage differentiation -0.084 0.24 -9999 0 -0.71 71 71
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.23 0.28 -9999 0 -0.5 504 504
JUNB -0.064 0.21 -9999 0 -0.6 64 64
FOS -0.24 0.36 -9999 0 -0.79 329 329
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.15 0.26 -9999 0 -0.42 382 382
STAT1/PIAS1 -0.13 0.23 -9999 0 -0.5 181 181
GRB2/SOS1/GAB family/SHP2/PI3K 0.002 0.037 -9999 0 -0.32 2 2
STAT3 (dimer) -0.087 0.25 -9999 0 -0.74 71 71
PRKCD -0.061 0.22 -9999 0 -0.61 78 78
IL6R -0.022 0.16 -9999 0 -0.79 44 44
SOCS3 -0.12 0.24 -9999 0 -0.74 87 87
gp130 (dimer)/JAK1/JAK1/LMO4 -0.057 0.18 -9999 0 -0.52 140 140
Rac1/GTP -0.15 0.21 -9999 0 -0.67 91 91
HCK -0.004 0.033 -9999 0 -0.29 14 14
MAPKKK cascade -0.006 0.084 -9999 0 -1 2 2
bone resorption -0.072 0.21 -9999 0 -0.62 49 49
IRF1 -0.066 0.22 -9999 0 -0.62 63 63
mol:GDP -0.13 0.25 -9999 0 -0.48 218 218
SOS1 0 0.003 -9999 0 -10000 0 0
VAV1 -0.13 0.25 -9999 0 -0.49 218 218
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.16 0.25 -9999 0 -0.8 92 92
PTPN11 -0.013 0.019 -9999 0 -10000 0 0
IL6/IL6RA -0.24 0.31 -9999 0 -0.62 419 419
gp130 (dimer)/TYK2/TYK2/LMO4 -0.06 0.18 -9999 0 -0.51 140 140
gp130 (dimer)/JAK2/JAK2/LMO4 -0.06 0.18 -9999 0 -0.52 140 140
IL6 -0.28 0.38 -9999 0 -0.78 401 401
PIAS3 0 0 -9999 0 -10000 0 0
PTPRE 0.003 0.035 -9999 0 -0.79 2 2
PIAS1 0 0 -9999 0 -10000 0 0
RAC1 0 0 -9999 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.18 0.24 -9999 0 -0.4 503 503
LMO4 0.009 0.049 -9999 0 -0.44 10 10
STAT3 (dimer)/PIAS3 -0.15 0.21 -9999 0 -0.78 70 70
MCL1 0.05 0.035 -9999 0 -10000 0 0
Neurotrophic factor-mediated Trk receptor signaling

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0 0 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.1 0.12 -10000 0 -0.33 85 85
NT3 (dimer)/TRKC -0.29 0.36 -10000 0 -0.68 465 465
NT3 (dimer)/TRKB -0.49 0.44 -10000 0 -0.77 696 696
SHC/Grb2/SOS1/GAB1/PI3K -0.004 0.036 -10000 0 -0.32 14 14
RAPGEF1 0 0 -10000 0 -10000 0 0
BDNF -0.064 0.21 -10000 0 -0.66 105 105
PIK3CA 0 0.009 -10000 0 -0.29 1 1
DYNLT1 0 0 -10000 0 -10000 0 0
NTRK1 -0.011 0.07 -10000 0 -0.37 33 33
NTRK2 -0.41 0.39 -10000 0 -0.79 573 573
NTRK3 -0.27 0.37 -10000 0 -0.78 377 377
NT-4/5 (dimer)/TRKB -0.58 0.48 -10000 0 -0.84 746 746
neuron apoptosis 0.24 0.24 0.58 298 -10000 0 298
SHC 2-3/Grb2 -0.26 0.27 -10000 0 -0.66 298 298
SHC1 0 0 -10000 0 -10000 0 0
SHC2 -0.24 0.29 -10000 0 -0.6 351 351
SHC3 -0.24 0.28 -10000 0 -0.66 287 287
STAT3 (dimer) -0.005 0.03 -10000 0 -0.38 4 4
NT3 (dimer)/TRKA -0.24 0.31 -10000 0 -0.6 434 434
RIN/GDP -0.065 0.12 -10000 0 -0.28 66 66
GIPC1 0 0.009 -10000 0 -0.29 1 1
KRAS -0.001 0.013 -10000 0 -0.29 2 2
DNAJA3 -0.14 0.2 -10000 0 -0.43 342 342
RIN/GTP -0.001 0.01 -10000 0 -10000 0 0
CCND1 0.018 0.075 -10000 0 -1 4 4
MAGED1 -0.001 0.018 -10000 0 -0.29 4 4
PTPN11 0 0 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) -0.27 0.37 -10000 0 -0.79 371 371
SHC/GRB2/SOS1 0 0.004 -10000 0 -10000 0 0
GRB2 0 0.009 -10000 0 -0.29 1 1
NGF (dimer)/TRKA/MATK -0.028 0.11 -10000 0 -0.53 41 41
TRKA/NEDD4-2 -0.008 0.053 -10000 0 -0.6 6 6
ELMO1 0 0 -10000 0 -10000 0 0
RhoG/GTP/ELMO1/DOCK1 0 0 -10000 0 -10000 0 0
NGF -0.014 0.098 -10000 0 -0.62 24 24
HRAS -0.003 0.028 -10000 0 -10000 0 0
DOCK1 0 0 -10000 0 -10000 0 0
GAB2 -0.004 0.042 -10000 0 -0.39 10 10
RIT2 -0.001 0.015 -10000 0 -0.29 3 3
RIT1 0 0 -10000 0 -10000 0 0
FRS2 -0.003 0.029 -10000 0 -0.29 11 11
DNM1 -0.005 0.063 -10000 0 -0.73 8 8
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0 0 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP -0.13 0.2 -10000 0 -0.42 342 342
mol:GDP -0.1 0.18 -10000 0 -0.36 231 231
NGF (dimer) -0.014 0.097 -10000 0 -0.62 24 24
RhoG/GDP 0 0 -10000 0 -10000 0 0
RIT1/GDP -0.061 0.12 -10000 0 -0.27 66 66
TIAM1 -0.001 0.018 -10000 0 -0.29 4 4
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
BDNF (dimer)/TRKB -0.31 0.3 -10000 0 -0.56 598 598
KIDINS220/CRKL/C3G 0 0 -10000 0 -10000 0 0
SHC/RasGAP 0 0 -10000 0 -10000 0 0
FRS2 family/SHP2 -0.001 0.014 -10000 0 -10000 0 0
SHC/GRB2/SOS1/GAB1 0 0.004 -10000 0 -10000 0 0
RIT1/GTP 0 0 -10000 0 -10000 0 0
NT3 (dimer) -0.13 0.29 -10000 0 -0.79 172 172
RAP1/GDP -0.072 0.084 -10000 0 -0.25 14 14
KIDINS220/CRKL 0 0 -10000 0 -10000 0 0
BDNF (dimer) -0.064 0.21 -10000 0 -0.66 105 105
ubiquitin-dependent protein catabolic process -0.015 0.076 -10000 0 -0.51 22 22
Schwann cell development -0.058 0.044 -10000 0 -10000 0 0
EHD4 0 0 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 -0.001 0.012 -10000 0 -10000 0 0
FRS2 family/SHP2/CRK family/C3G/GAB2 -0.001 0.011 -10000 0 -10000 0 0
RAP1B 0 0 -10000 0 -10000 0 0
RAP1A 0 0 -10000 0 -10000 0 0
CDC42/GTP -0.42 0.38 -10000 0 -0.82 428 428
ABL1 0 0 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0 0.006 -10000 0 -10000 0 0
Rap1/GTP -0.1 0.097 -10000 0 -10000 0 0
STAT3 -0.005 0.03 -10000 0 -0.38 4 4
axon guidance -0.4 0.34 -10000 0 -0.76 430 430
MAPK3 0.006 0.1 -10000 0 -0.5 38 38
MAPK1 0.006 0.1 -10000 0 -0.5 38 38
CDC42/GDP -0.061 0.12 -10000 0 -0.27 67 67
NTF3 -0.13 0.29 -10000 0 -0.79 172 172
NTF4 -0.27 0.37 -10000 0 -0.79 371 371
NGF (dimer)/TRKA/FAIM -0.015 0.075 -10000 0 -0.52 21 21
PI3K -0.008 0.068 -10000 0 -0.6 14 14
FRS3 0 0 -10000 0 -10000 0 0
FAIM 0 0 -10000 0 -10000 0 0
GAB1 0 0 -10000 0 -10000 0 0
RASGRF1 -0.15 0.21 -10000 0 -0.45 345 345
SOS1 0 0 -10000 0 -10000 0 0
MCF2L -0.24 0.33 -10000 0 -0.59 467 467
RGS19 -0.001 0.013 -10000 0 -0.29 2 2
CDC42 0 0 -10000 0 -10000 0 0
RAS family/GTP -0.001 0.082 -10000 0 -10000 0 0
Rac1/GDP -0.061 0.12 -10000 0 -0.28 55 55
NGF (dimer)/TRKA/GRIT -0.015 0.076 -10000 0 -0.52 21 21
neuron projection morphogenesis -0.1 0.21 -10000 0 -0.65 26 26
NGF (dimer)/TRKA/NEDD4-2 -0.015 0.076 -10000 0 -0.52 22 22
MAP2K1 0 0.003 -10000 0 -10000 0 0
NGFR -0.24 0.36 -10000 0 -0.79 334 334
NGF (dimer)/TRKA/GIPC/GAIP -0.009 0.053 -10000 0 -0.33 27 27
RAS family/GTP/PI3K -0.005 0.038 -10000 0 -0.34 14 14
FRS2 family/SHP2/GRB2/SOS1 -0.001 0.011 -10000 0 -10000 0 0
NRAS -0.001 0.013 -10000 0 -0.29 2 2
GRB2/SOS1 0 0.006 -10000 0 -10000 0 0
PRKCI 0 0.009 -10000 0 -0.29 1 1
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0 0 -10000 0 -10000 0 0
PRKCZ -0.001 0.024 -10000 0 -0.79 1 1
MAPKKK cascade -0.064 0.12 -10000 0 -0.82 21 21
RASA1 0 0 -10000 0 -10000 0 0
TRKA/c-Abl -0.008 0.05 -10000 0 -0.6 5 5
SQSTM1 0 0.009 -10000 0 -0.29 1 1
BDNF (dimer)/TRKB/GIPC -0.28 0.27 -10000 0 -0.51 598 598
NGF (dimer)/TRKA/p62/Atypical PKCs -0.012 0.064 -10000 0 -0.44 22 22
MATK -0.022 0.11 -10000 0 -0.48 49 49
NEDD4L -0.001 0.024 -10000 0 -0.79 1 1
RAS family/GDP -0.065 0.078 -10000 0 -10000 0 0
NGF (dimer)/TRKA -0.15 0.22 -10000 0 -0.46 342 342
Rac1/GTP -0.12 0.14 -10000 0 -0.34 261 261
FRS2 family/SHP2/CRK family -0.001 0.01 -10000 0 -10000 0 0
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 -0.1 0.23 -10000 0 -0.6 188 188
CRKL -0.04 0.16 -10000 0 -0.34 188 188
mol:PIP3 -0.018 0.035 0.77 2 -10000 0 2
AKT1 0.003 0.021 0.48 2 -10000 0 2
PTK2B 0 0 -10000 0 -10000 0 0
RAPGEF1 -0.03 0.15 -10000 0 -0.54 21 21
RANBP10 0 0 -10000 0 -10000 0 0
PIK3CA 0 0.009 -10000 0 -0.29 1 1
HGF/MET/SHIP2 -0.12 0.24 -10000 0 -0.56 240 240
MAP3K5 -0.021 0.15 -10000 0 -0.53 25 25
HGF/MET/CIN85/CBL/ENDOPHILINS -0.11 0.22 -10000 0 -0.51 240 240
AP1 -0.19 0.26 -10000 0 -0.58 330 330
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0 0 -10000 0 -10000 0 0
apoptosis -0.24 0.37 -10000 0 -0.78 330 330
STAT3 (dimer) -0.039 0.16 -10000 0 -0.62 21 21
GAB1/CRKL/SHP2/PI3K -0.066 0.13 -10000 0 -0.55 31 31
INPP5D 0 0 -10000 0 -10000 0 0
CBL/CRK -0.032 0.15 -10000 0 -0.54 21 21
PTPN11 0 0 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0 0 -10000 0 -10000 0 0
PTEN -0.001 0.034 -10000 0 -0.79 2 2
ELK1 -0.044 0.1 -10000 0 -0.27 188 188
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 -0.046 0.092 -10000 0 -0.41 21 21
PAK1 0.008 0.028 0.45 2 -10000 0 2
HGF/MET/RANBP10 -0.12 0.24 -10000 0 -0.56 240 240
HRAS -0.15 0.3 -10000 0 -0.76 191 191
DOCK1 -0.03 0.15 -10000 0 -0.54 21 21
GAB1 -0.05 0.16 -10000 0 -0.35 240 240
CRK -0.04 0.16 -10000 0 -0.58 21 21
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.15 0.3 -10000 0 -0.7 240 240
JUN -0.005 0.063 -10000 0 -0.79 7 7
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.078 0.15 -10000 0 -0.35 240 240
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
cell morphogenesis -0.019 0.18 -10000 0 -0.59 31 31
GRB2/SHC -0.066 0.13 -10000 0 -0.33 188 188
FOS -0.24 0.36 -10000 0 -0.79 329 329
GLMN 0 0 -10000 0 -10000 0 0
cell motility -0.044 0.1 -10000 0 -0.27 188 188
HGF/MET/MUC20 -0.12 0.24 -10000 0 -0.56 240 240
cell migration -0.065 0.13 -10000 0 -0.32 188 188
GRB2 0 0.009 -10000 0 -0.29 1 1
CBL 0 0 -10000 0 -10000 0 0
MET/RANBP10 -0.1 0.23 -10000 0 -0.6 188 188
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.077 0.15 -10000 0 -0.35 240 240
MET/MUC20 -0.1 0.23 -10000 0 -0.61 188 188
RAP1B -0.021 0.14 -10000 0 -0.5 21 21
RAP1A -0.021 0.14 -10000 0 -0.5 21 21
HGF/MET/RANBP9 -0.12 0.24 -10000 0 -0.56 240 240
RAF1 -0.1 0.29 -10000 0 -0.71 188 188
STAT3 -0.073 0.14 -10000 0 -0.63 21 21
cell proliferation -0.061 0.23 -10000 0 -0.48 240 240
RPS6KB1 -0.027 0.052 -10000 0 -0.18 21 21
MAPK3 -0.044 0.092 -10000 0 -0.24 188 188
MAPK1 -0.044 0.092 -10000 0 -0.24 188 188
RANBP9 0 0 -10000 0 -10000 0 0
MAPK8 -0.004 0.14 -10000 0 -0.48 33 33
SRC -0.071 0.14 -10000 0 -0.61 21 21
PI3K -0.072 0.14 -10000 0 -0.35 197 197
MET/Glomulin -0.094 0.21 -10000 0 -0.55 188 188
SOS1 0 0 -10000 0 -10000 0 0
MAP2K1 -0.086 0.27 -10000 0 -0.64 188 188
MET -0.14 0.3 -10000 0 -0.78 189 189
MAP4K1 -0.03 0.15 -10000 0 -0.5 27 27
PTK2 0 0 -10000 0 -10000 0 0
MAP2K2 -0.086 0.27 -10000 0 -0.64 188 188
BAD 0.011 0.02 0.45 2 -10000 0 2
MAP2K4 -0.011 0.14 -10000 0 -0.47 26 26
SHP2/GRB2/SOS1/GAB1 -0.096 0.19 -10000 0 -0.5 188 188
INPPL1 0 0 -10000 0 -10000 0 0
PXN 0 0 -10000 0 -10000 0 0
SH3KBP1 0 0 -10000 0 -10000 0 0
HGS -0.071 0.14 -10000 0 -0.35 188 188
PLCgamma1/PKC 0 0 -10000 0 -10000 0 0
HGF -0.053 0.2 -10000 0 -0.79 73 73
RASA1 0 0 -10000 0 -10000 0 0
NCK1 0 0 -10000 0 -10000 0 0
PTPRJ 0 0 -10000 0 -10000 0 0
NCK/PLCgamma1 -0.067 0.13 -10000 0 -0.32 188 188
PDPK1 -0.006 0.025 0.56 2 -10000 0 2
HGF/MET/SHIP -0.12 0.24 -10000 0 -0.56 240 240
Aurora C signaling

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0 0 -9999 0 -10000 0 0
Aurora C/Aurora B/INCENP -0.076 0.068 -9999 0 -0.3 12 12
metaphase 0 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
H3F3B -0.02 0.018 -9999 0 -10000 0 0
AURKB -0.17 0.14 -9999 0 -0.29 625 625
AURKC -0.005 0.043 -9999 0 -0.32 18 18
Integrins in angiogenesis

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.005 0.048 -9999 0 -0.6 6 6
alphaV beta3 Integrin -0.23 0.28 -9999 0 -0.54 459 459
PTK2 -0.089 0.19 -9999 0 -0.64 49 49
IGF1R -0.02 0.12 -9999 0 -0.6 36 36
PI4KB 0 0 -9999 0 -10000 0 0
MFGE8 -0.012 0.091 -9999 0 -0.62 21 21
SRC 0 0.009 -9999 0 -0.29 1 1
CDKN1B -0.088 0.12 -9999 0 -0.88 11 11
VEGFA -0.003 0.031 -9999 0 -0.29 12 12
ILK -0.086 0.12 -9999 0 -0.83 8 8
ROCK1 -0.001 0.024 -9999 0 -0.79 1 1
AKT1 -0.076 0.1 -9999 0 -0.77 8 8
PTK2B -0.019 0.095 -9999 0 -0.49 38 38
alphaV/beta3 Integrin/JAM-A -0.2 0.24 -9999 0 -0.47 463 463
CBL 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 -0.019 0.095 -9999 0 -0.52 37 37
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.14 0.25 -9999 0 -0.54 271 271
VEGF/Rho/ROCK/alphaV/beta3 Integrin -0.013 0.062 -9999 0 -0.46 10 10
alphaV/beta3 Integrin/Syndecan-1 -0.028 0.1 -9999 0 -0.53 38 38
PI4KA 0 0 -9999 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.33 0.35 -9999 0 -0.63 541 541
PI4 Kinase 0 0 -9999 0 -10000 0 0
PIK3CA 0 0.009 -9999 0 -0.29 1 1
alphaV/beta3 Integrin/Osteopontin -0.056 0.11 -9999 0 -0.54 37 37
RPS6KB1 -0.3 0.32 -9999 0 -0.69 355 355
TLN1 0 0 -9999 0 -10000 0 0
MAPK3 -0.33 0.39 -9999 0 -0.76 459 459
GPR124 -0.009 0.085 -9999 0 -0.79 13 13
MAPK1 -0.33 0.39 -9999 0 -0.76 459 459
PXN 0 0 -9999 0 -10000 0 0
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
alphaV/beta3 Integrin/Tumstatin -0.1 0.21 -9999 0 -0.53 214 214
cell adhesion -0.023 0.11 -9999 0 -0.51 47 47
ANGPTL3 -0.001 0.018 -9999 0 -0.29 4 4
VEGFR2 homodimer/VEGFA homodimer/Src -0.005 0.041 -9999 0 -0.52 6 6
IGF-1R heterotetramer -0.02 0.12 -9999 0 -0.59 36 36
Rac1/GDP 0 0 -9999 0 -10000 0 0
TGFBR2 -0.035 0.16 -9999 0 -0.79 49 49
ITGB3 -0.028 0.14 -9999 0 -0.74 41 41
IGF1 -0.18 0.33 -9999 0 -0.79 247 247
RAC1 0 0 -9999 0 -10000 0 0
regulation of cell-matrix adhesion -0.024 0.12 -9999 0 -0.59 43 43
apoptosis 0 0 -9999 0 -10000 0 0
CD47 -0.001 0.024 -9999 0 -0.79 1 1
alphaV/beta3 Integrin/CD47 -0.018 0.095 -9999 0 -0.52 38 38
VCL 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Del1 -0.05 0.18 -9999 0 -0.65 80 80
CSF1 -0.006 0.071 -9999 0 -0.79 9 9
PIK3C2A -0.087 0.12 -9999 0 -0.85 9 9
PI4 Kinase/Pyk2 -0.17 0.21 -9999 0 -0.6 76 76
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin -0.02 0.1 -9999 0 -0.53 38 38
FAK1/Vinculin -0.064 0.16 -9999 0 -0.5 45 45
alphaV beta3/Integrin/ppsTEM5 -0.024 0.12 -9999 0 -0.59 43 43
RHOA 0 0 -9999 0 -10000 0 0
VTN -0.027 0.1 -9999 0 -0.34 88 88
BCAR1 0 0 -9999 0 -10000 0 0
FGF2 -0.32 0.39 -9999 0 -0.79 446 446
F11R -0.23 0.31 -9999 0 -0.6 446 446
alphaV/beta3 Integrin/Lactadherin -0.025 0.12 -9999 0 -0.57 46 46
alphaV/beta3 Integrin/TGFBR2 -0.04 0.16 -9999 0 -0.66 66 66
alphaV/beta3 Integrin/c-FMS/Cbl/Cas -0.004 0.042 -9999 0 -0.47 9 9
HSP90AA1 0 0.009 -9999 0 -0.29 1 1
alphaV/beta3 Integrin/Talin -0.017 0.086 -9999 0 -0.48 37 37
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.12 0.14 -9999 0 -0.29 431 431
alphaV/beta3 Integrin/Pyk2 -0.019 0.096 -9999 0 -0.5 38 38
SDC1 -0.02 0.076 -9999 0 -0.3 73 73
VAV3 -0.008 0.054 -9999 0 -0.44 16 16
PTPN11 0 0 -9999 0 -10000 0 0
IRS1 -0.032 0.16 -9999 0 -0.79 45 45
FAK1/Paxillin -0.064 0.16 -9999 0 -0.5 45 45
cell migration -0.05 0.14 -9999 0 -0.45 42 42
ITGAV 0 0 -9999 0 -10000 0 0
PI3K -0.19 0.23 -9999 0 -0.43 466 466
SPP1 -0.077 0.13 -9999 0 -0.29 288 288
KDR -0.004 0.058 -9999 0 -0.79 6 6
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0 0 -9999 0 -10000 0 0
COL4A3 -0.13 0.29 -9999 0 -0.78 187 187
angiogenesis -0.3 0.39 -9999 0 -0.74 461 461
Rac1/GTP -0.007 0.049 -9999 0 -0.4 16 16
EDIL3 -0.052 0.19 -9999 0 -0.7 81 81
cell proliferation -0.04 0.16 -9999 0 -0.65 66 66
Plasma membrane estrogen receptor signaling

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.095 0.18 -10000 0 -0.46 197 197
ER alpha/Gai/GDP/Gbeta gamma -0.093 0.19 -10000 0 -0.48 180 180
AKT1 -0.1 0.32 -10000 0 -0.84 167 167
PIK3CA 0 0.009 -10000 0 -0.29 1 1
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.1 0.32 -10000 0 -0.85 166 166
mol:Ca2+ -0.028 0.15 -10000 0 -0.45 93 93
IGF1R -0.02 0.12 -10000 0 -0.6 36 36
E2/ER alpha (dimer)/Striatin -0.11 0.2 -10000 0 -0.53 183 183
SHC1 0 0 -10000 0 -10000 0 0
apoptosis 0.094 0.3 0.8 167 -10000 0 167
RhoA/GTP -0.069 0.14 -10000 0 -0.39 165 165
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.093 0.2 -10000 0 -0.54 175 175
regulation of stress fiber formation 0.023 0.14 0.45 12 -10000 0 12
E2/ERA-ERB (dimer) -0.11 0.2 -10000 0 -0.54 187 187
KRAS -0.001 0.013 -10000 0 -0.29 2 2
G13/GTP -0.088 0.17 -10000 0 -0.48 165 165
pseudopodium formation -0.023 0.14 -10000 0 -0.45 12 12
E2/ER alpha (dimer)/PELP1 -0.096 0.19 -10000 0 -0.52 165 165
GRB2 0 0.009 -10000 0 -0.29 1 1
GNG2 -0.011 0.092 -10000 0 -0.79 15 15
GNAO1 -0.03 0.13 -10000 0 -0.79 26 26
HRAS -0.003 0.028 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.061 0.22 -10000 0 -0.54 176 176
E2/ER beta (dimer) -0.013 0.089 -10000 0 -0.61 24 24
mol:GDP -0.086 0.2 -10000 0 -0.53 187 187
mol:NADP -0.061 0.22 -10000 0 -0.54 176 176
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
mol:IP3 -0.03 0.15 -10000 0 -0.47 93 93
IGF-1R heterotetramer -0.02 0.12 -10000 0 -0.59 36 36
PLCB1 -0.065 0.14 -10000 0 -0.49 92 92
PLCB2 -0.034 0.089 -10000 0 -0.62 15 15
IGF1 -0.18 0.33 -10000 0 -0.79 247 247
mol:L-citrulline -0.061 0.22 -10000 0 -0.54 176 176
RHOA 0 0 -10000 0 -10000 0 0
Gai/GDP -0.04 0.15 -10000 0 -0.85 26 26
JNK cascade -0.013 0.089 -10000 0 -0.61 24 24
BCAR1 0 0 -10000 0 -10000 0 0
ESR2 -0.017 0.12 -10000 0 -0.79 24 24
GNAQ -0.002 0.041 -10000 0 -0.79 3 3
ESR1 -0.15 0.28 -10000 0 -0.79 165 165
Gq family/GDP/Gbeta gamma -0.009 0.078 -10000 0 -0.71 9 9
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.023 0.13 -10000 0 -0.35 18 18
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.093 0.2 -10000 0 -0.54 175 175
GNAZ -0.007 0.075 -10000 0 -0.79 10 10
E2/ER alpha (dimer) -0.11 0.22 -10000 0 -0.61 165 165
STRN -0.015 0.11 -10000 0 -0.79 21 21
GNAL -0.19 0.33 -10000 0 -0.79 258 258
PELP1 0 0 -10000 0 -10000 0 0
MAPK11 0.005 0.084 -10000 0 -0.52 27 27
GNAI2 0 0 -10000 0 -10000 0 0
GNAI3 0 0 -10000 0 -10000 0 0
GNAI1 -0.045 0.18 -10000 0 -0.79 62 62
HBEGF -0.071 0.19 -10000 0 -0.45 187 187
cAMP biosynthetic process -0.19 0.25 -10000 0 -0.5 389 389
SRC -0.052 0.2 -10000 0 -0.45 177 177
PI3K -0.008 0.068 -10000 0 -0.6 14 14
GNB1 0 0 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma -0.079 0.18 -10000 0 -0.46 197 197
SOS1 0 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.15 0.23 -10000 0 -0.52 241 241
Gs family/GTP -0.19 0.26 -10000 0 -0.52 389 389
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP -0.002 0.014 -10000 0 -10000 0 0
vasodilation -0.057 0.21 -10000 0 -0.52 177 177
mol:DAG -0.03 0.15 -10000 0 -0.47 93 93
Gs family/GDP/Gbeta gamma -0.16 0.23 -10000 0 -0.51 239 239
MSN -0.027 0.15 -10000 0 -0.49 12 12
Gq family/GTP -0.038 0.094 -10000 0 -0.66 14 14
mol:PI-3-4-5-P3 -0.099 0.31 -10000 0 -0.82 166 166
NRAS -0.001 0.013 -10000 0 -0.29 2 2
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.057 0.21 0.52 177 -10000 0 177
GRB2/SOS1 0 0.006 -10000 0 -10000 0 0
RhoA/GDP -0.079 0.19 -10000 0 -0.49 187 187
NOS3 -0.066 0.24 -10000 0 -0.57 176 176
GNA11 -0.003 0.048 -10000 0 -0.79 4 4
MAPKKK cascade -0.069 0.26 -10000 0 -0.63 183 183
E2/ER alpha (dimer)/PELP1/Src -0.098 0.22 -10000 0 -0.56 175 175
ruffle organization -0.023 0.14 -10000 0 -0.45 12 12
ROCK2 -0.074 0.14 -10000 0 -0.55 12 12
GNA14 -0.013 0.084 -10000 0 -0.46 30 30
GNA15 -0.003 0.033 -10000 0 -0.36 8 8
GNA13 0 0 -10000 0 -10000 0 0
MMP9 -0.097 0.2 -10000 0 -0.48 184 184
MMP2 -0.045 0.19 -10000 0 -0.43 184 184
Signaling events mediated by PTP1B

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB -0.003 0.048 -10000 0 -0.79 4 4
Jak2/Leptin Receptor -0.16 0.23 -10000 0 -0.52 299 299
PTP1B/AKT1 -0.07 0.11 -10000 0 -0.34 115 115
FYN -0.001 0.034 -10000 0 -0.79 2 2
p210 bcr-abl/PTP1B -0.071 0.13 -10000 0 -0.38 119 119
EGFR -0.29 0.39 -10000 0 -0.79 410 410
EGF/EGFR -0.29 0.3 -10000 0 -0.56 554 554
CSF1 -0.006 0.071 -10000 0 -0.79 9 9
AKT1 0.001 0.003 -10000 0 -10000 0 0
INSR 0.001 0.01 -10000 0 -0.3 1 1
PTP1B/N-cadherin -0.097 0.12 -10000 0 -0.37 123 123
Insulin Receptor/Insulin -0.049 0.08 -10000 0 -0.4 22 22
HCK -0.004 0.033 -10000 0 -0.29 14 14
CRK 0 0 -10000 0 -10000 0 0
TYK2 -0.06 0.12 -10000 0 -0.36 115 115
EGF -0.15 0.32 -10000 0 -0.79 214 214
YES1 -0.001 0.024 -10000 0 -0.79 1 1
CAV1 -0.18 0.24 -10000 0 -0.51 298 298
TXN 0 0.018 -10000 0 -0.3 4 4
PTP1B/IRS1/GRB2 -0.087 0.14 -10000 0 -0.4 152 152
cell migration 0.071 0.13 0.38 119 -10000 0 119
STAT3 0 0.001 -10000 0 -10000 0 0
PRLR -0.006 0.072 -10000 0 -0.54 16 16
ITGA2B -0.018 0.078 -10000 0 -0.32 62 62
CSF1R -0.001 0.025 -10000 0 -0.54 2 2
Prolactin Receptor/Prolactin -0.007 0.058 -10000 0 -0.6 8 8
FGR -0.001 0.025 -10000 0 -0.54 2 2
PTP1B/p130 Cas -0.074 0.12 -10000 0 -0.36 117 117
Crk/p130 Cas -0.069 0.11 -10000 0 -0.36 97 97
DOK1 -0.046 0.12 -10000 0 -0.34 86 86
JAK2 -0.042 0.08 -10000 0 -0.32 31 31
Jak2/Leptin Receptor/Leptin -0.36 0.18 -10000 0 -0.49 558 558
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
PTPN1 -0.072 0.13 -10000 0 -0.39 119 119
LYN 0 0 -10000 0 -10000 0 0
CDH2 -0.054 0.12 -10000 0 -0.3 200 200
SRC -0.013 0.047 -10000 0 -10000 0 0
ITGB3 -0.028 0.14 -10000 0 -0.74 41 41
CAT1/PTP1B -0.084 0.17 -10000 0 -0.44 109 109
CAPN1 0.001 0.01 -10000 0 -10000 0 0
CSK 0 0 -10000 0 -10000 0 0
PI3K -0.044 0.094 -10000 0 -0.55 20 20
mol:H2O2 -0.005 0.005 -10000 0 -10000 0 0
STAT3 (dimer) -0.32 0.16 -10000 0 -0.43 544 544
negative regulation of transcription -0.041 0.079 -10000 0 -0.32 31 31
FCGR2A -0.001 0.013 -10000 0 -0.29 2 2
FER -0.007 0.08 -10000 0 -0.8 11 11
alphaIIb/beta3 Integrin -0.033 0.12 -10000 0 -0.62 40 40
BLK -0.044 0.11 -10000 0 -0.3 159 159
Insulin Receptor/Insulin/Shc 0 0.005 -10000 0 -10000 0 0
RHOA 0.002 0.004 -10000 0 -10000 0 0
LEPR -0.2 0.35 -10000 0 -0.79 292 292
BCAR1 0 0 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0 0.009 -10000 0 -0.29 1 1
mol:NADPH -0.005 0.005 -10000 0 -10000 0 0
TRPV6 -0.03 0.13 -10000 0 -0.44 22 22
PRL -0.004 0.032 -10000 0 -0.3 13 13
SOCS3 0.018 0.11 -10000 0 -1.5 6 6
SPRY2 -0.095 0.26 -10000 0 -0.8 130 130
Insulin Receptor/Insulin/IRS1 -0.022 0.11 -10000 0 -0.53 45 45
CSF1/CSF1R -0.073 0.12 -10000 0 -0.38 106 106
Ras protein signal transduction 0.037 0.036 -10000 0 -10000 0 0
IRS1 -0.032 0.16 -10000 0 -0.79 45 45
INS 0 0.001 -10000 0 -10000 0 0
LEP -0.64 0.31 -10000 0 -0.79 881 881
STAT5B -0.058 0.11 -10000 0 -0.31 122 122
STAT5A -0.059 0.11 -10000 0 -0.31 125 125
GRB2 0 0.009 -10000 0 -0.29 1 1
PDGFB-D/PDGFRB -0.076 0.12 -10000 0 -0.37 119 119
CSN2 0.018 0.035 -10000 0 -10000 0 0
PIK3CA 0 0.009 -10000 0 -0.29 1 1
LAT -0.014 0.053 -10000 0 -0.57 2 2
YBX1 -0.001 0.014 -10000 0 -10000 0 0
LCK -0.02 0.1 -10000 0 -0.41 53 53
SHC1 0 0 -10000 0 -10000 0 0
NOX4 -0.004 0.05 -10000 0 -0.41 13 13
amb2 Integrin signaling

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.023 0.062 -9999 0 -0.54 12 12
alphaM/beta2 Integrin/GPIbA -0.024 0.057 -9999 0 -0.48 11 11
alphaM/beta2 Integrin/proMMP-9 -0.083 0.082 -9999 0 -0.34 19 19
PLAUR -0.023 0.079 -9999 0 -0.29 86 86
HMGB1 -0.013 0.017 -9999 0 -10000 0 0
alphaM/beta2 Integrin/Talin -0.017 0.029 -9999 0 -0.3 1 1
AGER -0.015 0.04 -9999 0 -0.66 3 3
RAP1A 0 0 -9999 0 -10000 0 0
SELPLG 0 0 -9999 0 -10000 0 0
mol:LDL 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.074 0.096 -9999 0 -0.39 13 13
mol:GTP 0 0 -9999 0 -10000 0 0
MMP9 -0.13 0.15 -9999 0 -0.29 483 483
CYR61 -0.043 0.18 -9999 0 -0.79 59 59
TLN1 0 0 -9999 0 -10000 0 0
Rap1/GTP -0.057 0.11 -9999 0 -0.52 22 22
RHOA 0 0 -9999 0 -10000 0 0
P-selectin oligomer -0.18 0.33 -9999 0 -0.79 257 257
MYH2 -0.07 0.16 -9999 0 -0.4 125 125
MST1R -0.011 0.083 -9999 0 -0.55 21 21
leukocyte activation during inflammatory response -0.29 0.22 -9999 0 -0.46 668 668
APOB -0.48 0.38 -9999 0 -0.79 668 668
mol:GDP 0 0 -9999 0 -10000 0 0
complement component iC3b receptor activity 0 0 -9999 0 -10000 0 0
MMP2 -0.008 0.079 -9999 0 -0.75 12 12
JAM3 -0.005 0.063 -9999 0 -0.79 7 7
GP1BA -0.012 0.077 -9999 0 -0.4 33 33
alphaM/beta2 Integrin/CTGF -0.025 0.071 -9999 0 -0.57 15 15
alphaM/beta2 Integrin -0.071 0.13 -9999 0 -0.3 202 202
JAM3 homodimer -0.005 0.063 -9999 0 -0.79 7 7
ICAM2 -0.004 0.053 -9999 0 -0.79 5 5
ICAM1 -0.004 0.035 -9999 0 -0.29 16 16
phagocytosis triggered by activation of immune response cell surface activating receptor -0.061 0.14 -9999 0 -0.3 202 202
cell adhesion -0.024 0.057 -9999 0 -0.48 11 11
NFKB1 -0.096 0.21 -9999 0 -0.66 15 15
THY1 -0.002 0.025 -9999 0 -10000 0 0
RhoA/GDP 0 0 -9999 0 -10000 0 0
Lipoprotein(a) -0.33 0.26 -9999 0 -0.53 668 668
alphaM/beta2 Integrin/LRP/tPA -0.034 0.11 -9999 0 -0.54 46 46
IL6 -0.3 0.48 -9999 0 -0.93 400 400
ITGB2 -0.017 0.039 -9999 0 -0.3 16 16
elevation of cytosolic calcium ion concentration -0.025 0.049 -9999 0 -0.36 2 2
alphaM/beta2 Integrin/JAM2/JAM3 -0.044 0.13 -9999 0 -0.53 68 68
JAM2 -0.048 0.19 -9999 0 -0.79 66 66
alphaM/beta2 Integrin/ICAM1 -0.022 0.08 -9999 0 -0.53 21 21
alphaM/beta2 Integrin/uPA/Plg -0.019 0.033 -9999 0 -10000 0 0
RhoA/GTP -0.088 0.16 -9999 0 -0.37 224 224
positive regulation of phagocytosis -0.049 0.089 -9999 0 -0.45 19 19
Ron/MSP -0.016 0.098 -9999 0 -0.66 22 22
alphaM/beta2 Integrin/uPAR/uPA -0.025 0.05 -9999 0 -0.36 2 2
alphaM/beta2 Integrin/uPAR -0.029 0.048 -9999 0 -0.34 4 4
PLAU -0.007 0.045 -9999 0 -0.29 27 27
PLAT -0.028 0.14 -9999 0 -0.74 41 41
actin filament polymerization -0.066 0.15 -9999 0 -0.38 126 126
MST1 -0.012 0.089 -9999 0 -0.58 22 22
alphaM/beta2 Integrin/lipoprotein(a) -0.29 0.22 -9999 0 -0.47 668 668
TNF -0.087 0.22 -9999 0 -0.86 21 21
RAP1B 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.021 0.036 -9999 0 -0.3 1 1
fibrinolysis -0.019 0.032 -9999 0 -10000 0 0
HCK -0.004 0.033 -9999 0 -0.29 14 14
dendritic cell antigen processing and presentation -0.061 0.14 -9999 0 -0.3 202 202
VTN -0.027 0.1 -9999 0 -0.34 88 88
alphaM/beta2 Integrin/CYR61 -0.046 0.13 -9999 0 -0.56 60 60
LPA -0.001 0.02 -9999 0 -0.29 5 5
LRP1 -0.009 0.085 -9999 0 -0.79 13 13
cell migration -0.073 0.084 -9999 0 -0.47 16 16
FN1 -0.12 0.14 -9999 0 -0.29 431 431
alphaM/beta2 Integrin/Thy1 -0.018 0.031 -9999 0 -10000 0 0
MPO -0.051 0.19 -9999 0 -0.77 72 72
KNG1 -0.006 0.041 -9999 0 -0.29 22 22
RAP1/GDP 0 0 -9999 0 -10000 0 0
ROCK1 -0.065 0.16 -9999 0 -0.4 120 120
ELA2 0 0 -9999 0 -10000 0 0
PLG -0.002 0.025 -9999 0 -0.29 8 8
CTGF -0.012 0.093 -9999 0 -0.79 15 15
alphaM/beta2 Integrin/Hck -0.019 0.035 -9999 0 -0.31 5 5
ITGAM -0.015 0.028 -9999 0 -0.31 6 6
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.13 0.21 -9999 0 -0.5 257 257
HP -0.16 0.31 -9999 0 -0.71 244 244
leukocyte adhesion -0.076 0.13 -9999 0 -0.58 46 46
SELP -0.18 0.33 -9999 0 -0.79 257 257
Visual signal transduction: Rods

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0 0 -9999 0 -10000 0 0
GNAT1/GTP -0.003 0.023 -9999 0 -10000 0 0
Metarhodopsin II/Arrestin -0.01 0.04 -9999 0 -0.31 2 2
PDE6G/GNAT1/GTP -0.008 0.036 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
GNAT1 -0.004 0.034 -9999 0 -0.29 15 15
GRK1 -0.003 0.029 -9999 0 -0.29 11 11
CNG Channel -0.14 0.2 -9999 0 -0.43 316 316
mol:Na + -0.13 0.18 -9999 0 -0.41 308 308
mol:ADP -0.003 0.029 -9999 0 -0.29 11 11
RGS9-1/Gbeta5/R9AP -0.061 0.16 -9999 0 -0.53 106 106
mol:GDP 0 0 -9999 0 -10000 0 0
cGMP/CNG Channel -0.13 0.19 -9999 0 -0.42 293 293
CNGB1 -0.015 0.064 -9999 0 -0.29 55 55
RDH5 -0.48 0.38 -9999 0 -0.79 660 660
SAG -0.015 0.064 -9999 0 -0.29 55 55
mol:Ca2+ -0.12 0.18 -9999 0 -0.56 18 18
Na + (4 Units) -0.12 0.17 -9999 0 -0.54 18 18
RGS9 -0.08 0.23 -9999 0 -0.73 121 121
GNB1/GNGT1 -0.03 0.068 -9999 0 -10000 0 0
GNAT1/GDP -0.054 0.14 -9999 0 -0.46 106 106
GUCY2D -0.008 0.057 -9999 0 -0.36 24 24
GNGT1 -0.047 0.11 -9999 0 -0.29 175 175
GUCY2F -0.001 0.013 -9999 0 -0.29 2 2
GNB5 0 0 -9999 0 -10000 0 0
mol:GMP (4 units) -0.018 0.069 -9999 0 -0.45 22 22
mol:11-cis-retinal -0.48 0.38 -9999 0 -0.79 660 660
mol:cGMP -0.011 0.048 -9999 0 -0.45 8 8
GNB1 0 0 -9999 0 -10000 0 0
Rhodopsin -0.37 0.29 -9999 0 -0.6 660 660
SLC24A1 0 0 -9999 0 -10000 0 0
CNGA1 -0.22 0.35 -9999 0 -0.78 310 310
Metarhodopsin II -0.003 0.022 -9999 0 -10000 0 0
mol:Ca ++ 0 0 -9999 0 -10000 0 0
GC1/GCAP Family -0.012 0.051 -9999 0 -0.48 8 8
RGS9BP -0.019 0.072 -9999 0 -0.29 70 70
Metarhodopsin II/Transducin -0.009 0.021 -9999 0 -10000 0 0
GCAP Family/Ca ++ -0.008 0.042 -9999 0 -0.48 5 5
PDE6A/B -0.017 0.089 -9999 0 -0.6 22 22
mol:Pi -0.061 0.16 -9999 0 -0.52 106 106
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
Transducin -0.023 0.051 -9999 0 -0.28 2 2
PDE6B -0.017 0.11 -9999 0 -0.73 25 25
PDE6A -0.006 0.042 -9999 0 -0.29 23 23
PDE6G -0.012 0.058 -9999 0 -0.29 44 44
RHO -0.004 0.035 -9999 0 -0.29 16 16
PDE6 -0.062 0.14 -9999 0 -0.44 124 124
GUCA1A -0.012 0.059 -9999 0 -0.29 46 46
GC2/GCAP Family -0.008 0.043 -9999 0 -0.48 5 5
GUCA1C 0 0.009 -9999 0 -0.29 1 1
GUCA1B -0.004 0.053 -9999 0 -0.79 5 5
Nephrin/Neph1 signaling in the kidney podocyte

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity 0.096 0.2 0.63 121 -10000 0 121
KIRREL -0.079 0.25 -10000 0 -0.79 121 121
Nephrin/NEPH1Par3/Par6/Atypical PKCs -0.096 0.2 -10000 0 -0.63 121 121
PLCG1 0 0 -10000 0 -10000 0 0
ARRB2 0 0 -10000 0 -10000 0 0
WASL 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/CD2AP -0.07 0.15 -10000 0 -0.48 121 121
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP -0.043 0.11 -10000 0 -0.36 121 121
FYN -0.065 0.14 -10000 0 -0.46 121 121
mol:Ca2+ -0.069 0.15 -10000 0 -0.47 121 121
mol:DAG -0.069 0.15 -10000 0 -0.48 121 121
NPHS2 -0.008 0.031 -10000 0 -0.31 1 1
mol:IP3 -0.069 0.15 -10000 0 -0.48 121 121
regulation of endocytosis -0.055 0.14 -10000 0 -0.43 121 121
Nephrin/NEPH1/podocin/Cholesterol -0.072 0.15 -10000 0 -0.49 121 121
establishment of cell polarity -0.096 0.2 -10000 0 -0.63 121 121
Nephrin/NEPH1/podocin/NCK1-2 -0.062 0.14 -10000 0 -0.44 121 121
Nephrin/NEPH1/beta Arrestin2 -0.056 0.14 -10000 0 -0.43 121 121
NPHS1 -0.047 0.11 -10000 0 -0.29 177 177
Nephrin/NEPH1/podocin -0.065 0.14 -10000 0 -0.46 121 121
TJP1 -0.001 0.024 -10000 0 -0.79 1 1
NCK1 0 0 -10000 0 -10000 0 0
NCK2 0 0 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 -0.07 0.15 -10000 0 -0.48 121 121
CD2AP 0 0.009 -10000 0 -0.29 1 1
Nephrin/NEPH1/podocin/GRB2 -0.07 0.15 -10000 0 -0.48 121 121
GRB2 0 0.009 -10000 0 -0.29 1 1
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 -0.057 0.18 -10000 0 -0.5 130 130
cytoskeleton organization -0.055 0.14 -10000 0 -0.44 121 121
Nephrin/NEPH1 -0.069 0.15 -10000 0 -0.47 121 121
Nephrin/NEPH1/ZO-1 -0.076 0.16 -10000 0 -0.52 121 121
RXR and RAR heterodimerization with other nuclear receptor

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.017 0.031 -9999 0 -10000 0 0
VDR 0 0 -9999 0 -10000 0 0
FAM120B 0 0 -9999 0 -10000 0 0
RXRs/LXRs/DNA/9cRA -0.034 0.16 -9999 0 -0.4 21 21
RXRs/LXRs/DNA/Oxysterols -0.014 0.14 -9999 0 -0.49 19 19
MED1 -0.006 0.043 -9999 0 -0.29 24 24
mol:9cRA 0.005 0.008 -9999 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.024 0.092 -9999 0 -0.35 72 72
RXRs/NUR77 -0.16 0.24 -9999 0 -0.5 337 337
RXRs/PPAR -0.13 0.23 -9999 0 -0.38 453 453
NCOR2 0 0 -9999 0 -10000 0 0
VDR/VDR/Vit D3 0 0 -9999 0 -10000 0 0
RARs/VDR/DNA/Vit D3 -0.008 0.054 -9999 0 -0.45 15 15
RARA -0.004 0.035 -9999 0 -0.29 16 16
NCOA1 -0.001 0.024 -9999 0 -0.79 1 1
VDR/VDR/DNA 0 0 -9999 0 -10000 0 0
RARs/RARs/DNA/9cRA -0.008 0.055 -9999 0 -0.46 15 15
RARG 0 0 -9999 0 -10000 0 0
RPS6KB1 0.029 0.052 -9999 0 -10000 0 0
RARs/THRs/DNA/SMRT -0.023 0.088 -9999 0 -0.34 72 72
THRA -0.001 0.024 -9999 0 -0.79 1 1
mol:Bile acids 0 0 -9999 0 -10000 0 0
VDR/Vit D3/DNA 0 0 -9999 0 -10000 0 0
RXRs/PPAR/9cRA/PGJ2/DNA -0.12 0.2 -9999 0 -0.46 268 268
NR1H4 -0.003 0.032 -9999 0 -0.29 13 13
RXRs/LXRs/DNA -0.1 0.18 -9999 0 -0.42 268 268
NR1H2 0.016 0.006 -9999 0 -10000 0 0
NR1H3 0.016 0.007 -9999 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.11 0.19 -9999 0 -0.44 268 268
NR4A1 -0.071 0.23 -9999 0 -0.79 99 99
mol:ATRA 0 0 -9999 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.043 0.13 -9999 0 -0.27 268 268
RXRG -0.18 0.34 -9999 0 -0.78 271 271
RXR alpha/CCPG 0 0 -9999 0 -10000 0 0
RXRA 0.016 0.006 -9999 0 -10000 0 0
RXRB 0.016 0.007 -9999 0 -10000 0 0
THRB -0.044 0.18 -9999 0 -0.79 61 61
PPARG -0.19 0.34 -9999 0 -0.79 268 268
PPARD 0 0 -9999 0 -10000 0 0
TNF -0.014 0.18 -9999 0 -1.2 14 14
mol:Oxysterols 0.005 0.007 -9999 0 -10000 0 0
cholesterol transport -0.014 0.14 -9999 0 -0.48 19 19
PPARA -0.006 0.067 -9999 0 -0.79 8 8
mol:Vit D3 0 0 -9999 0 -10000 0 0
RARB -0.011 0.092 -9999 0 -0.79 15 15
RXRs/NUR77/BCL2 -0.12 0.19 -9999 0 -0.37 359 359
SREBF1 -0.005 0.14 -9999 0 -0.68 5 5
RXRs/RXRs/DNA/9cRA -0.12 0.2 -9999 0 -0.46 268 268
ABCA1 -0.008 0.16 -9999 0 -1.1 10 10
RARs/THRs -0.032 0.12 -9999 0 -0.47 72 72
RXRs/FXR -0.11 0.2 -9999 0 -0.47 268 268
BCL2 -0.027 0.14 -9999 0 -0.79 37 37
Ephrin A reverse signaling

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade -0.05 0.15 -9999 0 -0.53 103 103
EFNA5 -0.074 0.23 -9999 0 -0.78 104 104
FYN -0.026 0.15 -9999 0 -0.48 104 104
neuron projection morphogenesis -0.05 0.15 -9999 0 -0.53 103 103
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 -0.051 0.16 -9999 0 -0.53 103 103
EPHA5 -0.001 0.02 -9999 0 -0.29 5 5
S1P1 pathway

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.005 0.049 -9999 0 -0.61 6 6
PDGFRB 0.005 0.049 -9999 0 -0.79 4 4
SPHK1 -0.025 0.055 -9999 0 -1.1 2 2
mol:S1P -0.031 0.057 -9999 0 -0.97 2 2
S1P1/S1P/Gi -0.1 0.23 -9999 0 -0.39 380 380
GNAO1 -0.023 0.14 -9999 0 -0.57 49 49
PDGFB-D/PDGFRB/PLCgamma1 -0.12 0.18 -9999 0 -0.59 77 77
PLCG1 -0.091 0.22 -9999 0 -0.56 99 99
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.005 0.049 -9999 0 -0.79 4 4
GNAI2 0.008 0.006 -9999 0 -10000 0 0
GNAI3 0.008 0.006 -9999 0 -10000 0 0
GNAI1 -0.038 0.19 -9999 0 -0.8 62 62
mol:GDP 0 0 -9999 0 -10000 0 0
EDG1 0.005 0.046 -9999 0 -0.54 6 6
S1P1/S1P -0.044 0.075 -9999 0 -0.58 8 8
negative regulation of cAMP metabolic process -0.098 0.22 -9999 0 -0.38 380 380
MAPK3 -0.16 0.31 -9999 0 -0.57 370 370
calcium-dependent phospholipase C activity -0.003 0.004 -9999 0 -10000 0 0
Rac1/GDP 0 0 -9999 0 -10000 0 0
RhoA/GDP 0 0 -9999 0 -10000 0 0
KDR -0.004 0.059 -9999 0 -0.8 6 6
PLCB2 -0.008 0.086 -9999 0 -0.5 9 9
RAC1 0 0 -9999 0 -10000 0 0
RhoA/GTP -0.038 0.061 -9999 0 -0.48 8 8
receptor internalization -0.043 0.07 -9999 0 -0.53 8 8
PTGS2 -0.33 0.55 -9999 0 -1.1 369 369
Rac1/GTP -0.038 0.061 -9999 0 -0.48 8 8
RHOA 0 0 -9999 0 -10000 0 0
VEGFA -0.003 0.031 -9999 0 -0.29 12 12
negative regulation of T cell proliferation -0.098 0.22 -9999 0 -0.38 380 380
GO:0007205 0 0 -9999 0 -10000 0 0
GNAZ 0.001 0.077 -9999 0 -0.79 10 10
MAPK1 -0.16 0.31 -9999 0 -0.57 370 370
S1P1/S1P/PDGFB-D/PDGFRB -0.021 0.11 -9999 0 -0.64 10 10
ABCC1 0 0 -9999 0 -10000 0 0
Syndecan-3-mediated signaling events

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.002 0.026 -9999 0 -0.29 9 9
Syndecan-3/Src/Cortactin -0.18 0.2 -9999 0 -0.4 478 478
Syndecan-3/Neurocan -0.007 0.028 -9999 0 -10000 0 0
POMC -0.024 0.12 -9999 0 -0.49 54 54
EGFR -0.29 0.38 -9999 0 -0.78 410 410
Syndecan-3/EGFR -0.16 0.21 -9999 0 -0.44 405 405
AGRP -0.003 0.028 -9999 0 -0.29 10 10
NCSTN 0 0 -9999 0 -10000 0 0
PSENEN -0.001 0.013 -9999 0 -0.29 2 2
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B -0.001 0.024 -9999 0 -0.79 1 1
APH1A 0 0 -9999 0 -10000 0 0
NCAN -0.019 0.073 -9999 0 -0.29 72 72
long-term memory -0.002 0.02 -9999 0 -0.41 2 2
Syndecan-3/IL8 -0.016 0.066 -9999 0 -0.44 22 22
PSEN1 0 0 -9999 0 -10000 0 0
Src/Cortactin -0.002 0.018 -9999 0 -10000 0 0
FYN -0.001 0.034 -9999 0 -0.79 2 2
limb bud formation 0 0.003 -9999 0 -10000 0 0
MC4R -0.003 0.032 -9999 0 -0.29 13 13
SRC 0 0.009 -9999 0 -0.29 1 1
PTN -0.34 0.39 -9999 0 -0.78 480 480
FGFR/FGF/Syndecan-3 0 0.003 -9999 0 -10000 0 0
neuron projection morphogenesis -0.17 0.19 -9999 0 -0.39 478 478
Syndecan-3/AgRP -0.001 0.011 -9999 0 -10000 0 0
Syndecan-3/AgRP/MC4R -0.002 0.015 -9999 0 -10000 0 0
Fyn/Cortactin -0.003 0.031 -9999 0 -0.6 2 2
SDC3 0 0.003 -9999 0 -10000 0 0
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.015 0.065 -9999 0 -0.43 22 22
IL8 -0.033 0.13 -9999 0 -0.42 87 87
Syndecan-3/Fyn/Cortactin -0.002 0.02 -9999 0 -0.42 2 2
Syndecan-3/CASK 0 0.003 -9999 0 -10000 0 0
alpha-MSH/MC4R -0.02 0.094 -9999 0 -0.6 24 24
Gamma Secretase -0.001 0.014 -9999 0 -0.44 1 1
Signaling events mediated by the Hedgehog family

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.054 0.3 -10000 0 -0.81 131 131
IHH -0.014 0.082 -10000 0 -0.42 9 9
SHH Np/Cholesterol/GAS1 -0.032 0.12 -10000 0 -0.49 66 66
LRPAP1 0 0 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.032 0.12 0.48 66 -10000 0 66
SMO/beta Arrestin2 -0.076 0.23 -10000 0 -0.84 82 82
SMO -0.036 0.26 -10000 0 -0.86 91 91
AKT1 0.006 0.12 -10000 0 -0.55 16 16
ARRB2 0 0 -10000 0 -10000 0 0
BOC -0.058 0.21 -10000 0 -0.79 81 81
ADRBK1 0 0 -10000 0 -10000 0 0
heart looping -0.035 0.26 -10000 0 -0.83 91 91
STIL -0.039 0.21 -10000 0 -0.7 86 86
DHH N/PTCH2 -0.061 0.19 -10000 0 -0.63 104 104
DHH N/PTCH1 -0.09 0.24 -10000 0 -0.74 116 116
PIK3CA 0 0.009 -10000 0 -0.29 1 1
DHH -0.022 0.13 -10000 0 -0.76 32 32
PTHLH -0.081 0.38 -10000 0 -1.1 131 131
determination of left/right symmetry -0.035 0.26 -10000 0 -0.83 91 91
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
skeletal system development -0.079 0.37 -10000 0 -1 131 131
IHH N/Hhip -0.009 0.051 -10000 0 -0.41 6 6
DHH N/Hhip -0.019 0.1 -10000 0 -0.61 32 32
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.035 0.26 -10000 0 -0.83 91 91
pancreas development -0.003 0.041 -10000 0 -0.4 9 9
HHAT -0.001 0.024 -10000 0 -0.79 1 1
PI3K -0.008 0.068 -10000 0 -0.6 14 14
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.047 0.19 -10000 0 -0.79 65 65
somite specification -0.035 0.26 -10000 0 -0.83 91 91
SHH Np/Cholesterol/PTCH1 -0.071 0.2 -10000 0 -0.7 93 93
SHH Np/Cholesterol/PTCH2 -0.039 0.13 -10000 0 -0.48 82 82
SHH Np/Cholesterol/Megalin -0.14 0.21 -10000 0 -0.48 292 292
SHH 0.01 0.035 -10000 0 -0.61 1 1
catabolic process -0.047 0.26 -10000 0 -0.77 108 108
SMO/Vitamin D3 -0.075 0.22 -10000 0 -0.81 83 83
SHH Np/Cholesterol/Hhip -0.005 0.035 -10000 0 -0.49 3 3
LRP2 -0.22 0.35 -10000 0 -0.74 318 318
receptor-mediated endocytosis -0.15 0.25 -10000 0 -0.82 99 99
SHH Np/Cholesterol/BOC -0.039 0.13 -10000 0 -0.49 82 82
SHH Np/Cholesterol/CDO -0.009 0.059 -10000 0 -0.48 15 15
mesenchymal cell differentiation 0.005 0.035 0.48 3 -10000 0 3
mol:Vitamin D3 -0.03 0.22 -10000 0 -0.71 93 93
IHH N/PTCH2 -0.055 0.18 -10000 0 -0.66 85 85
CDON -0.01 0.089 -10000 0 -0.79 14 14
IHH N/PTCH1 -0.045 0.26 -10000 0 -0.83 97 97
Megalin/LRPAP1 -0.16 0.26 -10000 0 -0.6 291 291
PTCH2 -0.058 0.21 -10000 0 -0.79 81 81
SHH Np/Cholesterol -0.003 0.025 -10000 0 -0.49 1 1
PTCH1 -0.047 0.26 -10000 0 -0.77 108 108
HHIP -0.003 0.041 -10000 0 -0.4 9 9
PDGFR-alpha signaling pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.052 0.2 -9999 0 -0.8 74 74
PDGF/PDGFRA/CRKL -0.041 0.15 -9999 0 -0.6 73 73
positive regulation of JUN kinase activity -0.031 0.12 -9999 0 -0.46 73 73
CRKL 0 0 -9999 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.044 0.15 -9999 0 -0.61 73 73
AP1 -0.36 0.54 -9999 0 -1.2 329 329
mol:IP3 -0.035 0.16 -9999 0 -0.62 74 74
PLCG1 -0.035 0.16 -9999 0 -0.63 74 74
PDGF/PDGFRA/alphaV Integrin -0.041 0.15 -9999 0 -0.6 73 73
RAPGEF1 0 0 -9999 0 -10000 0 0
CRK 0 0 -9999 0 -10000 0 0
mol:Ca2+ -0.035 0.16 -9999 0 -0.62 74 74
CAV3 -0.001 0.015 -9999 0 -0.29 3 3
CAV1 -0.17 0.33 -9999 0 -0.79 241 241
SHC/Grb2/SOS1 -0.031 0.12 -9999 0 -0.46 73 73
PDGF/PDGFRA/Shf -0.041 0.15 -9999 0 -0.61 73 73
FOS -0.32 0.55 -9999 0 -1.1 329 329
JUN -0.024 0.059 -9999 0 -0.67 7 7
oligodendrocyte development -0.04 0.15 -9999 0 -0.6 73 73
GRB2 0 0.009 -9999 0 -0.29 1 1
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
mol:DAG -0.035 0.16 -9999 0 -0.62 74 74
PDGF/PDGFRA -0.052 0.2 -9999 0 -0.8 74 74
actin cytoskeleton reorganization -0.041 0.15 -9999 0 -0.6 74 74
SRF 0.015 0.022 -9999 0 -10000 0 0
SHC1 0 0 -9999 0 -10000 0 0
PI3K -0.041 0.15 -9999 0 -0.54 83 83
PDGF/PDGFRA/Crk/C3G -0.035 0.13 -9999 0 -0.52 73 73
JAK1 -0.025 0.16 -9999 0 -0.6 74 74
ELK1/SRF -0.027 0.12 -9999 0 -0.47 73 73
SHB -0.001 0.025 -9999 0 -0.54 2 2
SHF -0.001 0.027 -9999 0 -0.46 3 3
CSNK2A1 0.019 0.027 -9999 0 -10000 0 0
GO:0007205 -0.037 0.17 -9999 0 -0.65 73 73
SOS1 0 0 -9999 0 -10000 0 0
Ras protein signal transduction -0.031 0.12 -9999 0 -0.46 73 73
PDGF/PDGFRA/SHB -0.041 0.15 -9999 0 -0.6 74 74
PDGF/PDGFRA/Caveolin-1 -0.17 0.32 -9999 0 -0.7 266 266
ITGAV 0 0 -9999 0 -10000 0 0
ELK1 -0.035 0.16 -9999 0 -0.59 73 73
PIK3CA 0 0.009 -9999 0 -0.29 1 1
PDGF/PDGFRA/Crk -0.041 0.15 -9999 0 -0.6 73 73
JAK-STAT cascade -0.025 0.16 -9999 0 -0.6 74 74
cell proliferation -0.041 0.15 -9999 0 -0.61 73 73
E-cadherin signaling in keratinocytes

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation -0.009 0.053 -10000 0 -0.42 14 14
adherens junction organization 0.032 0.061 -10000 0 -0.3 29 29
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.14 0.18 -10000 0 -0.37 412 412
FMN1 0.025 0.086 -10000 0 -0.36 49 49
mol:IP3 -0.009 0.05 -10000 0 -0.39 14 14
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.01 0.052 -10000 0 -0.31 29 29
CTNNB1 0.001 0.004 -10000 0 -10000 0 0
AKT1 -0.01 0.051 -10000 0 -0.38 14 14
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.013 0.079 -10000 0 -0.5 28 28
CTNND1 0.011 0.009 -10000 0 -0.29 1 1
mol:PI-4-5-P2 0.033 0.055 -10000 0 -0.29 29 29
VASP 0.033 0.056 -10000 0 -10000 0 0
ZYX 0.033 0.056 -10000 0 -10000 0 0
JUB 0.032 0.062 -10000 0 -0.3 33 33
EGFR(dimer) -0.16 0.21 -10000 0 -0.42 417 417
E-cadherin/beta catenin-gamma catenin -0.013 0.081 -10000 0 -0.5 29 29
mol:PI-3-4-5-P3 -0.01 0.055 -10000 0 -0.4 14 14
PIK3CA 0.011 0.009 -10000 0 -0.29 1 1
PI3K -0.011 0.056 -10000 0 -0.41 14 14
FYN 0.04 0.055 -10000 0 -0.34 16 16
mol:Ca2+ -0.009 0.049 -10000 0 -0.38 14 14
JUP 0 0.026 -10000 0 -0.54 2 2
PIK3R1 0.001 0.09 -10000 0 -0.79 14 14
mol:DAG -0.009 0.05 -10000 0 -0.39 14 14
CDH1 -0.02 0.12 -10000 0 -0.79 28 28
RhoA/GDP -0.14 0.18 -10000 0 -0.37 412 412
establishment of polarity of embryonic epithelium 0.033 0.055 -10000 0 -10000 0 0
SRC 0 0.009 -10000 0 -0.29 1 1
RAC1 0 0 -10000 0 -10000 0 0
RHOA 0 0 -10000 0 -10000 0 0
EGFR -0.29 0.38 -10000 0 -0.78 410 410
CASR 0.033 0.056 -10000 0 -0.36 14 14
RhoA/GTP -0.008 0.044 -10000 0 -0.34 14 14
AKT2 -0.01 0.051 -10000 0 -0.38 14 14
actin cable formation 0.032 0.084 -10000 0 -0.42 21 21
apoptosis 0.01 0.052 0.39 14 -10000 0 14
CTNNA1 0.012 0.002 -10000 0 -10000 0 0
mol:GDP -0.15 0.2 -10000 0 -0.4 412 412
PIP5K1A 0.033 0.056 -10000 0 -0.29 29 29
PLCG1 -0.009 0.051 -10000 0 -0.4 14 14
Rac1/GTP -0.15 0.19 -10000 0 -0.39 406 406
homophilic cell adhesion 0.001 0.002 -10000 0 -10000 0 0
LPA receptor mediated events

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.019 0.097 -9999 0 -0.51 37 37
NF kappa B1 p50/RelA/I kappa B alpha -0.043 0.11 -9999 0 -0.4 14 14
AP1 -0.19 0.25 -9999 0 -0.47 423 423
mol:PIP3 -0.2 0.24 -9999 0 -0.7 123 123
AKT1 -0.016 0.078 -9999 0 -0.59 10 10
PTK2B 0.014 0.062 -9999 0 -0.3 25 25
RHOA 0.028 0.028 -9999 0 -0.23 1 1
PIK3CB 0 0 -9999 0 -10000 0 0
mol:Ca2+ -0.007 0.13 -9999 0 -0.35 128 128
MAGI3 -0.001 0.034 -9999 0 -0.79 2 2
RELA 0 0 -9999 0 -10000 0 0
apoptosis -0.062 0.15 -9999 0 -0.42 147 147
HRAS/GDP -0.002 0.019 -9999 0 -10000 0 0
positive regulation of microtubule depolymerization -0.019 0.14 -9999 0 -0.4 123 123
NF kappa B1 p50/RelA -0.053 0.14 -9999 0 -0.51 20 20
endothelial cell migration 0.007 0.12 -9999 0 -0.63 34 34
ADCY4 -0.004 0.15 -9999 0 -0.63 41 41
ADCY5 -0.071 0.19 -9999 0 -0.59 82 82
ADCY6 0.006 0.13 -9999 0 -0.6 31 31
ADCY7 0.006 0.13 -9999 0 -0.6 31 31
ADCY1 -0.003 0.14 -9999 0 -0.64 37 37
ADCY2 -0.015 0.16 -9999 0 -0.62 49 49
ADCY3 0.006 0.13 -9999 0 -0.6 31 31
ADCY8 0.003 0.13 -9999 0 -0.61 31 31
ADCY9 0.006 0.13 -9999 0 -0.6 31 31
GSK3B 0.021 0.059 -9999 0 -0.35 10 10
arachidonic acid secretion 0.009 0.13 -9999 0 -0.56 34 34
GNG2 -0.011 0.092 -9999 0 -0.79 15 15
TRIP6 -0.001 0.016 -9999 0 -0.51 1 1
GNAO1 -0.006 0.13 -9999 0 -0.52 56 56
HRAS -0.003 0.028 -9999 0 -10000 0 0
NFKBIA -0.003 0.15 -9999 0 -0.39 128 128
GAB1 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
lamellipodium assembly 0.001 0.004 -9999 0 -10000 0 0
JUN -0.005 0.063 -9999 0 -0.79 7 7
LPA/LPA2/NHERF2 -0.002 0.016 -9999 0 -10000 0 0
TIAM1 0.001 0.004 -9999 0 -10000 0 0
PIK3R1 -0.01 0.088 -9999 0 -0.79 14 14
mol:IP3 -0.007 0.13 -9999 0 -0.35 128 128
PLCB3 0.026 0.016 -9999 0 -10000 0 0
FOS -0.24 0.36 -9999 0 -0.79 329 329
positive regulation of mitosis 0.009 0.13 -9999 0 -0.56 34 34
LPA/LPA1-2-3 -0.073 0.17 -9999 0 -0.49 147 147
mol:Ca ++ 0 0 -9999 0 -10000 0 0
JNK cascade 0 0 -9999 0 -10000 0 0
BCAR1 0 0 -9999 0 -10000 0 0
stress fiber formation 0.002 0.1 -9999 0 -0.38 25 25
GNAZ 0.008 0.1 -9999 0 -0.48 43 43
EGFR/PI3K-beta/Gab1 -0.2 0.26 -9999 0 -0.74 123 123
positive regulation of dendritic cell cytokine production -0.072 0.17 -9999 0 -0.48 147 147
LPA/LPA2/MAGI-3 -0.002 0.025 -9999 0 -0.52 2 2
ARHGEF1 -0.011 0.069 -9999 0 -0.44 24 24
GNAI2 0.013 0.087 -9999 0 -0.46 34 34
GNAI3 0.013 0.087 -9999 0 -0.52 24 24
GNAI1 -0.018 0.16 -9999 0 -0.53 89 89
LPA/LPA3 -0.08 0.2 -9999 0 -0.6 128 128
LPA/LPA2 -0.002 0.016 -9999 0 -10000 0 0
LPA/LPA1 -0.017 0.096 -9999 0 -0.54 34 34
HB-EGF/EGFR -0.26 0.25 -9999 0 -0.57 410 410
HBEGF -0.071 0.11 -9999 0 -0.6 3 3
mol:DAG -0.007 0.13 -9999 0 -0.35 128 128
cAMP biosynthetic process -0.012 0.15 -9999 0 -0.58 52 52
NFKB1 0 0 -9999 0 -10000 0 0
SRC 0 0.009 -9999 0 -0.29 1 1
GNB1 0 0 -9999 0 -10000 0 0
LYN -0.003 0.15 -9999 0 -0.39 128 128
GNAQ -0.053 0.13 -9999 0 -0.41 131 131
LPAR2 -0.001 0.015 -9999 0 -0.29 3 3
LPAR3 -0.1 0.26 -9999 0 -0.66 171 171
LPAR1 -0.019 0.12 -9999 0 -0.79 24 24
IL8 -0.19 0.23 -9999 0 -0.44 433 433
PTK2 -0.066 0.16 -9999 0 -0.45 147 147
Rac1/GDP 0 0 -9999 0 -10000 0 0
CASP3 -0.062 0.15 -9999 0 -0.42 147 147
EGFR -0.29 0.38 -9999 0 -0.78 410 410
PLCG1 -0.029 0.15 -9999 0 -0.42 128 128
PLD2 -0.066 0.16 -9999 0 -0.45 147 147
G12/G13 -0.013 0.074 -9999 0 -0.48 24 24
PI3K-beta -0.019 0.093 -9999 0 -0.72 10 10
cell migration -0.021 0.053 -9999 0 -0.24 6 6
SLC9A3R2 -0.001 0.02 -9999 0 -0.29 5 5
PXN 0.002 0.1 -9999 0 -0.39 25 25
HRAS/GTP -0.035 0.12 -9999 0 -0.58 34 34
RAC1 0 0 -9999 0 -10000 0 0
MMP9 -0.13 0.15 -9999 0 -0.29 483 483
PRKCE 0.01 0.002 -9999 0 -10000 0 0
PRKCD 0.001 0.12 -9999 0 -0.39 9 9
Gi(beta/gamma) -0.037 0.12 -9999 0 -0.58 39 39
mol:LPA -0.002 0.021 -9999 0 -0.22 10 10
TRIP6/p130 Cas/FAK1/Paxillin -0.055 0.14 -9999 0 -0.49 26 26
MAPKKK cascade 0.009 0.13 -9999 0 -0.56 34 34
contractile ring contraction involved in cytokinesis 0.028 0.028 -9999 0 -0.23 1 1
mol:GDP 0 0 -9999 0 -10000 0 0
GNA14 -0.057 0.14 -9999 0 -0.42 136 136
GNA15 -0.053 0.13 -9999 0 -0.41 129 129
GNA12 0 0 -9999 0 -10000 0 0
GNA13 0 0 -9999 0 -10000 0 0
MAPT -0.021 0.15 -9999 0 -0.41 123 123
GNA11 -0.053 0.13 -9999 0 -0.41 132 132
Rac1/GTP 0.001 0.005 -9999 0 -10000 0 0
MMP2 0.007 0.12 -9999 0 -0.63 34 34
Fc-epsilon receptor I signaling in mast cells

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A -0.001 0.034 -9999 0 -0.79 2 2
LAT2 -0.063 0.14 -9999 0 -0.43 95 95
AP1 -0.15 0.21 -9999 0 -0.57 154 154
mol:PIP3 -0.027 0.2 -9999 0 -0.5 99 99
IKBKB 0.002 0.12 -9999 0 -0.32 54 54
AKT1 -0.082 0.17 -9999 0 -0.66 46 46
IKBKG 0.002 0.12 -9999 0 -0.32 54 54
MS4A2 -0.069 0.22 -9999 0 -0.76 99 99
mol:Sphingosine-1-phosphate 0 0 -9999 0 -10000 0 0
PIK3CA 0 0.009 -9999 0 -0.3 1 1
MAP3K1 0.005 0.13 -9999 0 -0.45 43 43
mol:Ca2+ -0.013 0.15 -9999 0 -0.36 99 99
LYN 0.011 0.004 -9999 0 -10000 0 0
CBLB -0.062 0.14 -9999 0 -0.52 51 51
SHC1 0 0 -9999 0 -10000 0 0
RasGAP/p62DOK -0.062 0.16 -9999 0 -0.48 142 142
positive regulation of cell migration 0 0 -9999 0 -10000 0 0
INPP5D 0 0 -9999 0 -10000 0 0
PLD2 -0.096 0.2 -9999 0 -0.48 217 217
PTPN13 -0.031 0.17 -9999 0 -0.54 68 68
PTPN11 0.01 0.006 -9999 0 -10000 0 0
GO:0007205 0 0 -9999 0 -10000 0 0
regulation of mast cell degranulation 0.006 0.15 -9999 0 -0.41 45 45
SYK 0.011 0.01 -9999 0 -0.29 1 1
GRB2 0 0.009 -9999 0 -0.29 1 1
LAT/PLCgamma1/GRB2/SLP76/GADs -0.086 0.18 -9999 0 -0.51 99 99
LAT -0.064 0.14 -9999 0 -0.43 96 96
PAK2 -0.004 0.14 -9999 0 -0.5 44 44
NFATC2 -0.1 0.24 -9999 0 -0.8 104 104
HRAS -0.014 0.15 -9999 0 -0.54 46 46
GAB2 -0.004 0.042 -9999 0 -0.39 10 10
PLA2G1B 0.028 0.018 -9999 0 -10000 0 0
Fc epsilon R1 -0.12 0.25 -9999 0 -0.6 217 217
Antigen/IgE/Fc epsilon R1 -0.11 0.23 -9999 0 -0.55 217 217
mol:GDP -0.02 0.16 -9999 0 -0.56 46 46
JUN -0.005 0.063 -9999 0 -0.79 7 7
mol:Ca++ 0 0 -9999 0 -10000 0 0
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
FOS -0.24 0.36 -9999 0 -0.79 329 329
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.067 0.15 -9999 0 -0.45 97 97
CHUK 0.002 0.12 -9999 0 -0.32 54 54
KLRG1 -0.062 0.14 -9999 0 -0.55 44 44
VAV1 -0.064 0.14 -9999 0 -0.44 98 98
calcium-dependent protein kinase C activity 0 0 -9999 0 -10000 0 0
CBL -0.062 0.14 -9999 0 -0.43 95 95
negative regulation of mast cell degranulation -0.056 0.12 -9999 0 -0.51 43 43
BTK -0.061 0.14 -9999 0 -0.57 43 43
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.086 0.2 -9999 0 -0.43 219 219
GAB2/PI3K/SHP2 -0.091 0.19 -9999 0 -0.73 49 49
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.069 0.16 -9999 0 -0.59 55 55
RAF1 0.015 0.022 -9999 0 -10000 0 0
Fc epsilon R1/FcgammaRIIB/SHIP -0.1 0.22 -9999 0 -0.51 219 219
FCER1G 0.003 0.012 -9999 0 -0.29 1 1
FCER1A -0.11 0.29 -9999 0 -0.8 161 161
Antigen/IgE/Fc epsilon R1/Fyn -0.1 0.22 -9999 0 -0.51 217 217
MAPK3 0.026 0.019 -9999 0 -10000 0 0
MAPK1 0.026 0.019 -9999 0 -10000 0 0
NFKB1 0 0 -9999 0 -10000 0 0
MAPK8 0.009 0.081 -9999 0 -0.68 10 10
DUSP1 -0.1 0.26 -9999 0 -0.79 142 142
NF-kappa-B/RelA -0.027 0.054 -9999 0 -0.23 3 3
actin cytoskeleton reorganization -0.027 0.15 -9999 0 -0.42 95 95
mol:Glucocorticoid Dexamethasone 0 0 -9999 0 -10000 0 0
PI3K -0.059 0.14 -9999 0 -0.53 53 53
FER -0.066 0.15 -9999 0 -0.44 102 102
RELA 0 0 -9999 0 -10000 0 0
ITK -0.035 0.11 -9999 0 -0.6 39 39
SOS1 0 0 -9999 0 -10000 0 0
PLCG1 -0.017 0.16 -9999 0 -0.57 46 46
cytokine secretion -0.019 0.04 -9999 0 -10000 0 0
SPHK1 -0.065 0.14 -9999 0 -0.56 49 49
PTK2 -0.029 0.16 -9999 0 -0.44 95 95
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.089 0.19 -9999 0 -0.44 217 217
EDG1 0 0 -9999 0 -10000 0 0
mol:DAG -0.022 0.2 -9999 0 -0.48 100 100
MAP2K2 0.023 0.019 -9999 0 -10000 0 0
MAP2K1 0.023 0.019 -9999 0 -10000 0 0
MAP2K7 0 0 -9999 0 -10000 0 0
KLRG1/SHP2 -0.057 0.13 -9999 0 -0.51 43 43
MAP2K4 0.017 0.033 -9999 0 -1 1 1
Fc epsilon R1/FcgammaRIIB -0.11 0.23 -9999 0 -0.55 219 219
mol:Choline -0.094 0.2 -9999 0 -0.47 217 217
SHC/Grb2/SOS1 -0.056 0.13 -9999 0 -0.54 41 41
FYN -0.001 0.034 -9999 0 -0.79 2 2
DOK1 -0.001 0.018 -9999 0 -0.29 4 4
PXN -0.019 0.15 -9999 0 -0.54 41 41
HCLS1 -0.062 0.14 -9999 0 -0.43 95 95
PRKCB -0.015 0.16 -9999 0 -0.38 105 105
FCGR2B -0.004 0.054 -9999 0 -0.7 6 6
IGHE 0 0.006 -9999 0 -10000 0 0
KLRG1/SHIP -0.057 0.13 -9999 0 -0.52 43 43
LCP2 0 0.009 -9999 0 -0.29 1 1
PLA2G4A -0.11 0.21 -9999 0 -0.5 207 207
RASA1 0 0 -9999 0 -10000 0 0
mol:Phosphatidic acid -0.094 0.2 -9999 0 -0.47 217 217
IKK complex 0.019 0.093 -9999 0 -0.23 49 49
WIPF1 0 0 -9999 0 -10000 0 0
Visual signal transduction: Cones

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin -0.007 0.054 -9999 0 -0.45 15 15
RGS9BP -0.019 0.072 -9999 0 -0.29 70 70
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 -0.003 0.029 -9999 0 -0.29 11 11
mol:Na + -0.02 0.053 -9999 0 -10000 0 0
mol:ADP 0.007 0.028 -9999 0 -10000 0 0
GNAT2 -0.001 0.018 -9999 0 -0.29 4 4
RGS9-1/Gbeta5/R9AP -0.061 0.16 -9999 0 -0.53 106 106
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP -0.001 0.015 -9999 0 -10000 0 0
GRK7 -0.002 0.026 -9999 0 -0.29 9 9
CNGB3 -0.01 0.054 -9999 0 -0.29 39 39
Cone Metarhodopsin II/X-Arrestin -0.001 0.017 -9999 0 -10000 0 0
mol:Ca2+ -0.092 0.088 -9999 0 -0.28 86 86
Cone PDE6 -0.053 0.14 -9999 0 -0.46 106 106
Cone Metarhodopsin II -0.003 0.019 -9999 0 -10000 0 0
Na + (4 Units) -0.097 0.082 -9999 0 -0.28 39 39
GNAT2/GDP -0.052 0.14 -9999 0 -0.45 106 106
GNB5 0 0 -9999 0 -10000 0 0
mol:GMP (4 units) 0.011 0.016 -9999 0 -10000 0 0
Cone Transducin -0.008 0.057 -9999 0 -0.48 15 15
SLC24A2 -0.17 0.14 -9999 0 -0.29 649 649
GNB3/GNGT2 -0.009 0.071 -9999 0 -0.6 15 15
GNB3 -0.011 0.088 -9999 0 -0.63 19 19
GNAT2/GTP -0.001 0.012 -9999 0 -10000 0 0
CNGA3 -0.028 0.086 -9999 0 -0.29 103 103
ARR3 -0.002 0.025 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel -0.02 0.053 -9999 0 -10000 0 0
mol:Pi -0.061 0.16 -9999 0 -0.52 106 106
Cone CNG Channel -0.016 0.04 -9999 0 -10000 0 0
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + -0.17 0.14 -9999 0 -0.29 649 649
RGS9 -0.08 0.23 -9999 0 -0.73 121 121
PDE6C 0 0.009 -9999 0 -0.29 1 1
GNGT2 -0.001 0.034 -9999 0 -0.79 2 2
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H -0.002 0.022 -9999 0 -0.29 6 6
Ras signaling in the CD4+ TCR pathway

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.12 0.18 -9999 0 -0.39 330 330
MAP3K8 0.001 0.073 -9999 0 -0.74 10 10
FOS -0.035 0.14 -9999 0 -0.46 40 40
PRKCA -0.013 0.13 -9999 0 -0.76 31 31
PTPN7 -0.009 0.073 -9999 0 -0.3 63 63
HRAS -0.003 0.028 -9999 0 -10000 0 0
PRKCB -0.011 0.12 -9999 0 -0.67 27 27
NRAS -0.001 0.013 -9999 0 -0.3 2 2
RAS family/GTP -0.002 0.015 -9999 0 -10000 0 0
MAPK3 -0.008 0.073 -9999 0 -0.29 1 1
MAP2K1 -0.013 0.14 -9999 0 -0.6 48 48
ELK1 -0.003 0.01 -9999 0 -0.29 1 1
BRAF -0.033 0.12 -9999 0 -0.57 48 48
mol:GTP -0.002 0.003 -9999 0 -0.006 329 329
MAPK1 -0.008 0.073 -9999 0 -0.29 1 1
RAF1 -0.033 0.12 -9999 0 -0.57 48 48
KRAS -0.001 0.012 -9999 0 -0.29 2 2
Nectin adhesion pathway

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB -0.003 0.048 -9999 0 -0.79 4 4
alphaV beta3 Integrin -0.021 0.11 -9999 0 -0.6 37 37
PTK2 -0.066 0.19 -9999 0 -0.57 122 122
positive regulation of JNK cascade -0.038 0.11 -9999 0 -0.34 122 122
CDC42/GDP -0.001 0.16 -9999 0 -0.46 122 122
Rac1/GDP 0.001 0.16 -9999 0 -0.45 122 122
RAP1B 0 0 -9999 0 -10000 0 0
RAP1A 0 0 -9999 0 -10000 0 0
CTNNB1 0 0 -9999 0 -10000 0 0
CDC42/GTP -0.047 0.13 -9999 0 -0.42 122 122
nectin-3/I-afadin -0.069 0.2 -9999 0 -0.62 122 122
RAPGEF1 -0.01 0.18 -9999 0 -0.52 122 122
mol:GTP 0 0 -9999 0 -10000 0 0
CRK -0.024 0.21 -9999 0 -0.61 122 122
PDGFB-D/PDGFRB -0.003 0.047 -9999 0 -0.79 4 4
TLN1 0 0.1 -9999 0 -0.56 14 14
Rap1/GTP -0.041 0.11 -9999 0 -0.36 122 122
IQGAP1 0 0 -9999 0 -10000 0 0
Rap1/GTP/I-afadin -0.003 0.035 -9999 0 -0.48 6 6
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.069 0.2 -9999 0 -0.62 122 122
PVR 0 0.009 -9999 0 -0.29 1 1
Necl-5(dimer) 0 0.009 -9999 0 -0.29 1 1
mol:GDP -0.013 0.2 -9999 0 -0.58 122 122
MLLT4 -0.005 0.059 -9999 0 -0.72 7 7
PIK3CA 0 0.009 -9999 0 -0.29 1 1
PI3K -0.058 0.17 -9999 0 -0.5 128 128
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin -0.003 0.045 -9999 0 -0.6 6 6
positive regulation of lamellipodium assembly -0.04 0.11 -9999 0 -0.35 122 122
PVRL1 0 0 -9999 0 -10000 0 0
PVRL3 -0.087 0.25 -9999 0 -0.79 121 121
PVRL2 -0.001 0.015 -9999 0 -10000 0 0
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
CDH1 -0.02 0.12 -9999 0 -0.79 28 28
CLDN1 -0.036 0.15 -9999 0 -0.58 68 68
JAM-A/CLDN1 -0.074 0.18 -9999 0 -0.51 154 154
SRC -0.078 0.22 -9999 0 -0.69 122 122
ITGB3 -0.028 0.14 -9999 0 -0.74 41 41
nectin-1(dimer)/I-afadin/I-afadin -0.003 0.045 -9999 0 -0.6 6 6
FARP2 -0.018 0.2 -9999 0 -0.57 122 122
RAC1 0 0 -9999 0 -10000 0 0
CTNNA1 0 0 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) -0.06 0.17 -9999 0 -0.54 122 122
nectin-1/I-afadin -0.003 0.045 -9999 0 -0.6 6 6
nectin-2/I-afadin -0.004 0.046 -9999 0 -0.6 6 6
RAC1/GTP/IQGAP1/filamentous actin 0 0 -9999 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin -0.06 0.17 -9999 0 -0.54 122 122
CDC42/GTP/IQGAP1/filamentous actin 0 0 -9999 0 -10000 0 0
F11R 0 0 -9999 0 -10000 0 0
positive regulation of filopodium formation -0.038 0.11 -9999 0 -0.34 122 122
alphaV/beta3 Integrin/Talin -0.04 0.13 -9999 0 -0.61 42 42
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin -0.004 0.046 -9999 0 -0.6 6 6
nectin-2(dimer)/I-afadin/I-afadin -0.004 0.046 -9999 0 -0.6 6 6
PIP5K1C -0.033 0.1 -9999 0 -0.58 15 15
VAV2 -0.02 0.2 -9999 0 -0.58 122 122
RAP1/GDP -0.048 0.13 -9999 0 -0.42 122 122
ITGAV 0 0 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin -0.06 0.17 -9999 0 -0.54 122 122
nectin-3(dimer)/I-afadin/I-afadin -0.069 0.2 -9999 0 -0.62 122 122
Rac1/GTP -0.049 0.14 -9999 0 -0.44 122 122
PTPRM -0.037 0.12 -9999 0 -0.32 126 126
E-cadherin/beta catenin/alpha catenin -0.013 0.074 -9999 0 -0.43 33 33
adherens junction assembly 0 0 -9999 0 -10000 0 0
CDC42 0 0 -9999 0 -10000 0 0
PLK1 signaling events

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion 0.029 0.031 -9999 0 -10000 0 0
BUB1B -0.041 0.053 -9999 0 -10000 0 0
PLK1 -0.008 0.024 -9999 0 -10000 0 0
PLK1S1 0 0.014 -9999 0 -10000 0 0
KIF2A 0.002 0.021 -9999 0 -10000 0 0
regulation of mitotic centrosome separation -0.008 0.024 -9999 0 -10000 0 0
GOLGA2 0 0 -9999 0 -10000 0 0
Hec1/SPC24 -0.17 0.12 -9999 0 -0.28 534 534
WEE1 -0.002 0.024 -9999 0 -10000 0 0
cytokinesis -0.056 0.058 -9999 0 -0.27 13 13
PP2A-alpha B56 0.027 0.019 -9999 0 -10000 0 0
AURKA 0 0.015 -9999 0 -10000 0 0
PICH/PLK1 -0.072 0.098 -9999 0 -0.31 18 18
CENPE -0.053 0.087 -9999 0 -0.18 179 179
RhoA/GTP 0 0 -9999 0 -10000 0 0
positive regulation of microtubule depolymerization 0.002 0.021 -9999 0 -10000 0 0
PPP2CA 0 0 -9999 0 -10000 0 0
FZR1 0 0 -9999 0 -10000 0 0
TPX2 -0.006 0.017 -9999 0 -10000 0 0
PAK1 -0.006 0.043 -9999 0 -0.29 25 25
SPC24 -0.18 0.14 -9999 0 -0.29 689 689
FBXW11 0 0 -9999 0 -10000 0 0
CLSPN -0.006 0.019 -9999 0 -10000 0 0
GORASP1 0 0 -9999 0 -10000 0 0
metaphase 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
NLP -0.005 0.013 -9999 0 -0.052 2 2
G2 phase of mitotic cell cycle -0.001 0.002 -9999 0 -10000 0 0
STAG2 -0.001 0.024 -9999 0 -0.79 1 1
GRASP65/GM130/RAB1/GTP 0.008 0.009 -9999 0 -10000 0 0
spindle elongation -0.008 0.024 -9999 0 -10000 0 0
ODF2 0.002 0.004 -9999 0 -10000 0 0
BUB1 0.021 0.015 -9999 0 -10000 0 0
TPT1 0 0.014 -9999 0 -10000 0 0
CDC25C -0.009 0.017 -9999 0 -10000 0 0
CDC25B 0.005 0.041 -9999 0 -0.29 20 20
SGOL1 -0.029 0.031 -9999 0 -10000 0 0
RHOA 0 0 -9999 0 -10000 0 0
CCNB1/CDK1 -0.021 0.044 -9999 0 -10000 0 0
CDC14B -0.01 0.11 -9999 0 -0.62 36 36
CDC20 -0.16 0.15 -9999 0 -0.29 588 588
PLK1/PBIP1 -0.028 0.053 -9999 0 -0.18 4 4
mitosis -0.006 0.007 -9999 0 -0.022 2 2
FBXO5 0 0.023 -9999 0 -0.15 1 1
CDC2 -0.001 0.002 -9999 0 -10000 0 0
NDC80 -0.18 0.14 -9999 0 -0.29 662 662
metaphase plate congression -0.002 0.016 -9999 0 -10000 0 0
ERCC6L -0.064 0.089 -9999 0 -0.29 11 11
NLP/gamma Tubulin -0.001 0.014 -9999 0 -10000 0 0
microtubule cytoskeleton organization 0 0.014 -9999 0 -10000 0 0
G2/M transition DNA damage checkpoint -0.001 0.001 -9999 0 -10000 0 0
PPP1R12A 0 0 -9999 0 -10000 0 0
interphase -0.001 0.001 -9999 0 -10000 0 0
PLK1/PRC1-2 -0.14 0.1 -9999 0 -0.29 274 274
GRASP65/GM130/RAB1/GTP/PLK1 -0.002 0.004 -9999 0 -10000 0 0
RAB1A 0 0 -9999 0 -10000 0 0
prophase 0 0 -9999 0 -10000 0 0
Aurora A/BORA -0.003 0.024 -9999 0 -0.17 2 2
mitotic prometaphase -0.002 0.001 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.014 0.051 -9999 0 -0.3 25 25
microtubule-based process -0.12 0.069 -9999 0 -0.2 7 7
Golgi organization -0.008 0.024 -9999 0 -10000 0 0
Cohesin/SA2 -0.01 0.018 -9999 0 -0.45 1 1
PPP1CB/MYPT1 0 0 -9999 0 -10000 0 0
KIF20A -0.22 0.13 -9999 0 -0.29 820 820
APC/C/CDC20 -0.088 0.081 -9999 0 -0.19 23 23
PPP2R1A 0 0 -9999 0 -10000 0 0
chromosome segregation -0.028 0.052 -9999 0 -0.18 6 6
PRC1 -0.074 0.13 -9999 0 -0.29 275 275
ECT2 -0.004 0.039 -9999 0 -0.2 4 4
C13orf34 -0.001 0.022 -9999 0 -0.17 2 2
NUDC -0.002 0.016 -9999 0 -10000 0 0
regulation of attachment of spindle microtubules to kinetochore -0.04 0.052 -9999 0 -10000 0 0
spindle assembly -0.004 0.02 -9999 0 -10000 0 0
spindle stabilization 0 0.014 -9999 0 -10000 0 0
APC/C/HCDH1 -0.017 0.094 -9999 0 -0.53 36 36
MKLP2/PLK1 -0.12 0.069 -9999 0 -0.2 7 7
CCNB1 -0.05 0.12 -9999 0 -0.29 221 221
PPP1CB 0 0 -9999 0 -10000 0 0
BTRC 0 0 -9999 0 -10000 0 0
ROCK2 -0.01 0.089 -9999 0 -0.51 32 32
TUBG1 0 0.014 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.024 0.041 -9999 0 -10000 0 0
MLF1IP -0.025 0.074 -9999 0 -0.2 156 156
INCENP 0.002 0.004 -9999 0 -10000 0 0
Rapid glucocorticoid signaling

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma -0.11 0.2 -10000 0 -0.47 262 262
MAPK9 0.008 0 -10000 0 -10000 0 0
adrenocorticotropin secretion -0.001 0.022 -10000 0 -0.2 13 13
GNB1/GNG2 -0.007 0.061 -10000 0 -0.52 15 15
GNB1 0 0 -10000 0 -10000 0 0
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.008 0 -10000 0 -10000 0 0
Gs family/GTP -0.12 0.21 -10000 0 -0.49 258 258
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0.027 0.048 0.11 258 -10000 0 258
GNAL -0.19 0.33 -10000 0 -0.79 258 258
GNG2 -0.011 0.092 -10000 0 -0.79 15 15
CRH -0.003 0.032 -10000 0 -0.29 13 13
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.005 0.041 -10000 0 -0.44 9 9
MAPK11 0.007 0.024 -10000 0 -0.44 3 3
Glypican 2 network

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.012 0.057 -9999 0 -0.29 43 43
GPC2 -0.038 0.1 -9999 0 -0.3 136 136
GPC2/Midkine -0.032 0.081 -9999 0 -0.4 19 19
neuron projection morphogenesis -0.032 0.081 -9999 0 -0.4 19 19
FAS signaling pathway (CD95)

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.011 0.052 0.28 37 -10000 0 37
RFC1 0.011 0.052 0.28 39 -10000 0 39
PRKDC 0.01 0.053 0.28 37 -10000 0 37
RIPK1 0 0.001 -10000 0 -10000 0 0
CASP7 -0.023 0.037 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1 -0.017 0.067 0.25 16 -0.38 18 34
MAP2K4 -0.058 0.16 -10000 0 -0.5 22 22
mol:ceramide -0.032 0.12 -10000 0 -0.55 22 22
GSN 0.004 0.076 0.28 36 -0.49 14 50
FASLG/FAS/FADD/FAF1/Caspase 8 -0.031 0.074 0.23 14 -0.46 18 32
FAS 0.003 0.06 -10000 0 -0.8 6 6
BID 0.001 0.015 0.32 2 -10000 0 2
MAP3K1 -0.021 0.094 -10000 0 -0.29 12 12
MAP3K7 0.006 0.011 -10000 0 -0.29 1 1
RB1 0.01 0.052 0.28 38 -0.29 1 39
CFLAR -0.001 0.023 -10000 0 -0.76 1 1
HGF/MET -0.14 0.26 -10000 0 -0.58 256 256
ARHGDIB 0.01 0.053 0.28 38 -10000 0 38
FADD 0.003 0.037 -10000 0 -0.31 15 15
actin filament polymerization -0.004 0.076 0.49 14 -0.28 36 50
NFKB1 -0.076 0.1 -10000 0 -0.29 18 18
MAPK8 -0.12 0.24 -10000 0 -0.43 403 403
DFFA 0.011 0.052 0.28 37 -10000 0 37
DNA fragmentation during apoptosis 0.01 0.052 0.28 37 -10000 0 37
FAS/FADD/MET -0.096 0.21 -10000 0 -0.55 190 190
CFLAR/RIP1 -0.001 0.017 -10000 0 -0.56 1 1
FAIM3 -0.002 0.056 -10000 0 -0.33 27 27
FAF1 0.008 0.006 -10000 0 -10000 0 0
PARP1 0.01 0.052 0.28 37 -10000 0 37
DFFB 0.011 0.052 0.28 37 -10000 0 37
CHUK -0.066 0.088 -10000 0 -0.3 1 1
FASLG -0.015 0.11 -10000 0 -0.42 58 58
FAS/FADD -0.006 0.053 -10000 0 -0.64 6 6
HGF -0.053 0.2 -10000 0 -0.79 73 73
LMNA 0.01 0.047 0.26 37 -10000 0 37
CASP6 0.01 0.052 0.28 38 -10000 0 38
CASP10 0.005 0.049 -10000 0 -0.8 4 4
CASP3 0.013 0.063 0.34 39 -10000 0 39
PTPN13 -0.023 0.13 -10000 0 -0.79 32 32
CASP8 0.003 0.023 0.45 2 -10000 0 2
IL6 -0.47 0.67 -10000 0 -1.4 400 400
MET -0.14 0.3 -10000 0 -0.78 189 189
ICAD/CAD 0.01 0.048 0.26 37 -10000 0 37
FASLG/FAS/FADD/FAF1/Caspase 10 -0.033 0.12 -10000 0 -0.56 22 22
activation of caspase activity by cytochrome c 0.001 0.015 0.32 2 -10000 0 2
PAK2 0.01 0.052 0.28 37 -10000 0 37
BCL2 -0.022 0.14 -10000 0 -0.79 37 37
Signaling events mediated by PRL

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 -0.06 0.12 -9999 0 -0.29 223 223
mol:Halofuginone 0 0.003 -9999 0 -10000 0 0
ITGA1 -0.008 0.079 -9999 0 -0.79 11 11
CDKN1A -0.057 0.087 -9999 0 -0.84 2 2
PRL-3/alpha Tubulin -0.002 0.018 -9999 0 -10000 0 0
mol:Ca2+ -0.033 0.096 -9999 0 -0.55 18 18
AGT -0.047 0.13 -9999 0 -0.34 151 151
CCNA2 -0.16 0.24 -9999 0 -0.49 347 347
TUBA1B 0 0 -9999 0 -10000 0 0
EGR1 -0.17 0.29 -9999 0 -0.6 347 347
CDK2/Cyclin E1 -0.067 0.09 -9999 0 -0.81 2 2
MAPK3 0.021 0.02 -9999 0 -10000 0 0
PRL-2 /Rab GGTase beta 0 0.006 -9999 0 -10000 0 0
MAPK1 0.021 0.02 -9999 0 -10000 0 0
PTP4A1 -0.12 0.23 -9999 0 -0.46 347 347
PTP4A3 -0.003 0.028 -9999 0 -0.29 10 10
PTP4A2 0 0.009 -9999 0 -0.29 1 1
ITGB1 0.021 0.02 -9999 0 -10000 0 0
SRC 0 0.009 -9999 0 -0.29 1 1
RAC1 -0.055 0.081 -9999 0 -10000 0 0
Rab GGTase beta/Rab GGTase alpha 0 0 -9999 0 -10000 0 0
PRL-1/ATF-5 -0.14 0.2 -9999 0 -0.59 2 2
RABGGTA 0 0 -9999 0 -10000 0 0
BCAR1 0.001 0.009 -9999 0 -10000 0 0
RHOC -0.055 0.081 -9999 0 -10000 0 0
RHOA -0.055 0.081 -9999 0 -10000 0 0
cell motility -0.034 0.1 -9999 0 -0.24 1 1
PRL-1/alpha Tubulin -0.13 0.2 -9999 0 -0.62 1 1
PRL-3/alpha1 Integrin -0.008 0.062 -9999 0 -0.6 11 11
ROCK1 -0.034 0.1 -9999 0 -0.24 1 1
RABGGTB 0 0 -9999 0 -10000 0 0
CDK2 0 0 -9999 0 -10000 0 0
mitosis -0.12 0.23 -9999 0 -0.45 347 347
ATF5 -0.001 0.018 -9999 0 -0.29 4 4
Presenilin action in Notch and Wnt signaling

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) -0.005 0.056 -10000 0 -0.54 11 11
HDAC1 0.002 0.008 -10000 0 -10000 0 0
AES 0.001 0.004 -10000 0 -10000 0 0
FBXW11 0 0 -10000 0 -10000 0 0
DTX1 -0.07 0.22 -10000 0 -0.79 97 97
LRP6/FZD1 0 0.006 -10000 0 -10000 0 0
TLE1 -0.005 0.067 -10000 0 -0.79 8 8
AP1 -0.11 0.17 -10000 0 -0.36 333 333
NCSTN 0 0 -10000 0 -10000 0 0
ADAM10 -0.003 0.048 -10000 0 -0.79 4 4
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.008 0.044 -10000 0 -10000 0 0
NICD/RBPSUH -0.003 0.042 -10000 0 -0.7 4 4
WIF1 -0.41 0.39 -10000 0 -0.78 581 581
NOTCH1 -0.003 0.045 -10000 0 -0.74 4 4
PSENEN -0.001 0.013 -10000 0 -0.29 2 2
KREMEN2 -0.14 0.15 -10000 0 -0.29 527 527
DKK1 -0.08 0.19 -10000 0 -0.79 54 54
beta catenin/beta TrCP1 -0.002 0.029 -10000 0 -10000 0 0
APH1B -0.001 0.024 -10000 0 -0.79 1 1
APH1A 0 0 -10000 0 -10000 0 0
AXIN1 0.003 0.015 -10000 0 -10000 0 0
CtBP/CBP/TCF1/TLE1/AES 0.003 0.039 -10000 0 -0.34 6 6
PSEN1 0 0 -10000 0 -10000 0 0
FOS -0.24 0.36 -10000 0 -0.79 329 329
JUN -0.005 0.063 -10000 0 -0.79 7 7
MAP3K7 0.001 0.01 -10000 0 -0.3 1 1
CTNNB1 -0.002 0.034 0.22 4 -10000 0 4
MAPK3 0 0 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.085 0.12 -10000 0 -0.6 34 34
HNF1A -0.001 0.025 -10000 0 -10000 0 0
CTBP1 0.001 0.004 -10000 0 -10000 0 0
MYC -0.032 0.22 -10000 0 -1.5 24 24
NKD1 -0.009 0.069 -10000 0 -0.42 24 24
FZD1 0 0 -10000 0 -10000 0 0
NOTCH1 precursor/Deltex homolog 1 -0.041 0.13 -10000 0 -0.44 101 101
apoptosis -0.11 0.17 -10000 0 -0.36 333 333
Delta 1/NOTCHprecursor -0.005 0.055 -10000 0 -0.53 11 11
DLL1 -0.005 0.063 -10000 0 -0.79 7 7
PPARD -0.001 0.013 -10000 0 -10000 0 0
Gamma Secretase -0.001 0.014 -10000 0 -0.44 1 1
APC 0.003 0.015 -10000 0 -10000 0 0
DVL1 -0.037 0.035 -10000 0 -10000 0 0
CSNK2A1 0.011 0.003 -10000 0 -10000 0 0
MAP3K7IP1 -0.002 0.003 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.12 0.14 -10000 0 -0.57 55 55
LRP6 0 0.009 -10000 0 -0.29 1 1
CSNK1A1 0.011 0.003 -10000 0 -10000 0 0
NLK 0.002 0.01 -10000 0 -10000 0 0
CCND1 -0.012 0.094 -10000 0 -1.5 4 4
WNT1 -0.001 0.013 -10000 0 -0.29 2 2
Axin1/APC/beta catenin 0.011 0.037 -10000 0 -10000 0 0
DKK2 -0.024 0.14 -10000 0 -0.76 35 35
NOTCH1 precursor/DVL1 -0.018 0.041 -10000 0 -0.64 4 4
GSK3B 0.001 0.003 -10000 0 -10000 0 0
FRAT1 0.001 0.004 -10000 0 -10000 0 0
NOTCH/Deltex homolog 1 -0.041 0.13 -10000 0 -0.67 5 5
PPP2R5D -0.015 0.037 0.35 6 -10000 0 6
MAPK1 0 0 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 -0.24 0.23 -10000 0 -0.47 566 566
RBPJ 0 0 -10000 0 -10000 0 0
CREBBP 0.014 0.004 -10000 0 -10000 0 0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A -0.54 0.36 -9999 0 -0.79 751 751
oxygen homeostasis 0 0 -9999 0 -10000 0 0
TCEB2 -0.007 0.045 -9999 0 -0.29 27 27
TCEB1 -0.001 0.015 -9999 0 -0.29 3 3
HIF1A/p53 -0.001 0.005 -9999 0 -10000 0 0
HIF1A -0.002 0.008 -9999 0 -10000 0 0
COPS5 0 0 -9999 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 -0.003 0.018 -9999 0 -10000 0 0
FIH (dimer) 0 0 -9999 0 -10000 0 0
CDKN2A -0.05 0.11 -9999 0 -0.29 188 188
ARNT/IPAS -0.41 0.28 -9999 0 -0.6 751 751
HIF1AN 0 0 -9999 0 -10000 0 0
GNB2L1 0 0 -9999 0 -10000 0 0
HIF1A/ARNT -0.001 0.005 -9999 0 -10000 0 0
CUL2 0 0 -9999 0 -10000 0 0
OS9 -0.001 0.013 -9999 0 -10000 0 0
RACK1/Elongin B/Elongin C -0.004 0.024 -9999 0 -0.3 1 1
response to hypoxia 0 0 -9999 0 -10000 0 0
HIF1A/Hsp90 -0.001 0.006 -9999 0 -10000 0 0
PHD1-3/OS9 -0.011 0.039 -9999 0 -0.47 2 2
HIF1A/RACK1/Elongin B/Elongin C -0.003 0.016 -9999 0 -10000 0 0
VHL 0 0 -9999 0 -10000 0 0
HSP90AA1 0 0.009 -9999 0 -0.29 1 1
HIF1A/JAB1 -0.001 0.005 -9999 0 -10000 0 0
EGLN3 -0.023 0.081 -9999 0 -0.79 1 1
EGLN2 -0.002 0.022 -9999 0 -0.29 6 6
EGLN1 -0.001 0.024 -9999 0 -0.79 1 1
TP53 0 0 -9999 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A -0.001 0.005 -9999 0 -10000 0 0
ARNT 0 0 -9999 0 -10000 0 0
ARD1A 0 0 -9999 0 -10000 0 0
RBX1 0 0 -9999 0 -10000 0 0
HIF1A/p19ARF -0.019 0.04 -9999 0 -10000 0 0
Signaling events mediated by HDAC Class III

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0 0 -10000 0 -10000 0 0
HDAC4 -0.001 0.024 -10000 0 -0.79 1 1
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle 0.011 0.076 0.6 1 -10000 0 1
CDKN1A -0.002 0.04 -10000 0 -0.94 2 2
KAT2B -0.001 0.024 -10000 0 -0.79 1 1
BAX -0.001 0.018 -10000 0 -0.29 4 4
FOXO3 -0.001 0.017 -10000 0 -0.33 3 3
FOXO1 -0.009 0.082 -10000 0 -0.79 12 12
FOXO4 0.022 0 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0 0 -10000 0 -10000 0 0
TAT -0.56 0.35 -10000 0 -0.79 760 760
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 0.01 0.029 -10000 0 -0.6 1 1
PPARGC1A -0.17 0.32 -10000 0 -0.76 241 241
FHL2 -0.004 0.054 -10000 0 -0.7 6 6
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0 0.007 -10000 0 -10000 0 0
HIST2H4A -0.011 0.076 -10000 0 -0.6 1 1
SIRT1/FOXO3a 0 0.014 -10000 0 -0.25 3 3
SIRT1 0 0.009 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0 0.017 -10000 0 -0.52 1 1
SIRT1/Histone H1b -0.003 0.012 -10000 0 -10000 0 0
apoptosis 0 0.011 -10000 0 -10000 0 0
SIRT1/PGC1A -0.11 0.21 -10000 0 -0.52 230 230
p53/SIRT1 0.001 0.019 0.43 2 -10000 0 2
SIRT1/FOXO4 0 0.007 -10000 0 -10000 0 0
FOXO1/FHL2/SIRT1 -0.007 0.059 -10000 0 -0.48 17 17
HIST1H1E 0.015 0.022 -10000 0 -10000 0 0
SIRT1/p300 0 0.007 -10000 0 -10000 0 0
muscle cell differentiation 0.002 0.023 0.51 1 -10000 0 1
TP53 0 0.009 -10000 0 -10000 0 0
KU70/SIRT1/BAX 0 0.011 -10000 0 -10000 0 0
CREBBP 0 0 -10000 0 -10000 0 0
MEF2D 0 0 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 -0.42 0.27 -10000 0 -0.6 760 760
ACSS2 0.02 0.019 -10000 0 -0.6 1 1
SIRT1/PCAF/MYOD -0.002 0.023 -10000 0 -0.52 1 1
Stabilization and expansion of the E-cadherin adherens junction

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.009 0.052 -10000 0 -0.32 29 29
epithelial cell differentiation -0.011 0.069 -10000 0 -0.44 28 28
CYFIP2 -0.01 0.065 -10000 0 -0.36 31 31
ENAH 0.058 0.057 -10000 0 -10000 0 0
EGFR -0.29 0.38 -10000 0 -0.78 410 410
EPHA2 -0.004 0.058 -10000 0 -0.79 6 6
MYO6 -0.011 0.067 -10000 0 -0.42 29 29
CTNNB1 0 0 -10000 0 -10000 0 0
ABI1/Sra1/Nap1 -0.005 0.038 -10000 0 -0.52 4 4
AQP5 -0.23 0.29 -10000 0 -0.58 430 430
CTNND1 0 0.009 -10000 0 -0.29 1 1
mol:PI-4-5-P2 -0.011 0.065 -10000 0 -0.41 28 28
regulation of calcium-dependent cell-cell adhesion -0.032 0.11 -10000 0 -0.41 85 85
EGF -0.15 0.31 -10000 0 -0.78 214 214
NCKAP1 0 0 -10000 0 -10000 0 0
AQP3 -0.037 0.14 -10000 0 -0.58 59 59
cortical microtubule organization -0.011 0.069 -10000 0 -0.44 28 28
GO:0000145 0.027 0.068 -10000 0 -0.39 28 28
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.011 0.07 -10000 0 -0.44 28 28
MLLT4 -0.005 0.059 -10000 0 -0.72 7 7
ARF6/GDP -0.011 0.059 -10000 0 -10000 0 0
ARF6 0 0 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 -0.003 0.036 -10000 0 -0.47 6 6
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP 0.037 0.071 -10000 0 -0.38 28 28
PVRL2 -0.001 0.015 -10000 0 -10000 0 0
ZYX -0.011 0.066 -10000 0 -0.42 28 28
ARF6/GTP -0.003 0.033 -10000 0 -0.43 6 6
CDH1 -0.02 0.12 -10000 0 -0.79 28 28
EGFR/EGFR/EGF/EGF -0.24 0.26 -10000 0 -0.46 562 562
RhoA/GDP -0.011 0.065 -10000 0 -0.41 28 28
actin cytoskeleton organization 0.033 0.07 -10000 0 -0.39 29 29
IGF-1R heterotetramer -0.02 0.12 -10000 0 -0.59 36 36
GIT1 -0.001 0.02 -10000 0 -0.29 5 5
IGF1R -0.02 0.12 -10000 0 -0.6 36 36
IGF1 -0.18 0.33 -10000 0 -0.79 247 247
DIAPH1 -0.002 0.043 -10000 0 -0.69 4 4
Wnt receptor signaling pathway 0.011 0.069 0.44 28 -10000 0 28
RHOA 0 0 -10000 0 -10000 0 0
RhoA/GTP -0.011 0.06 -10000 0 -10000 0 0
CTNNA1 0 0 -10000 0 -10000 0 0
VCL 0.033 0.072 -10000 0 -0.4 29 29
EFNA1 0 0.009 -10000 0 -0.29 1 1
LPP 0.031 0.078 -10000 0 -0.39 36 36
Ephrin A1/EPHA2 -0.012 0.069 -10000 0 -0.4 34 34
SEC6/SEC8 -0.012 0.065 -10000 0 -0.74 1 1
MGAT3 -0.033 0.11 -10000 0 -0.42 85 85
HGF/MET -0.11 0.2 -10000 0 -0.44 262 262
HGF -0.053 0.2 -10000 0 -0.79 73 73
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.009 0.052 -10000 0 -0.32 29 29
actin cable formation 0.072 0.055 -10000 0 -0.32 1 1
KIAA1543 0.032 0.087 -10000 0 -0.46 29 29
KIFC3 -0.011 0.068 -10000 0 -0.42 30 30
NCK1 0 0 -10000 0 -10000 0 0
EXOC3 0 0 -10000 0 -10000 0 0
ACTN1 -0.011 0.067 -10000 0 -0.42 29 29
NCK1/GIT1 -0.001 0.013 -10000 0 -10000 0 0
mol:GDP -0.011 0.069 -10000 0 -0.44 28 28
EXOC4 0 0 -10000 0 -10000 0 0
STX4 -0.011 0.066 -10000 0 -0.42 28 28
PIP5K1C -0.011 0.066 -10000 0 -0.42 28 28
LIMA1 -0.001 0.024 -10000 0 -0.79 1 1
ABI1 0 0 -10000 0 -10000 0 0
ROCK1 -0.01 0.053 -10000 0 -10000 0 0
adherens junction assembly 0.048 0.083 -10000 0 -0.66 6 6
IGF-1R heterotetramer/IGF1 -0.11 0.19 -10000 0 -0.43 279 279
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin -0.004 0.046 -10000 0 -0.6 6 6
MET -0.14 0.3 -10000 0 -0.78 189 189
PLEKHA7 -0.012 0.076 -10000 0 -0.46 28 28
mol:GTP -0.003 0.035 -10000 0 -0.46 6 6
establishment of epithelial cell apical/basal polarity -0.011 0.061 -10000 0 -0.7 1 1
cortical actin cytoskeleton stabilization -0.009 0.052 -10000 0 -0.32 29 29
regulation of cell-cell adhesion 0.033 0.07 -10000 0 -0.39 29 29
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.009 0.052 -10000 0 -0.32 29 29
TCGA08_rtk_signaling

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.053 0.2 -10000 0 -0.78 74 74
HRAS -0.003 0.028 -10000 0 -10000 0 0
EGFR -0.29 0.38 -10000 0 -0.78 410 410
AKT 0.013 0.084 -10000 0 -0.57 20 20
FOXO3 -0.002 0.041 -10000 0 -0.79 3 3
AKT1 0 0 -10000 0 -10000 0 0
FOXO1 -0.009 0.082 -10000 0 -0.79 12 12
AKT3 -0.014 0.11 -10000 0 -0.79 20 20
FOXO4 0 0 -10000 0 -10000 0 0
MET -0.14 0.3 -10000 0 -0.78 189 189
PIK3CA 0 0.009 -10000 0 -0.29 1 1
PIK3CB 0 0 -10000 0 -10000 0 0
NRAS -0.001 0.013 -10000 0 -0.29 2 2
PIK3CG -0.013 0.099 -10000 0 -0.79 17 17
PIK3R3 0 0.009 -10000 0 -0.29 1 1
PIK3R2 0 0 -10000 0 -10000 0 0
NF1 -0.001 0.024 -10000 0 -0.79 1 1
RAS -0.095 0.16 0.25 1 -0.37 213 214
ERBB2 -0.024 0.083 -10000 0 -0.3 89 89
proliferation/survival/translation -0.004 0.059 0.28 14 -10000 0 14
PI3K -0.087 0.16 -10000 0 -0.36 220 220
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
KRAS -0.001 0.013 -10000 0 -0.29 2 2
FOXO 0.027 0.029 -10000 0 -0.49 1 1
AKT2 0 0 -10000 0 -10000 0 0
PTEN -0.001 0.034 -10000 0 -0.79 2 2
LPA4-mediated signaling events

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 0 0.1 -9999 0 -0.53 41 41
ADCY5 -0.16 0.26 -9999 0 -0.53 354 354
ADCY6 0.02 0 -9999 0 -10000 0 0
ADCY7 0.02 0 -9999 0 -10000 0 0
ADCY1 -0.008 0.097 -9999 0 -0.53 29 29
ADCY2 -0.032 0.15 -9999 0 -0.53 90 90
ADCY3 0.02 0.005 -9999 0 -10000 0 0
ADCY8 0.01 0.028 -9999 0 -10000 0 0
PRKCE 0.011 0 -9999 0 -10000 0 0
ADCY9 0.02 0 -9999 0 -10000 0 0
mol:DAG 0 0 -9999 0 -10000 0 0
cAMP biosynthetic process -0.032 0.1 -9999 0 -0.31 75 75
Effects of Botulinum toxin

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.003 0.041 -9999 0 -0.2 43 43
UniProt:P19321 0 0 -9999 0 -10000 0 0
RIMS1/UNC13B -0.046 0.13 -9999 0 -0.6 46 46
STXBP1 -0.006 0.067 -9999 0 -0.79 8 8
ACh/CHRNA1 -0.062 0.082 -9999 0 -0.22 37 37
RAB3GAP2/RIMS1/UNC13B -0.038 0.11 -9999 0 -0.52 46 46
mol:Ca2+ 0 0 -9999 0 -10000 0 0
UniProt:P30996 0 0 -9999 0 -10000 0 0
UniProt:Q60393 0 0 -9999 0 -10000 0 0
CST086 0 0 -9999 0 -10000 0 0
RIMS1 -0.066 0.18 -9999 0 -0.43 170 170
mol:ACh 0.001 0.031 -9999 0 -0.15 35 35
RAB3GAP2 0 0 -9999 0 -10000 0 0
STX1A/SNAP25/VAMP2 -0.038 0.093 -9999 0 -0.39 54 54
UniProt:P10844 0 0 -9999 0 -10000 0 0
muscle contraction -0.062 0.082 -9999 0 -0.22 37 37
UNC13B 0 0 -9999 0 -10000 0 0
CHRNA1 -0.099 0.14 -9999 0 -0.29 371 371
UniProt:P10845 0 0 -9999 0 -10000 0 0
ACh/Synaptotagmin 1 -0.059 0.12 -9999 0 -0.47 60 60
SNAP25 -0.009 0.068 -9999 0 -0.37 35 35
VAMP2 0 0 -9999 0 -10000 0 0
SYT1 -0.087 0.18 -9999 0 -0.38 253 253
UniProt:Q00496 0 0 -9999 0 -10000 0 0
STXIA/STXBP1 -0.01 0.053 -9999 0 -0.52 8 8
STX1A/SNAP25 fragment 1/VAMP2 -0.038 0.093 -9999 0 -0.39 54 54
Syndecan-4-mediated signaling events

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.002 0.036 -9999 0 -10000 0 0
Syndecan-4/Syndesmos -0.024 0.037 -9999 0 -0.63 1 1
positive regulation of JNK cascade -0.05 0.1 -9999 0 -0.41 41 41
Syndecan-4/ADAM12 -0.032 0.055 -9999 0 -0.53 2 2
CCL5 -0.014 0.079 -9999 0 -0.36 44 44
Rac1/GDP 0 0 -9999 0 -10000 0 0
DNM2 0 0 -9999 0 -10000 0 0
ITGA5 0 0.009 -9999 0 -0.29 1 1
SDCBP 0 0 -9999 0 -10000 0 0
PLG -0.001 0.026 -9999 0 -0.29 8 8
ADAM12 -0.019 0.077 -9999 0 -0.31 68 68
mol:GTP 0 0 -9999 0 -10000 0 0
NUDT16L1 -0.001 0.02 -9999 0 -0.29 5 5
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
Syndecan-4/PKC alpha -0.054 0.044 -9999 0 -10000 0 0
Syndecan-4/Laminin alpha1 -0.07 0.13 -9999 0 -0.46 61 61
Syndecan-4/CXCL12/CXCR4 -0.053 0.11 -9999 0 -0.43 39 39
Syndecan-4/Laminin alpha3 -0.13 0.19 -9999 0 -0.48 204 204
MDK -0.012 0.057 -9999 0 -0.29 43 43
Syndecan-4/FZD7 -0.033 0.068 -9999 0 -0.46 15 15
Syndecan-4/Midkine -0.028 0.042 -9999 0 -0.63 1 1
FZD7 -0.017 0.11 -9999 0 -0.79 23 23
Syndecan-4/FGFR1/FGF -0.19 0.2 -9999 0 -0.5 116 116
THBS1 -0.004 0.053 -9999 0 -0.79 5 5
integrin-mediated signaling pathway -0.034 0.072 -9999 0 -0.46 16 16
positive regulation of MAPKKK cascade -0.05 0.1 -9999 0 -0.41 41 41
Syndecan-4/TACI -0.036 0.066 -9999 0 -0.5 7 7
CXCR4 -0.007 0.045 -9999 0 -0.29 26 26
cell adhesion -0.02 0.061 -9999 0 -0.34 29 29
Syndecan-4/Dynamin -0.024 0.036 -9999 0 -0.63 1 1
Syndecan-4/TSP1 -0.026 0.046 -9999 0 -0.48 5 5
Syndecan-4/GIPC -0.024 0.036 -9999 0 -0.63 1 1
Syndecan-4/RANTES -0.03 0.052 -9999 0 -0.48 6 6
ITGB1 0 0 -9999 0 -10000 0 0
LAMA1 -0.088 0.25 -9999 0 -0.77 124 124
LAMA3 -0.2 0.34 -9999 0 -0.79 276 276
RAC1 0 0 -9999 0 -10000 0 0
PRKCA 0.004 0.13 -9999 0 -0.72 31 31
Syndecan-4/alpha-Actinin -0.024 0.038 -9999 0 -0.54 2 2
TFPI -0.041 0.18 -9999 0 -0.78 58 58
F2 0 0.034 -9999 0 -0.29 14 14
alpha5/beta1 Integrin 0 0.006 -9999 0 -10000 0 0
positive regulation of cell adhesion -0.16 0.23 -9999 0 -0.52 210 210
ACTN1 -0.001 0.024 -9999 0 -0.79 1 1
TNC -0.022 0.12 -9999 0 -0.64 37 37
Syndecan-4/CXCL12 -0.056 0.11 -9999 0 -0.45 41 41
FGF6 -0.001 0.034 -9999 0 -0.79 2 2
RHOA 0 0 -9999 0 -10000 0 0
CXCL12 -0.061 0.21 -9999 0 -0.79 85 85
TNFRSF13B -0.028 0.11 -9999 0 -0.39 78 78
FGF2 -0.32 0.39 -9999 0 -0.79 446 446
FGFR1 -0.009 0.08 -9999 0 -0.68 14 14
Syndecan-4/PI-4-5-P2 -0.018 0.048 -9999 0 -0.64 1 1
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.11 0.15 -9999 0 -0.3 431 431
cell migration -0.024 0.019 -9999 0 -10000 0 0
PRKCD 0.005 0.014 -9999 0 -0.29 1 1
vasculogenesis -0.025 0.044 -9999 0 -0.46 5 5
SDC4 -0.018 0.051 -9999 0 -0.68 1 1
Syndecan-4/Tenascin C -0.035 0.075 -9999 0 -0.48 16 16
Syndecan-4/PI-4-5-P2/PKC alpha -0.043 0.035 -9999 0 -10000 0 0
Syndecan-4/Syntenin -0.024 0.036 -9999 0 -0.63 1 1
MMP9 -0.12 0.15 -9999 0 -0.29 483 483
Rac1/GTP -0.028 0.057 -9999 0 -0.34 29 29
cytoskeleton organization -0.024 0.036 -9999 0 -0.6 1 1
GIPC1 0 0.009 -9999 0 -0.29 1 1
Syndecan-4/TFPI -0.046 0.098 -9999 0 -0.46 36 36
IL27-mediated signaling events

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.001 0.017 -10000 0 -0.29 3 3
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.035 0.13 0.45 30 -10000 0 30
IL27/IL27R/JAK1 -0.074 0.19 -10000 0 -0.67 43 43
TBX21 -0.043 0.21 -10000 0 -0.63 70 70
IL12B -0.055 0.12 -10000 0 -0.29 229 229
IL12A -0.027 0.14 -10000 0 -0.55 68 68
IL6ST -0.091 0.27 -10000 0 -0.79 138 138
IL27RA/JAK1 -0.008 0.073 -10000 0 -1.1 4 4
IL27 -0.025 0.095 -10000 0 -0.29 121 121
TYK2 0.01 0.006 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.12 0.18 -10000 0 -10000 0 0
T-helper 2 cell differentiation 0.035 0.13 0.45 30 -10000 0 30
T cell proliferation during immune response 0.035 0.13 0.45 30 -10000 0 30
MAPKKK cascade -0.035 0.13 -10000 0 -0.45 30 30
STAT3 0 0 -10000 0 -10000 0 0
STAT2 0 0 -10000 0 -10000 0 0
STAT1 -0.004 0.039 -10000 0 -0.3 19 19
IL12RB1 -0.004 0.067 -10000 0 -0.32 43 43
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.059 0.23 -10000 0 -0.62 98 98
IL27/IL27R/JAK2/TYK2 -0.035 0.13 -10000 0 -0.47 27 27
positive regulation of T cell mediated cytotoxicity -0.035 0.13 -10000 0 -0.45 30 30
STAT1 (dimer) -0.092 0.22 0.52 8 -0.76 51 59
JAK2 0.005 0.025 -10000 0 -0.79 1 1
JAK1 0 0.024 -10000 0 -0.79 1 1
STAT2 (dimer) -0.044 0.11 -10000 0 -0.47 19 19
T cell proliferation -0.18 0.25 -10000 0 -0.46 413 413
IL12/IL12R/TYK2/JAK2 0.012 0.069 -10000 0 -10000 0 0
IL17A -0.12 0.18 -10000 0 -10000 0 0
mast cell activation 0.035 0.13 0.45 30 -10000 0 30
IFNG -0.001 0.025 -10000 0 -0.077 10 10
T cell differentiation -0.004 0.006 -10000 0 -0.02 16 16
STAT3 (dimer) -0.044 0.11 -10000 0 -0.49 16 16
STAT5A (dimer) -0.048 0.12 -10000 0 -0.47 31 31
STAT4 (dimer) -0.062 0.15 -10000 0 -0.5 61 61
STAT4 -0.032 0.16 -10000 0 -0.78 45 45
T cell activation -0.009 0.009 0.13 3 -10000 0 3
IL27R/JAK2/TYK2 -0.062 0.17 -10000 0 -0.91 7 7
GATA3 -0.039 0.28 -10000 0 -1.4 40 40
IL18 0.006 0.032 -10000 0 -10000 0 0
positive regulation of mast cell cytokine production -0.044 0.11 -10000 0 -0.47 17 17
IL27/EBI3 -0.026 0.083 -10000 0 -0.52 14 14
IL27RA -0.001 0.078 -10000 0 -1.4 3 3
IL6 -0.29 0.38 -10000 0 -0.79 400 400
STAT5A -0.006 0.067 -10000 0 -0.79 8 8
monocyte differentiation 0 0.001 -10000 0 -10000 0 0
IL2 0.004 0.03 0.48 3 -10000 0 3
IL1B 0.002 0.073 -10000 0 -0.52 19 19
EBI3 -0.004 0.076 -10000 0 -0.49 21 21
TNF -0.001 0.074 -10000 0 -0.61 13 13
Canonical Wnt signaling pathway

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.004 0.018 -10000 0 -10000 0 0
AES 0.004 0.015 -10000 0 -10000 0 0
FBXW11 0 0 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0 0.006 -10000 0 -10000 0 0
SMAD4 -0.001 0.024 -10000 0 -0.79 1 1
DKK2 -0.024 0.14 -10000 0 -0.76 35 35
TLE1 -0.002 0.069 -10000 0 -0.79 8 8
MACF1 0.006 0.006 -10000 0 -10000 0 0
CTNNB1 0.1 0.087 -10000 0 -10000 0 0
WIF1 -0.41 0.39 -10000 0 -0.77 581 581
beta catenin/RanBP3 0.014 0.078 0.38 40 -10000 0 40
KREMEN2 -0.14 0.15 -10000 0 -0.29 527 527
DKK1 -0.08 0.19 -10000 0 -0.79 54 54
beta catenin/beta TrCP1 0.1 0.083 -10000 0 -10000 0 0
FZD1 0 0.002 -10000 0 -10000 0 0
AXIN2 -0.014 0.21 -10000 0 -1.5 20 20
AXIN1 0.007 0.006 -10000 0 -10000 0 0
RAN 0.001 0.003 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.007 0.024 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.092 0.078 0.3 1 -0.49 6 7
Axin1/APC/GSK3 0.001 0.014 0.24 1 -10000 0 1
Axin1/APC/GSK3/beta catenin/Macf1 0.077 0.033 -10000 0 -10000 0 0
HNF1A 0.002 0.029 -10000 0 -10000 0 0
CTBP1 0.004 0.016 -10000 0 -10000 0 0
MYC -0.018 0.23 -10000 0 -1.5 25 25
RANBP3 0.001 0.003 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.085 0.12 -10000 0 -0.6 34 34
NKD1 -0.009 0.069 -10000 0 -0.42 24 24
TCF4 -0.005 0.083 -10000 0 -0.78 12 12
TCF3 0.004 0.017 -10000 0 -10000 0 0
WNT1/LRP6/FZD1/Axin1 0 0.006 -10000 0 -10000 0 0
Ran/GTP 0 0.001 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.014 0.099 0.45 45 -0.42 1 46
LEF1 -0.036 0.1 -10000 0 -0.3 140 140
DVL1 0.071 0.065 0.22 1 -10000 0 1
CSNK2A1 0 0.002 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.098 0.089 -10000 0 -0.58 5 5
DKK1/LRP6/Kremen 2 -0.12 0.14 -10000 0 -0.57 55 55
LRP6 0.002 0.01 -10000 0 -0.29 1 1
CSNK1A1 0.004 0.018 -10000 0 -10000 0 0
NLK 0.011 0.014 -10000 0 -0.3 2 2
CCND1 0.002 0.11 -10000 0 -1.6 4 4
WNT1 0.005 0.014 -10000 0 -0.29 2 2
GSK3A 0.009 0.006 -10000 0 -10000 0 0
GSK3B 0 0.001 -10000 0 -10000 0 0
FRAT1 0 0 -10000 0 -10000 0 0
PPP2R5D 0.044 0.045 0.34 7 -10000 0 7
APC 0.001 0.009 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 0.14 0.13 0.27 566 -10000 0 566
CREBBP 0.004 0.016 -10000 0 -10000 0 0
IL12-mediated signaling events

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.004 0.13 -10000 0 -0.4 54 54
TBX21 -0.013 0.34 -10000 0 -1.2 59 59
B2M 0.011 0.005 -10000 0 -10000 0 0
TYK2 0.017 0.015 -10000 0 -10000 0 0
IL12RB1 0.004 0.072 -10000 0 -0.33 43 43
GADD45B 0.031 0.22 -10000 0 -0.83 32 32
IL12RB2 -0.056 0.19 -10000 0 -0.43 184 184
GADD45G 0.021 0.22 -10000 0 -0.78 41 41
natural killer cell activation 0.007 0.018 -10000 0 -10000 0 0
RELB -0.003 0.028 -10000 0 -0.29 10 10
RELA 0 0 -10000 0 -10000 0 0
IL18 0.007 0.048 -10000 0 -0.3 7 7
IL2RA -0.031 0.12 -10000 0 -0.38 87 87
IFNG -0.04 0.1 -10000 0 -0.29 150 150
STAT3 (dimer) 0.024 0.22 -10000 0 -0.65 60 60
HLA-DRB5 -0.017 0.096 -10000 0 -0.33 84 84
FASLG 0.002 0.29 -10000 0 -1.1 46 46
NF kappa B2 p52/RelB -0.079 0.2 -10000 0 -0.73 69 69
CD4 0.008 0.006 -10000 0 -10000 0 0
SOCS1 -0.005 0.043 -10000 0 -0.79 1 1
EntrezGene:6955 -0.006 0.014 -10000 0 -10000 0 0
CD3D -0.026 0.14 -10000 0 -0.49 78 78
CD3E -0.019 0.13 -10000 0 -0.5 61 61
CD3G -0.035 0.17 -10000 0 -0.57 82 82
IL12Rbeta2/JAK2 -0.026 0.15 -10000 0 -0.61 50 50
CCL3 0.012 0.26 -10000 0 -0.97 41 41
CCL4 0.014 0.25 -10000 0 -0.94 39 39
HLA-A 0.008 0.032 -10000 0 -0.3 11 11
IL18/IL18R 0.02 0.14 -10000 0 -0.54 56 56
NOS2 0.018 0.25 -10000 0 -0.9 44 44
IL12/IL12R/TYK2/JAK2/SPHK2 -0.003 0.13 -10000 0 -0.39 56 56
IL1R1 -0.001 0.31 -10000 0 -1.2 49 49
IL4 -0.004 0.018 -10000 0 -10000 0 0
JAK2 0.016 0.029 -10000 0 -0.82 1 1
EntrezGene:6957 -0.005 0.013 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.032 0.25 -10000 0 -0.99 50 50
RAB7A 0.045 0.19 -10000 0 -0.74 25 25
lysosomal transport 0.047 0.19 -10000 0 -0.7 25 25
FOS -0.35 0.66 -10000 0 -1.3 342 342
STAT4 (dimer) 0.02 0.26 -10000 0 -0.86 57 57
STAT5A (dimer) -0.086 0.22 -10000 0 -0.7 80 80
GZMA 0.002 0.28 -10000 0 -1 45 45
GZMB -0.012 0.31 -10000 0 -1.1 55 55
HLX -0.001 0.015 -10000 0 -0.29 3 3
LCK 0.003 0.29 -10000 0 -0.83 73 73
TCR/CD3/MHC II/CD4 -0.065 0.19 -10000 0 -0.61 71 71
IL2/IL2R -0.03 0.1 -10000 0 -0.48 41 41
MAPK14 0.035 0.22 -10000 0 -0.77 44 44
CCR5 0.025 0.22 -10000 0 -0.87 32 32
IL1B 0.005 0.098 -10000 0 -0.69 19 19
STAT6 0.025 0.087 -10000 0 -0.26 5 5
STAT4 -0.032 0.16 -10000 0 -0.78 45 45
STAT3 0 0 -10000 0 -10000 0 0
STAT1 -0.005 0.038 -10000 0 -0.29 19 19
NFKB1 0 0 -10000 0 -10000 0 0
NFKB2 0 0.009 -10000 0 -0.29 1 1
IL12B -0.047 0.12 -10000 0 -0.29 217 217
CD8A 0 0.074 -10000 0 -0.37 34 34
CD8B -0.022 0.14 -10000 0 -0.54 66 66
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.003 0.13 0.4 54 -10000 0 54
IL2RB -0.012 0.064 -10000 0 -0.32 42 42
proteasomal ubiquitin-dependent protein catabolic process 0.027 0.24 -10000 0 -0.77 57 57
IL2RG -0.017 0.085 -10000 0 -0.36 53 53
IL12 -0.052 0.16 -10000 0 -0.59 65 65
STAT5A -0.006 0.067 -10000 0 -0.79 8 8
CD247 -0.011 0.12 -10000 0 -0.58 37 37
IL2 -0.002 0.025 -10000 0 -0.29 8 8
SPHK2 0 0 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A -0.031 0.19 -10000 0 -0.68 76 76
IL12/IL12R/TYK2/JAK2 0.007 0.29 -10000 0 -0.83 72 72
MAP2K3 0.03 0.22 -10000 0 -0.77 44 44
RIPK2 -0.001 0.02 -10000 0 -0.29 5 5
MAP2K6 0.026 0.23 -10000 0 -0.77 48 48
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA 0.008 0.026 -10000 0 -0.79 1 1
IL18RAP -0.014 0.15 -10000 0 -0.73 42 42
IL12Rbeta1/TYK2 0.014 0.056 -10000 0 -0.63 2 2
EOMES -0.024 0.18 -10000 0 -1.5 17 17
STAT1 (dimer) 0.027 0.22 -10000 0 -0.66 52 52
T cell proliferation 0.031 0.2 -10000 0 -0.61 59 59
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0 0.11 -10000 0 -0.79 20 20
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.062 0.17 -10000 0 -0.72 51 51
ATF2 0.041 0.21 -10000 0 -0.72 42 42
TCR signaling in naïve CD8+ T cells

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.035 0.12 -10000 0 -0.6 38 38
FYN 0.017 0.18 -10000 0 -0.7 47 47
LAT/GRAP2/SLP76 -0.028 0.14 -10000 0 -0.65 42 42
IKBKB -0.001 0.013 -10000 0 -0.29 2 2
AKT1 0.031 0.12 -10000 0 -0.46 44 44
B2M 0.012 0.004 -10000 0 -10000 0 0
IKBKG -0.008 0.026 -10000 0 -0.16 2 2
MAP3K8 -0.007 0.072 -10000 0 -0.74 10 10
mol:Ca2+ -0.024 0.047 -10000 0 -0.12 211 211
integrin-mediated signaling pathway -0.002 0.028 -10000 0 -0.52 3 3
LAT/GRAP2/SLP76/VAV1/PI3K Class IA 0.022 0.17 -10000 0 -0.68 48 48
TRPV6 -0.16 0.32 -10000 0 -0.77 225 225
CD28 0.002 0.074 -10000 0 -0.52 18 18
SHC1 0.012 0.18 -10000 0 -0.75 44 44
receptor internalization -0.001 0.2 -10000 0 -0.77 52 52
PRF1 0 0.22 -10000 0 -1.1 36 36
KRAS -0.001 0.013 -10000 0 -0.29 2 2
GRB2 0 0.009 -10000 0 -0.29 1 1
COT/AKT1 0.032 0.1 -10000 0 -0.37 48 48
LAT 0.01 0.18 -10000 0 -0.73 48 48
EntrezGene:6955 0.001 0.003 -10000 0 -10000 0 0
CD3D -0.023 0.14 -10000 0 -0.48 78 78
CD3E -0.016 0.13 -10000 0 -0.49 61 61
CD3G -0.031 0.16 -10000 0 -0.56 82 82
RASGRP2 0.004 0.041 -10000 0 -0.18 45 45
RASGRP1 0.036 0.12 -10000 0 -0.46 46 46
HLA-A 0.009 0.031 -10000 0 -0.29 11 11
RASSF5 -0.002 0.042 -10000 0 -0.66 4 4
RAP1A/GTP/RAPL -0.002 0.028 -10000 0 -0.52 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.033 0.043 -10000 0 -0.12 40 40
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.014 0.047 -10000 0 -0.24 28 28
PRKCA -0.013 0.084 -10000 0 -0.3 61 61
GRAP2 -0.013 0.1 -10000 0 -0.72 21 21
mol:IP3 0.019 0.15 0.27 182 -0.45 42 224
EntrezGene:6957 0.001 0.003 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.005 0.2 -10000 0 -0.9 40 40
ORAI1 0.077 0.15 0.38 211 -10000 0 211
CSK 0.009 0.18 -10000 0 -0.76 44 44
B7 family/CD28 -0.026 0.18 -10000 0 -0.66 58 58
CHUK 0 0 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.001 0.21 -10000 0 -0.75 61 61
PTPN6 0.008 0.18 -10000 0 -0.76 45 45
VAV1 0.011 0.18 -10000 0 -0.75 46 46
Monovalent TCR/CD3 -0.023 0.2 -10000 0 -0.68 68 68
CBL 0 0 -10000 0 -10000 0 0
LCK 0.011 0.19 -10000 0 -0.75 48 48
PAG1 0.009 0.18 -10000 0 -0.79 42 42
RAP1A 0 0 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.001 0.21 -10000 0 -0.76 58 58
CD80 -0.068 0.13 -10000 0 -0.29 285 285
CD86 0.008 0.023 -10000 0 -0.3 6 6
PDK1/CARD11/BCL10/MALT1 -0.017 0.057 -10000 0 -0.28 33 33
HRAS -0.003 0.028 -10000 0 -10000 0 0
GO:0035030 0 0.15 -10000 0 -0.54 58 58
CD8A 0 0.073 -10000 0 -0.37 34 34
CD8B -0.021 0.15 -10000 0 -0.55 66 66
PTPRC -0.001 0.071 -10000 0 -0.48 19 19
PDK1/PKC theta 0.034 0.15 -10000 0 -0.59 46 46
CSK/PAG1 0.014 0.18 -10000 0 -0.78 39 39
SOS1 0 0 -10000 0 -10000 0 0
peptide-MHC class I -0.002 0.018 -10000 0 -10000 0 0
GRAP2/SLP76 -0.034 0.17 -10000 0 -0.75 45 45
STIM1 0.04 0.078 -10000 0 -10000 0 0
RAS family/GTP 0.041 0.054 -10000 0 -0.17 31 31
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.005 0.22 -10000 0 -0.85 52 52
mol:DAG -0.007 0.1 -10000 0 -0.41 42 42
RAP1A/GDP 0.016 0.018 -10000 0 -10000 0 0
PLCG1 0.001 0.003 -10000 0 -10000 0 0
CD247 -0.008 0.12 -10000 0 -0.58 37 37
cytotoxic T cell degranulation 0.003 0.21 -10000 0 -0.95 39 39
RAP1A/GTP -0.003 0.013 -10000 0 -0.068 23 23
mol:PI-3-4-5-P3 0.027 0.14 -10000 0 -0.54 48 48
LAT/GRAP2/SLP76/VAV1/PLCgamma1 0.012 0.17 0.29 170 -0.6 42 212
NRAS -0.001 0.013 -10000 0 -0.29 2 2
ZAP70 -0.031 0.12 -10000 0 -0.42 81 81
GRB2/SOS1 0 0.006 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.025 0.14 -10000 0 -0.62 42 42
MALT1 0 0 -10000 0 -10000 0 0
TRAF6 0 0 -10000 0 -10000 0 0
CD8 heterodimer -0.031 0.13 -10000 0 -0.56 53 53
CARD11 -0.007 0.052 -10000 0 -0.79 2 2
PRKCB -0.012 0.084 -10000 0 -0.33 50 50
PRKCE -0.006 0.068 -10000 0 -0.28 39 39
PRKCQ 0.025 0.17 -10000 0 -0.67 49 49
LCP2 0 0.009 -10000 0 -0.29 1 1
BCL10 0 0 -10000 0 -10000 0 0
regulation of survival gene product expression 0.032 0.1 -10000 0 -0.39 44 44
IKK complex 0.041 0.044 -10000 0 -0.12 29 29
RAS family/GDP -0.002 0.006 -10000 0 -10000 0 0
MAP3K14 0.036 0.08 -10000 0 -0.29 39 39
PDPK1 0.034 0.11 -10000 0 -0.44 41 41
TCR/CD3/MHC I/CD8/Fyn -0.004 0.23 -10000 0 -0.92 50 50
Coregulation of Androgen receptor activity

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 -0.002 0.032 -10000 0 -0.79 1 1
SVIL -0.004 0.056 -10000 0 -0.79 5 5
ZNF318 0.022 0.057 -10000 0 -10000 0 0
JMJD2C -0.003 0.041 -10000 0 -0.14 79 79
T-DHT/AR/Ubc9 -0.081 0.18 -10000 0 -0.54 146 146
CARM1 0 0 -10000 0 -10000 0 0
PRDX1 0.003 0.012 -10000 0 -0.29 1 1
PELP1 0.005 0.012 -10000 0 -10000 0 0
CTNNB1 0.001 0.015 -10000 0 -10000 0 0
AKT1 0.007 0.018 -10000 0 -10000 0 0
PTK2B 0.001 0.013 -10000 0 -10000 0 0
MED1 0.002 0.047 -10000 0 -0.29 20 20
MAK 0.011 0.1 0.26 1 -0.55 20 21
response to oxidative stress 0.001 0.004 -10000 0 -10000 0 0
HIP1 -0.005 0.061 -10000 0 -0.79 6 6
GSN -0.012 0.091 -10000 0 -0.79 14 14
NCOA2 -0.039 0.17 -10000 0 -0.79 54 54
NCOA6 -0.001 0.02 -10000 0 -0.29 1 1
DNA-PK 0.022 0.058 -10000 0 -10000 0 0
NCOA4 0 0 -10000 0 -10000 0 0
PIAS3 0.001 0.015 -10000 0 -10000 0 0
cell proliferation -0.008 0.11 -10000 0 -0.87 11 11
XRCC5 0.006 0.015 -10000 0 -10000 0 0
UBE3A -0.005 0.03 -10000 0 -10000 0 0
T-DHT/AR/SNURF -0.094 0.21 -10000 0 -0.57 162 162
FHL2 -0.018 0.12 -10000 0 -1.2 5 5
RANBP9 0 0.018 -10000 0 -10000 0 0
JMJD1A -0.011 0.056 -10000 0 -0.14 159 159
CDK6 -0.009 0.093 -10000 0 -0.73 17 17
TGFB1I1 -0.003 0.046 -10000 0 -0.79 3 3
T-DHT/AR/CyclinD1 -0.094 0.19 -10000 0 -0.55 151 151
XRCC6 0.006 0.015 -10000 0 -10000 0 0
T-DHT/AR -0.067 0.21 -10000 0 -0.53 164 164
CTDSP1 0.004 0.005 -10000 0 -10000 0 0
CTDSP2 0.015 0.038 -10000 0 -10000 0 0
BRCA1 -0.002 0.034 -10000 0 -0.49 3 3
TCF4 0.003 0.088 -10000 0 -0.78 12 12
CDKN2A -0.042 0.11 -10000 0 -0.29 167 167
SRF 0.024 0.019 -10000 0 -10000 0 0
NKX3-1 -0.082 0.19 -10000 0 -1.2 23 23
KLK3 -0.17 0.5 -10000 0 -1.5 127 127
TMF1 0.004 0.005 -10000 0 -10000 0 0
HNRNPA1 0.008 0.021 -10000 0 -10000 0 0
AOF2 -0.008 0.023 -10000 0 -0.072 127 127
APPL1 0.034 0.032 -10000 0 -10000 0 0
T-DHT/AR/Caspase 8 -0.074 0.19 -10000 0 -0.53 147 147
AR -0.1 0.27 -10000 0 -0.79 147 147
UBA3 0.004 0.005 -10000 0 -10000 0 0
PATZ1 0.008 0.021 -10000 0 -10000 0 0
PAWR 0.003 0.025 -10000 0 -0.79 1 1
PRKDC 0.005 0.024 -10000 0 -0.29 4 4
PA2G4 0.011 0.027 -10000 0 -10000 0 0
UBE2I 0 0 -10000 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.069 0.17 -10000 0 -0.5 146 146
RPS6KA3 -0.008 0.074 -10000 0 -0.79 9 9
T-DHT/AR/ARA70 -0.085 0.18 -10000 0 -0.54 147 147
LATS2 0.009 0.023 -10000 0 -10000 0 0
T-DHT/AR/PRX1 -0.064 0.18 0.19 1 -0.49 146 147
Cyclin D3/CDK11 p58 0 0.006 -10000 0 -10000 0 0
VAV3 -0.01 0.075 -10000 0 -0.43 26 26
KLK2 -0.12 0.32 -10000 0 -1.2 79 79
CASP8 0.004 0.011 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.099 0.2 -10000 0 -0.54 181 181
TMPRSS2 -0.17 0.39 -10000 0 -1.2 141 141
CCND1 -0.016 0.074 -10000 0 -0.34 46 46
PIAS1 -0.005 0.03 -10000 0 -10000 0 0
mol:T-DHT -0.008 0.033 -10000 0 -0.078 183 183
CDC2L1 0.001 0.002 -10000 0 -10000 0 0
PIAS4 -0.011 0.049 -10000 0 -10000 0 0
T-DHT/AR/CDK6 -0.085 0.2 -10000 0 -0.54 161 161
CMTM2 0.003 0.013 -10000 0 -0.29 1 1
SNURF -0.021 0.13 -10000 0 -0.79 29 29
ZMIZ1 0.004 0.03 -10000 0 -0.36 1 1
CCND3 0.002 0.01 -10000 0 -10000 0 0
TGIF1 0.008 0.021 -10000 0 -10000 0 0
FKBP4 -0.003 0.033 -10000 0 -0.3 9 9
Insulin Pathway

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP -0.13 0.22 -9999 0 -0.46 301 301
TC10/GTP -0.11 0.18 -9999 0 -0.4 285 285
Insulin Receptor/Insulin/IRS1/Shp2 -0.02 0.097 -9999 0 -0.49 45 45
HRAS -0.003 0.028 -9999 0 -10000 0 0
APS homodimer -0.013 0.06 -9999 0 -0.29 49 49
GRB14 -0.1 0.22 -9999 0 -0.48 231 231
FOXO3 -0.015 0.07 -9999 0 -0.7 10 10
AKT1 -0.058 0.12 -9999 0 -0.51 11 11
INSR 0.012 0.009 -9999 0 -0.29 1 1
Insulin Receptor/Insulin -0.003 0.026 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
GRB10 0 0 -9999 0 -10000 0 0
SORBS1 -0.2 0.35 -9999 0 -0.79 285 285
CRK 0 0 -9999 0 -10000 0 0
PTPN1 0.033 0.03 -9999 0 -10000 0 0
CAV1 -0.099 0.24 -9999 0 -0.5 259 259
CBL/APS/CAP/Crk-II/C3G -0.12 0.2 -9999 0 -0.45 285 285
Insulin Receptor/Insulin/IRS1/NCK2 -0.02 0.097 -9999 0 -0.49 45 45
mol:GDP 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.023 0.096 -9999 0 -0.42 59 59
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B -0.012 0.055 -9999 0 -10000 0 0
RPS6KB1 -0.009 0.13 -9999 0 -0.46 11 11
PARD6A -0.002 0.023 -9999 0 -0.29 7 7
CBL 0 0 -9999 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -9999 0 -10000 0 0
DOK1 0 0.002 -9999 0 -10000 0 0
PIK3R1 -0.01 0.089 -9999 0 -0.79 14 14
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.05 0.11 -9999 0 -0.48 11 11
HRAS/GTP -0.016 0.073 -9999 0 -0.47 2 2
Insulin Receptor 0.012 0.009 -9999 0 -0.29 1 1
Insulin Receptor/Insuli/IRS1/GRB2/SHC -0.019 0.09 -9999 0 -0.45 45 45
PRKCI -0.013 0.032 -9999 0 -10000 0 0
Insulin Receptor/Insulin/GRB14/PDK1 -0.063 0.14 -9999 0 -0.4 143 143
SHC1 0 0 -9999 0 -10000 0 0
negative regulation of MAPKKK cascade 0 0.002 -9999 0 -10000 0 0
PI3K -0.023 0.097 -9999 0 -0.43 59 59
NCK2 0 0 -9999 0 -10000 0 0
RHOQ 0 0 -9999 0 -10000 0 0
mol:H2O2 0 0.003 -9999 0 -10000 0 0
HRAS/GDP -0.002 0.019 -9999 0 -10000 0 0
AKT2 -0.058 0.12 -9999 0 -0.51 11 11
PRKCZ -0.014 0.036 -9999 0 -0.6 1 1
SH2B2 -0.013 0.061 -9999 0 -0.29 49 49
SHC/SHIP -0.017 0.085 -9999 0 -0.42 45 45
F2RL2 -0.06 0.15 -9999 0 -0.36 185 185
TRIP10 0 0 -9999 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0 0.004 -9999 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0 0 -9999 0 -10000 0 0
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0 0.004 -9999 0 -10000 0 0
RAPGEF1 0 0 -9999 0 -10000 0 0
RASA1 0 0 -9999 0 -10000 0 0
NCK1 0 0 -9999 0 -10000 0 0
CBL/APS/CAP/Crk-II -0.13 0.21 -9999 0 -0.48 285 285
TC10/GDP 0 0 -9999 0 -10000 0 0
Insulin Receptor/Insulin/SHC/GRB10 0 0.003 -9999 0 -10000 0 0
INPP5D 0.007 0.096 -9999 0 -0.46 45 45
SOS1 0 0 -9999 0 -10000 0 0
SGK1 -0.01 0.08 -9999 0 -1 7 7
mol:cAMP 0 0 -9999 0 -10000 0 0
PTPN11 0 0 -9999 0 -10000 0 0
IRS1 -0.032 0.16 -9999 0 -0.79 45 45
p62DOK/RasGAP 0 0.003 -9999 0 -10000 0 0
INS 0.003 0.004 -9999 0 -10000 0 0
mol:PI-3-4-P2 0.007 0.095 -9999 0 -0.45 45 45
GRB2 0 0.009 -9999 0 -0.29 1 1
EIF4EBP1 -0.014 0.14 -9999 0 -0.46 26 26
PTPRA 0.012 0.002 -9999 0 -10000 0 0
PIK3CA 0 0.009 -9999 0 -0.29 1 1
TC10/GTP/CIP4 0 0 -9999 0 -10000 0 0
PDPK1 0 0 -9999 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos -0.013 0.064 -9999 0 -0.32 45 45
Insulin Receptor/Insulin/IRS1 -0.021 0.098 -9999 0 -0.5 45 45
Insulin Receptor/Insulin/IRS3 -0.001 0.007 -9999 0 -10000 0 0
Par3/Par6 -0.027 0.075 -9999 0 -0.45 24 24
Regulation of Androgen receptor activity

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.021 0.003 -9999 0 -10000 0 0
SMARCC1 0.005 0.019 -9999 0 -0.55 1 1
REL -0.006 0.09 -9999 0 -0.79 14 14
HDAC7 0.008 0.13 -9999 0 -0.58 18 18
JUN 0 0.063 -9999 0 -0.79 7 7
EP300 0 0 -9999 0 -10000 0 0
KAT2B -0.001 0.024 -9999 0 -0.79 1 1
KAT5 0.002 0.005 -9999 0 -10000 0 0
MAPK14 0.006 0.095 -9999 0 -0.61 25 25
FOXO1 -0.009 0.082 -9999 0 -0.79 12 12
T-DHT/AR -0.004 0.14 -9999 0 -0.61 20 20
MAP2K6 -0.01 0.12 -9999 0 -0.78 26 26
BRM/BAF57 -0.001 0.01 -9999 0 -10000 0 0
MAP2K4 0.008 0.025 -9999 0 -0.79 1 1
SMARCA2 0.004 0.006 -9999 0 -10000 0 0
PDE9A -0.088 0.29 -9999 0 -1.2 63 63
NCOA2 -0.032 0.17 -9999 0 -0.79 54 54
CEBPA -0.005 0.075 -9999 0 -0.79 10 10
EHMT2 0.005 0.006 -9999 0 -10000 0 0
cell proliferation 0.014 0.15 -9999 0 -0.5 24 24
NR0B1 -0.01 0.053 -9999 0 -10000 0 0
EGR1 -0.25 0.37 -9999 0 -0.79 347 347
RXRs/9cRA -0.12 0.21 -9999 0 -0.48 268 268
AR/RACK1/Src -0.005 0.11 -9999 0 -0.53 22 22
AR/GR -0.054 0.13 -9999 0 -0.43 64 64
GNB2L1 0.002 0.004 -9999 0 -10000 0 0
PKN1 0 0.009 -9999 0 -0.29 1 1
RCHY1 0 0 -9999 0 -10000 0 0
epidermal growth factor receptor activity -0.001 0.003 -9999 0 -10000 0 0
MAPK8 0.015 0.061 -9999 0 -0.61 10 10
T-DHT/AR/TIF2/CARM1 -0.018 0.16 -9999 0 -0.62 41 41
SRC 0.021 0.094 -9999 0 -0.46 34 34
NR3C1 -0.012 0.095 -9999 0 -0.79 16 16
KLK3 -0.2 0.41 -9999 0 -1.2 150 150
APPBP2 0.008 0.017 -9999 0 -0.29 3 3
TRIM24 0.005 0.006 -9999 0 -10000 0 0
T-DHT/AR/TIP60 -0.028 0.099 -9999 0 -0.51 34 34
TMPRSS2 -0.16 0.41 -9999 0 -1.2 139 139
RXRG -0.19 0.34 -9999 0 -0.78 271 271
mol:9cRA -0.001 0.002 -9999 0 -10000 0 0
RXRA 0 0 -9999 0 -10000 0 0
RXRB 0 0 -9999 0 -10000 0 0
CARM1 0.008 0.006 -9999 0 -10000 0 0
NR2C2 -0.008 0.079 -9999 0 -0.79 11 11
KLK2 -0.043 0.24 -9999 0 -0.77 92 92
AR -0.028 0.14 -9999 0 -0.34 157 157
SENP1 0 0 -9999 0 -10000 0 0
HSP90AA1 0 0.009 -9999 0 -0.29 1 1
MDM2 0.004 0.024 -9999 0 -0.29 5 5
SRY 0.003 0.01 -9999 0 -10000 0 0
GATA2 -0.024 0.13 -9999 0 -0.63 41 41
MYST2 0.002 0.01 -9999 0 -0.29 1 1
HOXB13 -0.14 0.15 -9999 0 -0.3 501 501
T-DHT/AR/RACK1/Src -0.013 0.1 -9999 0 -0.54 22 22
positive regulation of transcription -0.024 0.13 -9999 0 -0.63 41 41
DNAJA1 0.009 0.006 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.006 0.013 -9999 0 -10000 0 0
NCOA1 0.012 0.026 -9999 0 -0.82 1 1
SPDEF -0.057 0.2 -9999 0 -0.61 110 110
T-DHT/AR/TIF2 0.011 0.1 -9999 0 -0.45 27 27
T-DHT/AR/Hsp90 -0.035 0.095 -9999 0 -0.51 34 34
GSK3B 0.008 0.006 -9999 0 -10000 0 0
NR2C1 0.003 0.006 -9999 0 -10000 0 0
mol:T-DHT 0.014 0.099 -9999 0 -0.5 34 34
SIRT1 0 0 -9999 0 -10000 0 0
ZMIZ2 0.005 0.013 -9999 0 -10000 0 0
POU2F1 0.021 0.026 -9999 0 -0.42 1 1
T-DHT/AR/DAX-1 -0.036 0.099 -9999 0 -0.52 34 34
CREBBP 0 0 -9999 0 -10000 0 0
SMARCE1 0.004 0.017 -9999 0 -0.3 3 3
Regulation of nuclear SMAD2/3 signaling

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.002 0.01 -10000 0 -10000 0 0
HSPA8 0.001 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha -0.099 0.2 -10000 0 -0.56 165 165
AKT1 0.014 0.006 -10000 0 -10000 0 0
GSC -0.036 0.3 -10000 0 -1.5 42 42
NKX2-5 -0.045 0.1 -10000 0 -0.29 171 171
muscle cell differentiation 0.007 0.051 0.76 1 -10000 0 1
SMAD2-3/SMAD4/SP1 0.006 0.04 -10000 0 -0.45 2 2
SMAD4 0.014 0.041 -10000 0 -0.82 1 1
CBFB 0 0 -10000 0 -10000 0 0
SAP18 0.001 0.002 -10000 0 -10000 0 0
Cbp/p300/MSG1 -0.19 0.25 -10000 0 -0.51 406 406
SMAD3/SMAD4/VDR 0.005 0.03 -10000 0 -0.43 2 2
MYC -0.017 0.12 -10000 0 -0.79 24 24
CDKN2B 0.029 0.13 -10000 0 -1.5 7 7
AP1 -0.12 0.2 -10000 0 -0.41 330 330
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.002 0.02 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.001 0.041 -10000 0 -0.35 1 1
SP3 0 0 -10000 0 -10000 0 0
CREB1 0 0 -10000 0 -10000 0 0
FOXH1 -0.044 0.12 -10000 0 -0.29 204 204
SMAD3/SMAD4/GR -0.01 0.073 -10000 0 -0.56 17 17
GATA3 -0.037 0.15 -10000 0 -0.58 66 66
SKI/SIN3/HDAC complex/NCoR1 0.002 0.014 -10000 0 -10000 0 0
MEF2C/TIF2 -0.055 0.13 -10000 0 -0.59 42 42
endothelial cell migration -0.008 0.06 1.5 1 -10000 0 1
MAX 0.001 0.005 -10000 0 -10000 0 0
RBBP7 -0.002 0.025 -10000 0 -0.29 8 8
RBBP4 0 0.024 -10000 0 -0.79 1 1
RUNX2 -0.005 0.036 -10000 0 -0.29 17 17
RUNX3 -0.006 0.066 -10000 0 -0.58 12 12
RUNX1 -0.001 0.024 -10000 0 -0.79 1 1
CTBP1 0 0 -10000 0 -10000 0 0
NR3C1 -0.011 0.095 -10000 0 -0.79 16 16
VDR 0 0 -10000 0 -10000 0 0
CDKN1A 0.05 0.078 -10000 0 -1.5 2 2
KAT2B 0 0.024 -10000 0 -0.79 1 1
SMAD2/SMAD2/SMAD4/FOXH1 -0.03 0.072 -10000 0 -0.46 6 6
DCP1A 0 0 -10000 0 -10000 0 0
SKI 0.001 0.002 -10000 0 -10000 0 0
SERPINE1 0.007 0.061 -10000 0 -1.5 1 1
SMAD3/SMAD4/ATF2 -0.003 0.04 -10000 0 -0.56 4 4
SMAD3/SMAD4/ATF3 -0.078 0.19 -10000 0 -0.55 154 154
SAP30 -0.001 0.018 -10000 0 -0.29 4 4
Cbp/p300/PIAS3 0.005 0.023 -10000 0 -10000 0 0
JUN -0.074 0.22 -10000 0 -0.4 330 330
SMAD3/SMAD4/IRF7 -0.02 0.068 -10000 0 -0.45 2 2
TFE3 0.017 0.006 -10000 0 -10000 0 0
COL1A2 0.027 0.1 -10000 0 -1.2 3 3
mesenchymal cell differentiation 0.004 0.034 0.54 1 -10000 0 1
DLX1 -0.053 0.13 -10000 0 -0.32 184 184
TCF3 0 0.009 -10000 0 -0.29 1 1
FOS -0.22 0.37 -10000 0 -0.78 329 329
SMAD3/SMAD4/Max -0.002 0.029 -10000 0 -0.54 1 1
Cbp/p300/SNIP1 0 0.002 -10000 0 -10000 0 0
ZBTB17 0 0.006 -10000 0 -10000 0 0
LAMC1 0.042 0.047 -10000 0 -0.62 2 2
TGIF2/HDAC complex/SMAD3/SMAD4 -0.001 0.028 -10000 0 -0.54 1 1
IRF7 -0.031 0.092 -10000 0 -0.31 104 104
ESR1 -0.15 0.28 -10000 0 -0.58 287 287
HNF4A -0.006 0.041 -10000 0 -0.29 22 22
MEF2C 0 0.097 -10000 0 -0.68 4 4
SMAD2-3/SMAD4 -0.003 0.033 -10000 0 -0.53 1 1
Cbp/p300/Src-1 0.003 0.022 -10000 0 -0.52 1 1
IGHV3OR16-13 -0.001 0.01 -10000 0 -10000 0 0
TGIF2/HDAC complex 0 0 -10000 0 -10000 0 0
CREBBP 0.002 0.007 -10000 0 -10000 0 0
SKIL -0.003 0.029 -10000 0 -0.29 11 11
HDAC1 0.001 0.002 -10000 0 -10000 0 0
HDAC2 0.001 0.002 -10000 0 -10000 0 0
SNIP1 0.001 0.003 -10000 0 -10000 0 0
GCN5L2 0.001 0.006 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.001 0.029 -10000 0 -0.53 1 1
MSG1/HSC70 -0.22 0.29 -10000 0 -0.6 406 406
SMAD2 0.015 0.02 -10000 0 -10000 0 0
SMAD3 0.015 0.029 -10000 0 -10000 0 0
SMAD3/E2F4-5/DP1/p107/SMAD4 0.034 0.038 -10000 0 -0.35 2 2
SMAD2/SMAD2/SMAD4 0.026 0.039 -10000 0 -1.1 1 1
NCOR1 0 0.024 -10000 0 -0.79 1 1
NCOA2 -0.039 0.17 -10000 0 -0.79 54 54
NCOA1 -0.001 0.024 -10000 0 -0.79 1 1
MYOD/E2A -0.003 0.022 -10000 0 -10000 0 0
SMAD2-3/SMAD4/SP1/MIZ-1 0.028 0.051 -10000 0 -0.41 2 2
IFNB1 0.011 0.093 -10000 0 -0.43 7 7
SMAD3/SMAD4/MEF2C -0.027 0.078 -10000 0 -0.76 3 3
CITED1 -0.3 0.38 -10000 0 -0.79 406 406
SMAD2-3/SMAD4/ARC105 -0.001 0.028 -10000 0 -0.47 1 1
RBL1 -0.003 0.043 -10000 0 -0.59 5 5
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB 0.047 0.062 -10000 0 -0.49 7 7
RUNX1-3/PEBPB2 -0.004 0.049 -10000 0 -0.58 7 7
SMAD7 -0.067 0.14 -10000 0 -0.58 8 8
MYC/MIZ-1 -0.012 0.09 -10000 0 -0.61 24 24
SMAD3/SMAD4 0.017 0.06 0.27 40 -0.43 2 42
IL10 0.018 0.12 -10000 0 -0.5 42 42
PIASy/HDAC complex 0.011 0.004 -10000 0 -10000 0 0
PIAS3 0.001 0.005 -10000 0 -10000 0 0
CDK2 0.002 0.008 -10000 0 -10000 0 0
IL5 0.014 0.11 -10000 0 -0.5 40 40
CDK4 0.001 0.02 -10000 0 -0.29 4 4
PIAS4 0.011 0.004 -10000 0 -10000 0 0
ATF3 -0.11 0.27 -10000 0 -0.78 154 154
SMAD3/SMAD4/SP1 0 0.032 -10000 0 -0.52 2 2
FOXG1 -0.023 0.077 -10000 0 -0.29 80 80
FOXO3 0.025 0.034 -10000 0 -0.6 3 3
FOXO1 0.02 0.066 -10000 0 -0.6 12 12
FOXO4 0.026 0.008 -10000 0 -10000 0 0
heart looping 0 0.096 -10000 0 -0.68 4 4
CEBPB 0.012 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/DLX1 -0.029 0.078 -10000 0 -0.55 10 10
MYOD1 -0.004 0.033 -10000 0 -10000 0 0
SMAD3/SMAD4/HNF4 -0.006 0.037 -10000 0 -0.68 1 1
SMAD3/SMAD4/GATA3 -0.024 0.11 -10000 0 -0.56 40 40
SnoN/SIN3/HDAC complex/NCoR1 -0.003 0.029 -10000 0 -0.29 11 11
SMAD3/SMAD4/RUNX1-3/PEBPB2 0 0.051 -10000 0 -0.52 8 8
SMAD3/SMAD4/SP1-3 0.003 0.029 -10000 0 -0.45 2 2
MED15 0 0 -10000 0 -10000 0 0
SP1 0.019 0.015 -10000 0 -10000 0 0
SIN3B 0.001 0.002 -10000 0 -10000 0 0
SIN3A 0.001 0.002 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 -0.014 0.091 -10000 0 -0.46 7 7
ITGB5 0.052 0.046 -10000 0 -10000 0 0
TGIF/SIN3/HDAC complex/CtBP 0.002 0.012 -10000 0 -10000 0 0
SMAD3/SMAD4/AR -0.074 0.19 -10000 0 -0.55 147 147
AR -0.1 0.27 -10000 0 -0.78 147 147
negative regulation of cell growth -0.025 0.072 -10000 0 -0.48 2 2
SMAD3/SMAD4/MYOD -0.006 0.034 -10000 0 -0.54 1 1
E2F5 -0.005 0.039 -10000 0 -0.29 20 20
E2F4 0 0 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.002 0.057 -10000 0 -0.54 1 1
SMAD2-3/SMAD4/FOXO1-3a-4 0.002 0.046 -10000 0 -0.34 4 4
TFDP1 -0.001 0.018 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 -0.12 0.2 -10000 0 -0.41 329 329
SMAD3/SMAD4/RUNX2 -0.004 0.034 -10000 0 -0.54 1 1
TGIF2 0 0 -10000 0 -10000 0 0
TGIF1 0 0 -10000 0 -10000 0 0
ATF2 -0.002 0.041 -10000 0 -0.79 3 3
Regulation of Telomerase

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.055 0.12 -9999 0 -0.62 4 4
RAD9A 0 0.009 -9999 0 -0.29 1 1
AP1 -0.18 0.28 -9999 0 -0.61 330 330
IFNAR2 0.01 0.025 -9999 0 -0.79 1 1
AKT1 -0.036 0.11 -9999 0 -0.29 62 62
ER alpha/Oestrogen -0.11 0.22 -9999 0 -0.61 165 165
NFX1/SIN3/HDAC complex 0.026 0.025 -9999 0 -10000 0 0
EGF -0.15 0.31 -9999 0 -0.78 214 214
SMG5 0 0 -9999 0 -10000 0 0
SMG6 0 0 -9999 0 -10000 0 0
SP3/HDAC2 0 0 -9999 0 -10000 0 0
TERT/c-Abl -0.067 0.089 -9999 0 -0.58 4 4
SAP18 0.006 0.006 -9999 0 -10000 0 0
MRN complex 0 0 -9999 0 -10000 0 0
WT1 -0.14 0.15 -9999 0 -0.29 561 561
WRN 0 0 -9999 0 -10000 0 0
SP1 0.011 0.006 -9999 0 -10000 0 0
SP3 0.009 0.005 -9999 0 -10000 0 0
TERF2IP 0 0 -9999 0 -10000 0 0
Telomerase/Nucleolin -0.052 0.078 -9999 0 -0.59 2 2
Mad/Max 0 0.006 -9999 0 -10000 0 0
TERT -0.056 0.12 -9999 0 -0.64 4 4
CCND1 -0.048 0.13 -9999 0 -1.3 4 4
MAX 0.009 0.005 -9999 0 -10000 0 0
RBBP7 0.004 0.026 -9999 0 -0.29 8 8
RBBP4 0.005 0.025 -9999 0 -0.79 1 1
TERF2 0 0 -9999 0 -10000 0 0
PTGES3 0 0 -9999 0 -10000 0 0
SIN3A 0.006 0.006 -9999 0 -10000 0 0
Telomerase/911 0.012 0.024 -9999 0 -10000 0 0
CDKN1B 0.009 0.074 -9999 0 -0.86 3 3
RAD1 0 0 -9999 0 -10000 0 0
XRCC5 0 0 -9999 0 -10000 0 0
XRCC6 0 0 -9999 0 -10000 0 0
SAP30 0.005 0.019 -9999 0 -0.29 4 4
TRF2/PARP2 0 0 -9999 0 -10000 0 0
UBE3A 0.009 0.005 -9999 0 -10000 0 0
JUN 0.002 0.064 -9999 0 -0.79 7 7
E6 0 0.001 -9999 0 -10000 0 0
HPV-16 E6/E6AP 0 0 -9999 0 -10000 0 0
FOS -0.23 0.37 -9999 0 -0.79 329 329
IFN-gamma/IRF1 -0.025 0.063 -9999 0 -0.36 5 5
PARP2 0 0 -9999 0 -10000 0 0
BLM -0.03 0.089 -9999 0 -0.29 113 113
Telomerase -0.006 0.028 -9999 0 -10000 0 0
IRF1 0.011 0.02 -9999 0 -0.28 3 3
ESR1 -0.15 0.29 -9999 0 -0.58 288 288
KU/TER 0 0 -9999 0 -10000 0 0
ATM/TRF2 0 0 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0 0.007 -9999 0 -10000 0 0
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0 0.007 -9999 0 -10000 0 0
HDAC1 0.006 0.006 -9999 0 -10000 0 0
HDAC2 0.011 0.005 -9999 0 -10000 0 0
ATM 0 0 -9999 0 -10000 0 0
SMAD3 0.021 0.011 -9999 0 -10000 0 0
ABL1 0 0 -9999 0 -10000 0 0
MXD1 0.009 0.01 -9999 0 -0.29 1 1
MRE11A 0 0 -9999 0 -10000 0 0
HUS1 0 0 -9999 0 -10000 0 0
RPS6KB1 -0.001 0.015 -9999 0 -0.29 3 3
TERT/NF kappa B1/14-3-3 -0.065 0.1 -9999 0 -0.67 3 3
NR2F2 0.001 0.042 -9999 0 -0.79 3 3
MAPK3 0.014 0.019 -9999 0 -10000 0 0
MAPK1 0.014 0.019 -9999 0 -10000 0 0
TGFB1/TGF beta receptor Type II 0.001 0.016 -9999 0 -0.29 3 3
NFKB1 0 0 -9999 0 -10000 0 0
HNRNPC 0 0 -9999 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0 0 -9999 0 -10000 0 0
NBN 0 0 -9999 0 -10000 0 0
EGFR -0.29 0.38 -9999 0 -0.78 410 410
mol:Oestrogen 0 0.001 -9999 0 -10000 0 0
EGF/EGFR -0.33 0.35 -9999 0 -0.66 552 552
MYC -0.008 0.12 -9999 0 -0.79 24 24
IL2 0.004 0.026 -9999 0 -0.29 8 8
KU 0 0 -9999 0 -10000 0 0
RAD50 0 0 -9999 0 -10000 0 0
HSP90AA1 0 0.009 -9999 0 -0.29 1 1
TGFB1 0.001 0.016 -9999 0 -0.29 3 3
TRF2/BLM -0.017 0.051 -9999 0 -10000 0 0
FRAP1 0 0 -9999 0 -10000 0 0
KU/TERT -0.063 0.087 -9999 0 -0.58 4 4
SP1/HDAC2 0 0 -9999 0 -10000 0 0
PINX1 0 0 -9999 0 -10000 0 0
Telomerase/EST1A -0.052 0.078 -9999 0 -0.59 2 2
Smad3/Myc -0.012 0.076 -9999 0 -0.52 24 24
911 complex 0 0.004 -9999 0 -10000 0 0
IFNG -0.03 0.1 -9999 0 -0.28 150 150
Telomerase/PinX1 -0.052 0.078 -9999 0 -0.59 2 2
Telomerase/AKT1/mTOR/p70S6K 0.003 0.055 -9999 0 -10000 0 0
SIN3B 0.006 0.006 -9999 0 -10000 0 0
YWHAE 0 0 -9999 0 -10000 0 0
Telomerase/EST1B -0.052 0.078 -9999 0 -0.59 2 2
response to DNA damage stimulus 0.003 0 -9999 0 -10000 0 0
MRN complex/TRF2/Rap1 0 0 -9999 0 -10000 0 0
TRF2/WRN 0 0 -9999 0 -10000 0 0
Telomerase/hnRNP C1/C2 -0.052 0.078 -9999 0 -0.59 2 2
E2F1 -0.085 0.14 -9999 0 -0.29 345 345
ZNFX1 0.006 0.006 -9999 0 -10000 0 0
PIF1 -0.061 0.12 -9999 0 -10000 0 0
NCL 0 0 -9999 0 -10000 0 0
DKC1 -0.001 0.013 -9999 0 -0.29 2 2
telomeric DNA binding 0 0 -9999 0 -10000 0 0
Syndecan-2-mediated signaling events

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.06 0.077 -9999 0 -0.42 7 7
EPHB2 -0.005 0.038 -9999 0 -10000 0 0
Syndecan-2/TACI -0.018 0.075 -9999 0 -0.52 19 19
LAMA1 -0.088 0.25 -9999 0 -0.77 124 124
Syndecan-2/alpha2 ITGB1 -0.12 0.21 -9999 0 -0.46 293 293
HRAS -0.003 0.028 -9999 0 -10000 0 0
Syndecan-2/CASK -0.003 0.033 -9999 0 -0.52 4 4
ITGA5 0 0.009 -9999 0 -0.29 1 1
BAX 0.033 0.061 -9999 0 -0.72 3 3
EPB41 0 0 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion -0.002 0.03 -9999 0 -0.47 4 4
LAMA3 -0.2 0.34 -9999 0 -0.79 276 276
EZR -0.001 0.015 -9999 0 -0.29 3 3
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
CAV2 -0.1 0.27 -9999 0 -0.79 146 146
Syndecan-2/MMP2 -0.008 0.07 -9999 0 -0.63 12 12
RP11-540L11.1 0 0 -9999 0 -10000 0 0
alpha2 ITGB1 -0.016 0.096 -9999 0 -0.6 29 29
dendrite morphogenesis -0.005 0.037 -9999 0 -0.51 4 4
Syndecan-2/GM-CSF -0.006 0.039 -9999 0 -0.52 4 4
determination of left/right symmetry 0.017 0.039 -9999 0 -0.6 4 4
Syndecan-2/PKC delta -0.003 0.033 -9999 0 -0.52 4 4
GNB2L1 0 0 -9999 0 -10000 0 0
MAPK3 0.022 0.039 -9999 0 -0.47 4 4
MAPK1 0.022 0.039 -9999 0 -0.47 4 4
Syndecan-2/RACK1 -0.003 0.032 -9999 0 -0.48 4 4
NF1 -0.001 0.024 -9999 0 -0.79 1 1
FGFR/FGF/Syndecan-2 0.017 0.039 -9999 0 -0.6 4 4
ITGA2 -0.021 0.13 -9999 0 -0.79 29 29
MAPK8 0.027 0.065 -9999 0 -0.57 12 12
Syndecan-2/alpha2/beta1 Integrin -0.062 0.18 -9999 0 -0.5 133 133
Syndecan-2/Kininogen -0.005 0.039 -9999 0 -0.52 4 4
ITGB1 0 0 -9999 0 -10000 0 0
SRC -0.003 0.029 -9999 0 -0.45 4 4
Syndecan-2/CASK/Protein 4.1 -0.002 0.03 -9999 0 -0.48 4 4
extracellular matrix organization -0.003 0.033 -9999 0 -0.51 4 4
actin cytoskeleton reorganization -0.06 0.077 -9999 0 -0.42 7 7
Syndecan-2/Caveolin-2/Ras -0.066 0.17 -9999 0 -0.48 146 146
Syndecan-2/Laminin alpha3 -0.13 0.23 -9999 0 -0.52 280 280
Syndecan-2/RasGAP -0.003 0.03 -9999 0 -0.45 4 4
alpha5/beta1 Integrin 0 0.006 -9999 0 -10000 0 0
PRKCD 0 0.009 -9999 0 -0.29 1 1
Syndecan-2 dimer -0.005 0.037 -9999 0 -0.52 4 4
GO:0007205 0 0.002 -9999 0 -10000 0 0
DNA mediated transformation 0 0 -9999 0 -10000 0 0
Syndecan-2/RasGAP/Src -0.003 0.028 -9999 0 -0.43 4 4
RHOA 0 0 -9999 0 -10000 0 0
SDCBP 0 0 -9999 0 -10000 0 0
TNFRSF13B -0.028 0.11 -9999 0 -0.39 78 78
RASA1 0 0 -9999 0 -10000 0 0
alpha2/beta1 Integrin -0.016 0.096 -9999 0 -0.6 29 29
Syndecan-2/Synbindin -0.002 0.032 -9999 0 -0.52 4 4
TGFB1 -0.001 0.015 -9999 0 -0.29 3 3
CASP3 0.03 0.032 -9999 0 -0.46 4 4
FN1 -0.12 0.14 -9999 0 -0.29 431 431
Syndecan-2/IL8 -0.022 0.085 -9999 0 -0.52 26 26
SDC2 0.017 0.04 -9999 0 -0.6 4 4
KNG1 -0.006 0.041 -9999 0 -0.29 22 22
Syndecan-2/Neurofibromin -0.003 0.036 -9999 0 -0.52 5 5
TRAPPC4 0 0 -9999 0 -10000 0 0
CSF2 -0.007 0.045 -9999 0 -0.29 26 26
Syndecan-2/TGFB1 -0.003 0.033 -9999 0 -0.52 4 4
Syndecan-2/Syntenin/PI-4-5-P2 -0.002 0.03 -9999 0 -0.48 4 4
Syndecan-2/Ezrin -0.002 0.03 -9999 0 -0.47 4 4
PRKACA 0.029 0.035 -9999 0 -0.47 5 5
angiogenesis -0.021 0.085 -9999 0 -0.52 26 26
MMP2 -0.008 0.079 -9999 0 -0.75 12 12
IL8 -0.033 0.13 -9999 0 -0.42 87 87
calcineurin-NFAT signaling pathway -0.018 0.075 -9999 0 -0.52 19 19
TCGA08_retinoblastoma

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B -0.003 0.063 -10000 0 -0.66 9 9
CDKN2C 0.006 0.037 -10000 0 -0.78 2 2
CDKN2A -0.052 0.12 -10000 0 -0.31 188 188
CCND2 0.006 0.033 0.24 8 -0.16 12 20
RB1 -0.007 0.032 0.16 7 -0.25 8 15
CDK4 0.01 0.03 0.25 9 -10000 0 9
CDK6 0.006 0.039 0.27 8 -0.21 14 22
G1/S progression -0.006 0.036 0.25 8 -0.18 4 12
IL2 signaling events mediated by STAT5

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.008 0.043 -9999 0 -0.39 10 10
ELF1 -0.012 0.051 -9999 0 -0.38 16 16
CCNA2 -0.11 0.14 -9999 0 -0.29 427 427
PIK3CA 0.012 0.009 -9999 0 -0.29 1 1
JAK3 0.008 0.034 -9999 0 -0.29 14 14
PIK3R1 0.001 0.09 -9999 0 -0.79 14 14
JAK1 0.011 0.024 -9999 0 -0.79 1 1
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.057 0.08 -9999 0 -0.58 9 9
SHC1 0.012 0.001 -9999 0 -10000 0 0
SP1 -0.005 0.041 -9999 0 -0.38 13 13
IL2RA 0.001 0.13 -9999 0 -1 16 16
IL2RB -0.001 0.066 -9999 0 -0.32 42 42
SOS1 0.012 0.001 -9999 0 -10000 0 0
IL2RG -0.006 0.087 -9999 0 -0.36 53 53
G1/S transition of mitotic cell cycle 0.004 0.13 -9999 0 -0.8 24 24
PTPN11 0.012 0.001 -9999 0 -10000 0 0
CCND2 0.017 0.11 -9999 0 -1 13 13
LCK -0.009 0.1 -9999 0 -0.41 53 53
GRB2 0.011 0.009 -9999 0 -0.29 1 1
IL2 0.004 0.026 -9999 0 -0.29 8 8
CDK6 -0.011 0.092 -9999 0 -0.73 17 17
CCND3 0.063 0.071 -9999 0 -0.57 5 5
BCR signaling pathway

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN 0.004 0.11 -10000 0 -0.44 36 36
IKBKB 0.015 0.053 -10000 0 -0.26 3 3
AKT1 0.002 0.082 0.24 2 -0.27 25 27
IKBKG 0.018 0.055 -10000 0 -0.28 3 3
CALM1 -0.011 0.092 -10000 0 -0.45 30 30
PIK3CA 0 0.009 -10000 0 -0.29 1 1
MAP3K1 -0.01 0.15 -10000 0 -0.63 35 35
MAP3K7 0 0.009 -10000 0 -0.29 1 1
mol:Ca2+ -0.019 0.097 0.24 1 -0.48 30 31
DOK1 -0.001 0.018 -10000 0 -0.29 4 4
AP-1 -0.041 0.11 -10000 0 -0.26 78 78
LYN 0 0.001 -10000 0 -10000 0 0
BLNK 0 0 -10000 0 -10000 0 0
SHC1 0 0 -10000 0 -10000 0 0
BCR complex -0.079 0.21 -10000 0 -0.62 119 119
CD22 -0.061 0.18 -10000 0 -0.54 100 100
CAMK2G -0.002 0.086 -10000 0 -0.41 30 30
CSNK2A1 0 0 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 -0.047 0.13 -10000 0 -0.76 16 16
GO:0007205 -0.02 0.098 0.24 1 -0.49 30 31
SYK 0 0.009 -10000 0 -0.29 1 1
ELK1 -0.011 0.093 -10000 0 -0.46 30 30
NFATC1 -0.018 0.13 -10000 0 -0.56 34 34
B-cell antigen/BCR complex -0.079 0.21 -10000 0 -0.62 119 119
PAG1/CSK -0.001 0.013 -10000 0 -10000 0 0
NFKBIB 0.015 0.02 0.085 1 -10000 0 1
HRAS -0.009 0.1 -10000 0 -0.47 31 31
NFKBIA 0.015 0.02 0.085 1 -10000 0 1
NF-kappa-B/RelA/I kappa B beta 0.019 0.016 -10000 0 -10000 0 0
RasGAP/Csk -0.058 0.16 -10000 0 -0.51 100 100
mol:GDP -0.02 0.09 -10000 0 -0.46 30 30
PTEN -0.001 0.034 -10000 0 -0.79 2 2
CD79B -0.027 0.13 -10000 0 -0.58 52 52
NF-kappa-B/RelA/I kappa B alpha 0.019 0.016 -10000 0 -10000 0 0
GRB2 0 0.009 -10000 0 -0.29 1 1
PI3K/BCAP/CD19 -0.029 0.16 -10000 0 -0.47 101 101
PIK3R1 -0.01 0.089 -10000 0 -0.79 14 14
mol:IP3 -0.029 0.096 0.24 1 -0.5 30 31
CSK 0 0 -10000 0 -10000 0 0
FOS -0.13 0.22 -10000 0 -0.44 349 349
CHUK 0.018 0.055 -10000 0 -0.28 3 3
IBTK 0 0 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 -0.023 0.077 -10000 0 -0.48 18 18
PTPN6 -0.057 0.16 -10000 0 -0.72 41 41
RELA 0 0 -10000 0 -10000 0 0
BCL2A1 0.015 0.02 -10000 0 -0.12 1 1
VAV2 -0.071 0.16 -10000 0 -0.52 97 97
ubiquitin-dependent protein catabolic process 0.019 0.019 0.088 1 -10000 0 1
BTK -0.004 0.005 -10000 0 -10000 0 0
CD19 -0.081 0.17 -10000 0 -0.53 97 97
MAP4K1 -0.015 0.07 -10000 0 -0.31 53 53
CD72 -0.009 0.054 -10000 0 -0.31 32 32
PAG1 -0.001 0.02 -10000 0 -10000 0 0
MAPK14 0.002 0.13 -10000 0 -0.54 31 31
SH3BP5 -0.001 0.024 -10000 0 -0.79 1 1
PIK3AP1 -0.01 0.1 0.27 1 -0.53 30 31
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.041 0.13 -10000 0 -0.47 85 85
RAF1 0 0.096 -10000 0 -0.44 30 30
RasGAP/p62DOK/SHIP -0.055 0.15 -10000 0 -0.49 100 100
CD79A -0.083 0.22 -10000 0 -0.53 171 171
re-entry into mitotic cell cycle -0.04 0.11 -10000 0 -0.26 78 78
RASA1 0 0 -10000 0 -10000 0 0
MAPK3 0.016 0.082 -10000 0 -0.42 17 17
MAPK1 0.016 0.082 -10000 0 -0.42 17 17
CD72/SHP1 -0.055 0.15 -10000 0 -0.68 41 41
NFKB1 0 0 -10000 0 -10000 0 0
MAPK8 -0.001 0.13 -10000 0 -0.52 38 38
actin cytoskeleton organization -0.027 0.15 -10000 0 -0.64 33 33
NF-kappa-B/RelA 0.042 0.033 0.17 1 -10000 0 1
Calcineurin -0.02 0.07 -10000 0 -0.44 17 17
PI3K -0.06 0.13 -10000 0 -0.52 45 45
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.031 0.11 0.27 1 -0.57 30 31
SOS1 0 0 -10000 0 -10000 0 0
Bam32/HPK1 -0.048 0.17 -10000 0 -0.83 35 35
DAPP1 -0.05 0.19 -10000 0 -0.96 35 35
cytokine secretion -0.015 0.12 -10000 0 -0.52 34 34
mol:DAG -0.029 0.096 0.24 1 -0.5 30 31
PLCG2 -0.002 0.035 -10000 0 -0.62 3 3
MAP2K1 0.008 0.089 -10000 0 -0.48 17 17
B-cell antigen/BCR complex/FcgammaRIIB -0.07 0.19 -10000 0 -0.55 122 122
mol:PI-3-4-5-P3 -0.044 0.093 0.34 2 -0.36 44 46
ETS1 0.004 0.089 -10000 0 -0.48 21 21
B-cell antigen/BCR complex/LYN/SYK/BLNK -0.056 0.16 -10000 0 -0.51 97 97
B-cell antigen/BCR complex/LYN -0.057 0.18 -10000 0 -0.56 100 100
MALT1 0 0 -10000 0 -10000 0 0
TRAF6 0.001 0.003 -10000 0 -10000 0 0
RAC1 -0.03 0.16 -10000 0 -0.71 33 33
B-cell antigen/BCR complex/LYN/SYK -0.057 0.17 -10000 0 -0.55 98 98
CARD11 -0.014 0.1 -10000 0 -0.48 30 30
FCGR2B -0.004 0.054 -10000 0 -0.7 6 6
PPP3CA -0.001 0.013 -10000 0 -10000 0 0
BCL10 0 0 -10000 0 -10000 0 0
IKK complex 0.017 0.027 -10000 0 -10000 0 0
PTPRC -0.008 0.07 -10000 0 -0.48 19 19
PDPK1 -0.029 0.063 0.22 2 -0.26 25 27
PPP3CB 0 0 -10000 0 -10000 0 0
PPP3CC 0 0 -10000 0 -10000 0 0
POU2F2 0.019 0.014 -10000 0 -0.14 1 1
Thromboxane A2 receptor signaling

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.005 0.035 -10000 0 -0.29 15 15
GNB1/GNG2 -0.015 0.048 -10000 0 -0.19 69 69
AKT1 0.05 0.072 -10000 0 -0.21 32 32
EGF -0.15 0.31 -10000 0 -0.78 214 214
mol:TXA2 0 0 -10000 0 -10000 0 0
FGR -0.01 0.053 -10000 0 -0.45 5 5
mol:Ca2+ 0.047 0.1 -10000 0 -0.3 64 64
LYN -0.01 0.05 -10000 0 -0.45 3 3
RhoA/GTP -0.008 0.03 -10000 0 -0.14 11 11
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK 0.052 0.11 -10000 0 -0.35 64 64
GNG2 -0.011 0.092 -10000 0 -0.79 15 15
ARRB2 0 0 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 0.028 0.063 -10000 0 -0.55 9 9
G beta5/gamma2 -0.019 0.065 -10000 0 -0.25 70 70
PRKCH 0.048 0.11 -10000 0 -0.35 64 64
DNM1 -0.005 0.063 -10000 0 -0.73 8 8
TXA2/TP beta/beta Arrestin3 -0.004 0.026 -10000 0 -0.3 7 7
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
PTGDR -0.031 0.15 -10000 0 -0.71 47 47
G12 family/GTP -0.021 0.073 -10000 0 -0.31 64 64
ADRBK1 0 0 -10000 0 -10000 0 0
ADRBK2 -0.004 0.053 -10000 0 -0.79 5 5
RhoA/GTP/ROCK1 0 0.016 -10000 0 -0.52 1 1
mol:GDP -0.036 0.081 0.35 25 -10000 0 25
mol:NADP 0 0 -10000 0 -10000 0 0
RAB11A -0.001 0.013 -10000 0 -0.29 2 2
PRKG1 -0.053 0.2 -10000 0 -0.79 74 74
mol:IP3 0.047 0.12 -10000 0 -0.38 64 64
cell morphogenesis 0 0.016 -10000 0 -0.52 1 1
PLCB2 0.044 0.15 -10000 0 -0.52 64 64
mol:cGMP 0 0 -10000 0 -10000 0 0
BLK -0.008 0.062 -10000 0 -0.4 9 9
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.011 0.051 -10000 0 -0.41 4 4
RHOA 0 0 -10000 0 -10000 0 0
PTGIR -0.002 0.026 -10000 0 -0.29 9 9
PRKCB1 0.045 0.12 -10000 0 -0.38 64 64
GNAQ -0.002 0.041 -10000 0 -0.79 3 3
mol:L-citrulline 0 0 -10000 0 -10000 0 0
TXA2/TXA2-R family 0.047 0.16 -10000 0 -0.54 64 64
LCK -0.015 0.071 -10000 0 -0.45 17 17
TXA2/TP beta/beta Arrestin3/RAB11/GDP -0.012 0.056 -10000 0 -0.35 1 1
TXA2-R family/G12 family/GDP/G beta/gamma 0.024 0.037 -10000 0 -0.29 9 9
TXA2/TP beta/beta Arrestin2/RAB11/GDP -0.011 0.055 -10000 0 -0.34 1 1
MAPK14 0.051 0.079 -10000 0 -0.23 64 64
TGM2/GTP 0.047 0.13 -10000 0 -0.43 64 64
MAPK11 0.051 0.082 -10000 0 -0.24 64 64
ARHGEF1 0.039 0.061 -10000 0 -0.18 37 37
GNAI2 0 0 -10000 0 -10000 0 0
JNK cascade 0.049 0.12 -10000 0 -0.4 64 64
RAB11/GDP -0.001 0.012 -10000 0 -0.29 2 2
ICAM1 0.046 0.093 -10000 0 -0.28 64 64
cAMP biosynthetic process 0.043 0.12 -10000 0 -0.36 64 64
Gq family/GTP/EBP50 0.017 0.04 -10000 0 -0.25 18 18
actin cytoskeleton reorganization 0 0.016 -10000 0 -0.52 1 1
SRC -0.01 0.05 -10000 0 -0.41 4 4
GNB5 0 0 -10000 0 -10000 0 0
GNB1 0 0 -10000 0 -10000 0 0
EGF/EGFR -0.028 0.1 -10000 0 -0.3 49 49
VCAM1 0.044 0.1 -10000 0 -0.32 64 64
TP beta/Gq family/GDP/G beta5/gamma2 0.028 0.063 -10000 0 -0.55 9 9
platelet activation 0.066 0.1 -10000 0 -0.31 64 64
PGI2/IP -0.002 0.018 -10000 0 -10000 0 0
PRKACA -0.014 0.07 -10000 0 -0.37 40 40
Gq family/GDP/G beta5/gamma2 0.026 0.065 -10000 0 -0.55 9 9
TXA2/TP beta/beta Arrestin2 -0.005 0.052 -10000 0 -0.65 7 7
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.01 0.07 -10000 0 -0.34 40 40
mol:DAG 0.046 0.13 -10000 0 -0.42 64 64
EGFR -0.29 0.38 -10000 0 -0.78 410 410
TXA2/TP alpha 0.048 0.15 -10000 0 -0.5 64 64
Gq family/GTP -0.004 0.036 -10000 0 -0.27 18 18
YES1 -0.01 0.051 -10000 0 -0.4 5 5
GNAI2/GTP -0.012 0.058 -10000 0 -0.46 5 5
PGD2/DP -0.024 0.12 -10000 0 -0.61 40 40
SLC9A3R1 -0.026 0.083 -10000 0 -10000 0 0
FYN -0.011 0.054 -10000 0 -0.43 6 6
mol:NO 0 0 -10000 0 -10000 0 0
GNA15 -0.003 0.033 -10000 0 -0.36 8 8
PGK/cGMP -0.036 0.13 -10000 0 -0.52 74 74
RhoA/GDP 0 0 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma -0.017 0.082 -10000 0 -0.56 15 15
NOS3 0 0 -10000 0 -10000 0 0
RAC1 0 0 -10000 0 -10000 0 0
PRKCA 0.041 0.13 -10000 0 -0.38 72 72
PRKCB 0.043 0.12 -10000 0 -0.37 72 72
PRKCE 0.05 0.11 -10000 0 -0.35 64 64
PRKCD 0.048 0.12 -10000 0 -0.38 64 64
PRKCG 0.044 0.12 -10000 0 -0.39 64 64
muscle contraction 0.05 0.15 -10000 0 -0.5 64 64
PRKCZ 0.052 0.11 -10000 0 -0.35 64 64
ARR3 -0.002 0.025 -10000 0 -10000 0 0
TXA2/TP beta -0.013 0.065 -10000 0 -0.49 6 6
PRKCQ 0.037 0.14 -10000 0 -0.39 78 78
MAPKKK cascade 0.044 0.14 -10000 0 -0.48 64 64
SELE 0.038 0.12 -10000 0 -0.42 64 64
TP beta/GNAI2/GDP/G beta/gamma -0.016 0.082 -10000 0 -0.56 15 15
ROCK1 -0.001 0.024 -10000 0 -0.79 1 1
GNA14 -0.013 0.084 -10000 0 -0.46 30 30
chemotaxis 0.046 0.18 -10000 0 -0.62 64 64
GNA12 0 0 -10000 0 -10000 0 0
GNA13 0 0 -10000 0 -10000 0 0
GNA11 -0.003 0.048 -10000 0 -0.79 4 4
Rac1/GTP 0 0 -10000 0 -10000 0 0
Regulation of p38-alpha and p38-beta

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0 0 -9999 0 -10000 0 0
response to insulin stimulus 0 0 -9999 0 -10000 0 0
RIPK1 0 0 -9999 0 -10000 0 0
response to stress 0 0 -9999 0 -10000 0 0
MAP2K6 -0.018 0.12 -9999 0 -0.79 25 25
mol:GTP 0 0 -9999 0 -10000 0 0
MAP2K4 -0.001 0.024 -9999 0 -0.79 1 1
RAC1-CDC42/GTP/PAK family -0.12 0.14 -9999 0 -0.27 487 487
response to UV 0 0 -9999 0 -10000 0 0
YES1 -0.001 0.024 -9999 0 -0.79 1 1
interleukin-1 receptor activity 0 0 -9999 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -9999 0 -10000 0 0
MAP3K3 0 0 -9999 0 -10000 0 0
FYN -0.001 0.034 -9999 0 -0.79 2 2
MAP3K12 0 0 -9999 0 -10000 0 0
FGR -0.001 0.025 -9999 0 -0.54 2 2
p38 alpha/TAB1 -0.007 0.033 -9999 0 -0.35 3 3
PRKG1 -0.053 0.2 -9999 0 -0.79 74 74
DUSP8 -0.002 0.042 -9999 0 -0.66 4 4
PGK/cGMP/p38 alpha -0.032 0.1 -9999 0 -0.39 77 77
apoptosis -0.006 0.032 -9999 0 -0.33 3 3
RAL/GTP 0 0 -9999 0 -10000 0 0
LYN 0 0 -9999 0 -10000 0 0
DUSP1 -0.1 0.26 -9999 0 -0.79 142 142
PAK1 -0.007 0.044 -9999 0 -0.29 25 25
SRC 0 0.009 -9999 0 -0.29 1 1
RAC1/OSM/MEKK3/MKK3 0 0.006 -9999 0 -10000 0 0
TRAF6 0 0 -9999 0 -10000 0 0
RAC1 0 0 -9999 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -9999 0 -10000 0 0
mol:LPS 0 0 -9999 0 -10000 0 0
mol:cGMP 0 0 -9999 0 -10000 0 0
CCM2 -0.001 0.013 -9999 0 -0.29 2 2
RAC1-CDC42/GTP 0 0 -9999 0 -10000 0 0
MAPK11 0.018 0.068 -9999 0 -0.34 21 21
BLK -0.044 0.11 -9999 0 -0.3 159 159
HCK -0.004 0.033 -9999 0 -0.29 14 14
MAP2K3 0 0.009 -9999 0 -0.29 1 1
DUSP16 0 0 -9999 0 -10000 0 0
DUSP10 -0.001 0.015 -9999 0 -10000 0 0
TRAF6/MEKK3 0 0 -9999 0 -10000 0 0
MAP3K7IP1 0 0 -9999 0 -10000 0 0
MAPK14 0.029 0.048 -9999 0 -0.34 4 4
positive regulation of innate immune response 0.024 0.074 -9999 0 -0.36 21 21
LCK -0.02 0.1 -9999 0 -0.41 53 53
p38alpha-beta/MKP7 -0.012 0.054 -9999 0 -0.38 8 8
p38alpha-beta/MKP5 -0.012 0.054 -9999 0 -0.41 5 5
PGK/cGMP -0.041 0.15 -9999 0 -0.61 74 74
PAK2 0 0 -9999 0 -10000 0 0
p38alpha-beta/MKP1 -0.058 0.13 -9999 0 -0.41 84 84
CDC42 0 0 -9999 0 -10000 0 0
RALB 0 0 -9999 0 -10000 0 0
RALA 0 0 -9999 0 -10000 0 0
PAK3 -0.35 0.39 -9999 0 -0.79 487 487
Aurora A signaling

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A -0.026 0.031 -9999 0 -10000 0 0
BIRC5 -0.21 0.13 -9999 0 -0.29 780 780
NFKBIA -0.024 0.034 -9999 0 -10000 0 0
CPEB1 -0.15 0.31 -9999 0 -0.78 204 204
AKT1 -0.024 0.034 -9999 0 -10000 0 0
NDEL1 0 0 -9999 0 -10000 0 0
Aurora A/BRCA1 -0.024 0.033 -9999 0 -0.55 1 1
NDEL1/TACC3 -0.041 0.061 -9999 0 -10000 0 0
GADD45A 0 0 -9999 0 -10000 0 0
GSK3B 0.003 0.004 -9999 0 -10000 0 0
PAK1/Aurora A -0.03 0.04 -9999 0 -10000 0 0
MDM2 -0.001 0.02 -9999 0 -0.29 5 5
JUB -0.003 0.048 -9999 0 -0.79 4 4
TPX2 -0.11 0.1 -9999 0 -10000 0 0
TP53 -0.011 0.017 -9999 0 -10000 0 0
DLG7 -0.03 0.037 -9999 0 -10000 0 0
AURKAIP1 -0.003 0.031 -9999 0 -0.29 12 12
ARHGEF7 0 0 -9999 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -9999 0 -10000 0 0
Aurora A/NDEL1/TACC3 -0.043 0.065 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.024 0.033 -9999 0 -0.54 1 1
AURKA -0.037 0.046 -9999 0 -10000 0 0
AURKB -0.009 0.011 -9999 0 -10000 0 0
CDC25B -0.018 0.026 -9999 0 -10000 0 0
G2/M transition checkpoint -0.025 0.04 -9999 0 -0.49 4 4
mRNA polyadenylation -0.11 0.19 -9999 0 -0.52 203 203
Aurora A/CPEB -0.11 0.2 -9999 0 -0.52 203 203
Aurora A/TACC1/TRAP/chTOG -0.032 0.089 -9999 0 -0.47 42 42
BRCA1 -0.001 0.027 -9999 0 -0.46 3 3
centrosome duplication -0.03 0.039 -9999 0 -10000 0 0
regulation of centrosome cycle -0.04 0.061 -9999 0 -10000 0 0
spindle assembly -0.032 0.088 -9999 0 -0.46 42 42
TDRD7 0 0 -9999 0 -10000 0 0
Aurora A/RasGAP/Survivin -0.1 0.072 -9999 0 -0.61 1 1
CENPA -0.006 0.012 -9999 0 -10000 0 0
Aurora A/PP2A -0.026 0.031 -9999 0 -10000 0 0
meiosis 0 0 -9999 0 -10000 0 0
protein catabolic process 0.006 0.029 -9999 0 -10000 0 0
negative regulation of DNA binding -0.009 0.02 -9999 0 -10000 0 0
prophase 0 0 -9999 0 -10000 0 0
GIT1/beta-PIX -0.001 0.013 -9999 0 -10000 0 0
RASA1 0 0 -9999 0 -10000 0 0
Ajuba/Aurora A -0.025 0.04 -9999 0 -0.49 4 4
mitotic prometaphase -0.013 0.011 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.037 0.046 -9999 0 -10000 0 0
TACC1 -0.03 0.15 -9999 0 -0.79 42 42
TACC3 -0.046 0.11 -9999 0 -0.29 173 173
Aurora A/Antizyme1 -0.022 0.025 -9999 0 -10000 0 0
Aurora A/RasGAP -0.026 0.031 -9999 0 -10000 0 0
OAZ1 0 0 -9999 0 -10000 0 0
RAN 0 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
PRKACA 0.003 0.004 -9999 0 -10000 0 0
GIT1 -0.001 0.02 -9999 0 -0.29 5 5
GIT1/beta-PIX/PAK1 -0.004 0.023 -9999 0 -10000 0 0
Importin alpha/Importin beta/TPX2 -0.11 0.1 -9999 0 -10000 0 0
PPP2R5D 0 0 -9999 0 -10000 0 0
Aurora A/TPX2 -0.11 0.09 -9999 0 -10000 0 0
PAK1 -0.007 0.044 -9999 0 -0.29 25 25
CKAP5 0 0 -9999 0 -10000 0 0
Arf6 trafficking events

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 -0.44 0.39 -10000 0 -0.79 610 610
CLTC 0.027 0.018 -10000 0 -10000 0 0
calcium ion-dependent exocytosis 0.024 0.02 -10000 0 -0.18 10 10
Dynamin 2/GTP -0.007 0.028 -10000 0 -10000 0 0
EXOC4 0 0 -10000 0 -10000 0 0
CD59 0.025 0.019 -10000 0 -0.26 2 2
CPE 0.006 0.081 -10000 0 -0.53 25 25
CTNNB1 0 0 -10000 0 -10000 0 0
membrane fusion -0.002 0.019 -10000 0 -0.2 10 10
CTNND1 0.025 0.032 -10000 0 -10000 0 0
DNM2 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.029 0.014 -10000 0 -10000 0 0
TSHR -0.007 0.11 -10000 0 -0.53 49 49
INS 0.011 0.005 -10000 0 -10000 0 0
BIN1 -0.007 0.072 -10000 0 -0.74 10 10
mol:Choline -0.002 0.019 -10000 0 -0.2 10 10
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.009 0.038 -10000 0 -10000 0 0
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0 0 -10000 0 -10000 0 0
mol:Ca2+ -0.007 0.028 -10000 0 -10000 0 0
JUP 0.025 0.017 -10000 0 -0.26 1 1
ASAP2/amphiphysin II -0.004 0.045 -10000 0 -0.48 10 10
ARF6/GTP 0 0 -10000 0 -10000 0 0
CDH1 0.018 0.049 -10000 0 -0.27 28 28
clathrin-independent pinocytosis 0 0 -10000 0 -10000 0 0
MAPK8IP3 0 0.009 -10000 0 -0.29 1 1
positive regulation of endocytosis 0 0 -10000 0 -10000 0 0
EXOC2 -0.005 0.037 -10000 0 -0.29 18 18
substrate adhesion-dependent cell spreading 0 0.001 -10000 0 -10000 0 0
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0 0 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion 0.008 0.032 -10000 0 -10000 0 0
positive regulation of phagocytosis 0.018 0 -10000 0 -10000 0 0
ARF6/GTP/JIP3 0 0.005 -10000 0 -10000 0 0
ACAP1 -0.001 0.019 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 0.02 0.015 -10000 0 -10000 0 0
clathrin heavy chain/ACAP1 0.032 0.022 -10000 0 -10000 0 0
JIP4/KLC1 0 0 -10000 0 -10000 0 0
EXOC1 0 0 -10000 0 -10000 0 0
exocyst 0 0.001 -10000 0 -10000 0 0
RALA/GTP 0 0 -10000 0 -10000 0 0
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0 0 -10000 0 -10000 0 0
receptor recycling 0 0 -10000 0 -10000 0 0
CTNNA1 0.025 0.031 -10000 0 -10000 0 0
NME1 0.009 0.038 -10000 0 -10000 0 0
clathrin coat assembly 0.027 0.018 -10000 0 -10000 0 0
IL2RA 0.017 0.045 -10000 0 -0.31 16 16
VAMP3 0.018 0 -10000 0 -10000 0 0
GLUT4/clathrin heavy chain/ACAP1 -0.22 0.2 -10000 0 -0.39 610 610
EXOC6 0 0 -10000 0 -10000 0 0
PLD1 -0.003 0.032 -10000 0 -0.34 10 10
PLD2 0 0 -10000 0 -10000 0 0
EXOC5 0 0 -10000 0 -10000 0 0
PIP5K1C 0.03 0.014 -10000 0 -10000 0 0
SDC1 0.021 0.024 -10000 0 -0.35 1 1
ARF6/GDP -0.008 0.034 -10000 0 -10000 0 0
EXOC7 0 0 -10000 0 -10000 0 0
E-cadherin/beta catenin -0.008 0.033 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.002 0.019 -10000 0 -0.2 10 10
endocytosis 0.004 0.045 0.47 10 -10000 0 10
SCAMP2 0 0 -10000 0 -10000 0 0
ADRB2 -0.071 0.19 -10000 0 -0.42 253 253
EXOC3 0 0 -10000 0 -10000 0 0
ASAP2 -0.001 0.024 -10000 0 -0.79 1 1
Dynamin 2/GDP -0.007 0.028 -10000 0 -10000 0 0
KLC1 0 0 -10000 0 -10000 0 0
AVPR2 -0.13 0.22 -10000 0 -0.42 397 397
RALA 0 0 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.007 0.028 -10000 0 -10000 0 0
Osteopontin-mediated events

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, stand